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ABSTRACT 
 Cognitive behavior therapy (CBT) has proven to be an effective treatment for many 
individuals with eating disorders.  On the other hand, a substantial proportion of eating disorder 
patients fail to recover through CBT and other tested treatments.  To improve the efficacy of the 
approach, it may be helpful to add treatment elements that are effective for partially related 
conditions, such as anxiety disorders.  Therapist-assisted in vivo exposure (IVE), one of the most 
supported interventions for anxiety disorders, may reduce distress and increase self-efficacy for a 
range of foods and eating, weight, and shape situations that patients with eating disorders fear 
and avoid.  To investigate the efficacy of IVE as an additive element to CBT, a multiple-baseline 
design across behaviors was conducted using patients at a university-based outpatient eating 
disorder clinic.  For each participant, distress and self-efficacy ratings were examined at multiple 
time points before and after each IVE session.  Changes in distress and self-efficacy ratings for 
the variables targeted by each IVE were compared to variables not targeted by the exposure 
session.  As predicted, visual inspection of mean and level generally found a decrease in distress 
and an increase in self-efficacy ratings following IVE sessions; however, this pattern of change 
also often occurred for variables that were not directly targeted by the IVE.  According to visual 
inspection of trend, target variables generally did not exhibit predicted changes in slope 
following IVE sessions.  Analyses using within-subject Cohen’s d effect sizes tended to 
converge with findings from visual inspection of mean, while the adjusted R2 values computed 
via Allison’s mean plus trend difference were similar to results from visual inspection of trend.  
Although limitations with the study’s design preclude conclusions about whether IVE 
contributed to reductions in anxiety or improvements in self-efficacy specific to target variables, 
 iii 
the results suggest that challenging IVE sessions were perceived as valuable by some 
participants.  Further research is warranted to understand the efficacy of IVE, a potentially 
valuable additive component to CBT for eating disorders.  
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Introduction 
 Sir William Gull coined the term “anorexia nervosa” (AN) in 1874, and medical 
descriptions of the condition can be found as far back as 1689 (Pearce, 2004).  Despite the early 
identification of AN, surprisingly little is known about how to resolve the disorder (Walsh, 
2013).  Research over the past half century has failed to provide convincing evidence of 
improved treatments for AN (Steinhausen, 2002), in many ways providing more guidance on 
what approaches to avoid than to implement (Vitousek & Gray, 2005).  AN continues to rank 
among the most dangerous psychiatric disorders, with an estimated mortality rate of 5% 
(Steinhausen, 2009).  In contrast, clear clinical cases of bulimia nervosa (BN) did not emerge 
until the 1970s (Russell, 1997).  In a relatively short period of time, effective treatment 
approaches have been established for BN, particularly cognitive behavior therapy (CBT; 
Fairburn, 2008; Waller, 2016; Wilson, Grilo, & Vitousek, 2007).  The physical and 
psychological consequences of BN are not as severe as those of AN, with an approximate crude 
mortality rate of less than 1% (Steinhausen, 2009).  On the other hand, a substantial proportion 
of BN patients who receive CBT fail to recover (Wilson et al., 2007).  Moreover, long-term 
studies find that both BN and AN exhibit a chronic course and high relapse rates, and not 
infrequently develop into a lifelong unspecified eating disorder (Steinhausen, 2009).  
 Eating disorders are complex conditions, exhibiting symptoms of and comorbidity with 
mood, anxiety, obsessive-compulsive, impulse-control, substance use, and/or personality 
disorders (Braun, Sunday, & Halmi, 1994; Hudson, Hiripi, Pope, & Kessler, 2007; Rastam, 
1992).  Patients with eating disorders, particularly AN, also demonstrate distinctive features that 
further complicate the clinical picture and thwart successful treatment, including an intrinsic 
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motivation to maintain certain symptoms, resistance to change, physical and psychological 
consequences of semi-starvation, and the cultivation of fear as a mechanism for dieting and 
weight loss (Garner, Vitousek, & Pike, 1997; Vitousek, Watson, & Wilson, 1998; Vitousek & 
Gray, 2005).  Research investigating novel treatment approaches for eating disorders is 
undoubtedly warranted.  Evidence-based approaches for psychological conditions that overlap 
with eating disorders may serve as good candidates to investigate.  Before importing successful 
interventions for other conditions, however, the unique features of eating disorders should be 
considered.  The clinical features of eating disorder may inform whether and how interventions 
should be modified to appropriately fit this clinical population. 
Clinical Features of Eating Disorders 
 The Diagnostic and Statistical Manual of Mental Disorders – Fifth Edition (DSM-5; 
American Psychiatric Association, 2013) identifies AN, BN, and binge-eating disorder (BED) as 
the three primary eating disorders.  Unlike the feeding and eating disorders of infancy and early 
childhood, symptoms of AN, BN, and BED usually emerge in adolescence or young adulthood 
(American Psychiatric Association, 2013).  Both AN and BN are typified by core beliefs about 
the importance of weight and shape as a measure of self-worth, which contribute to the 
development of stereotyped behaviors to try to control body weight (Fairburn, Cooper, & 
Shafran, 2003).  These behaviors typically include significant dietary restraint, binge eating, 
and/or compensatory behaviors such as self-induced vomiting, laxative use, and excessive 
exercise.  Although BN is defined by binge eating and purging, these symptoms do not 
distinguish the disorder from all cases of AN: individuals with the binge-eating/purging type of 
AN also experience recurrent episodes of binge eating and/or purging, in contrast to those with 
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the restricting type of AN.  What does differentiate the diagnoses of AN and BN is body weight: 
while AN is characterized by low body weight, BN is associated with body weight at or above a 
normal range.  Both disorders disproportionately affect women, who are approximately ten times 
more likely than men to experience AN or BN.  Among young females, the twelve-month 
prevalence is approximately 0.4% for AN and 1 – 1.5% for BN (American Psychiatric 
Association, 2013).  
 Individuals who exhibit impairment from disordered eating but do not meet full criteria 
for AN, BN, or BED typically fall under the diagnostic category of “other specified feeding or 
eating disorder” (OSFED) or “unspecified feeding or eating disorder” (American Psychiatric 
Association, 2013).  Examples of presentations that are subsumed under the heterogeneous 
category of OSFED include: “atypical anorexia,” in which all criteria for AN are met but the 
individual’s weight is within or above normal limits; “bulimia nervosa (of low frequency and/or 
limited duration),” in which all criteria for BN are met but the frequency of binge-eating 
episodes and compensatory behavior is less than once per week and/or the duration is less than 
three months; and “purging disorder,” in which recurrent purging behavior occurs in the absence 
of binge eating.  Previously classified in the DSM-IV as “eating disorders not otherwise 
specified” (EDNOS), this diverse category of disorders is the most common diagnosis provided 
to adults and adolescents who exhibit disordered eating (Le Grange, Swanson, Crow, & 
Merikangas, 2012).  Evidence suggests that the clinical severity of EDNOS is comparable to that 
of AN and BN (Fairburn & Bohn, 2005). 
  Given the overlapping clinical features of AN, BN, BED, and OSFED, some experts 
within the field argue that all eating disorders should be conceptualized and treated within a 
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transdiagnostic framework (Fairburn et al., 2003).  According to the transdiagnostic view, AN, 
BN, BED, and OSFED are better understood as comprising one broad eating disorder diagnostic 
category rather than representing distinct conditions.  Support for this position comes from the 
similar behavioral and cognitive symptoms of AN, BN, and OSFED.  Additionally, individuals 
with eating disorders commonly experience variation in the severity and form of these symptoms 
over time, resulting in the “crossing over” from one diagnostic category to the other (Eddy et al., 
2008; Fairburn 2008).   
 Despite the intuitive appeal of the transdiagnostic view of eating disorders, other experts 
have maintained that meaningful distinctions exist between AN and BN that necessitate 
somewhat dissimilar treatment approaches for the two conditions (Garner et al., 1997).  Of note 
are distinct personality traits associated with AN and BN.  This is particularly true for the 
perfectionistic and obsessional traits typical of individuals with the restricting type of AN 
(Vitousek & Manke, 1994).  Individuals with AN also commonly present with distinctive 
features not usually reported by individuals with BN, including deriving a sense of stability, 
structure, and predictability (Nordbo, Espeset, Gulliksen, Skarderud, & Holte, 2006), identity 
(Tan, Hope, & Stewart, 2003), pride (Casper & Davis, 1977; Skarderud, 2007), and 
competitiveness (Leung, Waller, & Thomas, 1999) through the achievement of restraint and 
thinness.  Additionally, diagnostic crossover from the restrictive type of AN to BN or vice versa 
appears to be relatively uncommon (Eddy et al., 2008).  
 Although there are divergent perspectives on how eating disorders should be 
conceptualized within a diagnostic framework, cognitive-behavioral treatments designed to treat 
eating disorders from a transdiagnostic (e.g., Fairburn, 2008) or disorder-specific (e.g., Garner et 
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al., 1997) perspective overlap substantially.  Despite evidence for the superiority of CBT relative 
to other treatments for BN and BED (Waller, 2016), self-identified cognitive-behavioral 
therapists exhibit variability in their reported use of CBT interventions when treating eating 
disorders (Waller, Stringer, & Meyer, 2012).  It has been argued that therapist deviation from 
transdiagnostic CBT manuals for eating disorders is problematic (Waller et al., 2012; Waller, 
2016), which may be generally true when treating patients with BN or BED.  On the other hand, 
recent CBT protocols for adults with AN have demonstrated efficacy for only about 30% of 
patients in the intent-to-treat sample (Fairburn et al., 2013).  In view of these modest outcomes, 
therapist modifications to manualized CBT (e.g., increased use of motivational strategies) when 
treating adults with AN could be a sign of competent clinical judgment rather than problematic 
therapist drift. 
The Role of Anxiety in Eating Disorders 
 Comorbidity of anxiety and eating disorders.  Eating disorders exhibit high 
comorbidity with a number of other psychological conditions, including mood, obsessive-
compulsive, impulse-control, substance use, personality, and anxiety disorders (Braun et al., 
1994; Hudson et al., 2007; Rastam, 1992).  Anxiety in particular appears to be a strong risk 
factor for the development of an eating disorder (Jacobi, Hayward, de Zwann, Kraemer, & 
Agras, 2004).  For decades, researchers have noted an overlap between eating disorders and 
anxiety disorders, and evidence suggests that women with eating disorders are indeed more 
likely to have a comorbid anxiety disorder relative to normal controls (Pallister & Waller, 2008).  
While some of this comorbidity might be explained by the effects of semi-starvation, which can 
trigger anxiety and obsessive-compulsive behaviors in healthy individuals (Keys, Brožek, 
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Henschel, Mickelsen, & Taylor, 1950), symptoms of anxiety are often present prior to the onset 
of an eating disorder (e.g., Bulik, Sullivan, Fear, & Joyce, 1997; Godart et al., 2003) and thus 
cannot be explained fully by the effects of starvation.  Some researchers have posited that 
individuals with anxiety disorders and eating disorders share a common predisposition for rapid 
fear conditioning to non-threatening stimuli (e.g., certain foods), which leads to avoidance of 
these feared stimuli (Hildebrandt, Bacow, Markella, & Loeb, 2012; Strober, 2004).   
 Anxiety as a feature of eating disorders.  Not only are eating and anxiety disorders 
highly comorbid, anxiety is a prominent feature of many eating disorder symptoms, which 
contributed to early theories that conceptualized AN as a “weight phobia” or “fat phobia” (Crisp, 
1970).  Anxiety related to eating, weight, and shape has been found to be associated with binge 
eating (Arnow, Kenardy, & Agras, 1992), vomiting (Carter & Duncan, 1984), laxative abuse 
(Weltzin, Bulik, McConaha, & Kaye, 1995), calorie restriction (Chesler, 1995), and poor 
treatment compliance (Weltzin et al., 1995).  Like individuals with anxiety disorders, those with 
eating disorders also demonstrate attentional bias toward information they perceive as 
threatening (Pallister & Waller, 2008), such as words related to fatness (Rieger et al., 1998).  
Among patients with BN, it has been suggested that purging serves as an escape-avoidance 
behavior that reduces anxiety associated with overeating (Rosen & Leitenberg, 1982), and that 
binge eating serves as an escape-avoidance response from undesirable affective states (Schmidt 
& Marks, 1988).  
 Individuals with eating disorders also display “safety behaviors,” which serve to reduce 
the occurrence of feared outcomes in the short-term but inadvertently maintain anxiety in the 
long-term (Salkovskis, 1991).  Common safety behaviors used by individuals with eating 
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disorders in an effort to avoid the feared outcome of weight gain include rigid eating patterns, 
strict dietary rules and restrictions, and body checking and avoidance (Pallister & Waller, 2008).  
These safety behaviors maintain anxiety over the long-term as the non-occurrence of the feared 
outcome is attributed to the safety behavior (Salkovskis, 1991).  In other words, if an individual 
believes that eating a high-calorie food will result in uncontrollable weight gain and 
consequently avoids all high-calorie foods, then she or he will have few opportunities to 
challenge this belief, contributing to further food avoidance.  
Exposure as a Treatment for Anxiety within Eating Disorders 
 Rationale for exposure as a treatment for anxiety.  Given the apparent role of anxiety 
in the development and maintenance of eating disorders, effective treatment might be achieved 
by directly targeting anxious cognitions and avoidance behaviors in patients with eating 
disorders (Pallister & Waller, 2008).  Exposure therapy is the most effective psychological 
intervention for anxiety disorders (Abramowitz, 2013), and stands out as an obvious choice to 
treat anxiety in patients with eating disorders.   
 Traditional theories hypothesized that exposure targets fear responses through the 
behavioral mechanism of extinction (Mowrer, 1939).  Specifically, by exposing an individual to 
a feared stimulus (e.g., a snake) when the feared outcome (e.g., being harmed) does not occur, 
the association between the stimulus and fear weakens until it is eventually extinguished through 
repeated exposure trials (i.e., habituation).  According to Foa and Kozak’s (1986) emotional 
processing theory, exposure works by activating a “fear structure,” which stores information in 
memory about a stimulus (e.g., snake), response to the stimulus (e.g., fight, flight, or freeze), and 
an interpretation of the stimulus and/or response that evokes fear (e.g., “the snake will hurt me”; 
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“I must run away to guarantee my safety”).  Once this fear structure is activated from memory 
through in vivo or imaginal exposure to the feared stimulus, incompatible information is then 
incorporated into the memory (e.g., “the snake is not going to hurt me”; “I will be safe if I stay in 
the presence of the snake”), resulting in the development of a “non-fear structure.”  It is 
theorized that with repeated exposure trials this non-fear structure will replace (Foa & Kozak, 
1986), or at least compete with (Foa & McNally, 1996), the initial fear structure.  During 
exposure trials, the integration of incompatible information that reduces the valence of the fear 
structure is theorized to be evidenced by both within-session and between-session habituation.    
 Applying emotional processing theory to eating disorders, exposure should be effective 
by activating a fear structure, which might consist of a feared food item (e.g., pizza), a fearful 
response (e.g., refusal to eat pizza), and a fearful interpretation (e.g., “if I eat pizza I will become 
obese”), and then incorporating incompatible information while this fear structure is activated.  
For example, exposure might be done by asking a patient to repeatedly eat pizza (e.g., two times 
per week), which would theoretically lead to the incorporation of incompatible information (e.g., 
“I will not become obese if I eat pizza”) that replaces or competes with the initial fear structure, 
ultimately reducing fear and subsequent avoidance of pizza.   
 Despite its widespread acceptance, a growing body of research has yielded findings that 
are inconsistent with tenets of emotional processing theory, and suggest that habituation of fear 
may not be the operative process through which exposure reduces anxiety (Craske et al., 2008).  
Although more research is necessary, the literature thus far does not consistently support the 
hypothesis that higher levels of initial fear activation or greater within-session habituation during 
exposure therapy are associated with greater reductions of fear at follow-up.  Additionally, many 
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participants who undergo exposure therapy report successful outcomes while failing to exhibit 
significant between-session habituation on physiological measures (Craske et al., 2008). 
 An alternative to the fear habituation model is the Pavlovian concept of inhibitory 
learning (Bouton, 1993; Miller & Matzel, 1988).  Rather than weakening the association between 
a conditioned stimulus (CS) and unconditioned stimulus (US), exposure procedures may work by 
strengthening the inhibitory association between the CS and US.  According to the theory of 
inhibitory learning, the original feared association is not extinguished through exposure, and can 
reemerge through various means (Craske et al., 2008), such as “spontaneous recovery” which 
can occur after the mere passage of time (Baum, 1988), or “renewal” which can occur upon 
presenting the CS in a novel context (Bouton, 1993).  As inhibitory associations are more fragile 
and context-specific than excitatory associations (Myers & Davis, 2007), individuals may 
continue to experience fear at long-term follow-up even if they achieve between-session 
habituation of fear during exposure trials.  In contrast to the fear habituation model, Craske et al. 
(2008) suggest that the ability to tolerate fear may be more important than fear reduction during 
exposure therapy.  
 Although both the fear habituation and inhibitory learning models emphasize corrective 
learning as the key mechanism for change and call for treatment that exposes patients to their 
feared stimuli, the specific approach to exposure treatment differs somewhat across these 
perspectives (Craske, Treanor, Conway, Zbozinek, & Vervliet, 2014).  For example, in a 
standard fear habituation approach to exposure therapy, patients are asked to endure an anxiety-
provoking situation until their fear subsides.  An inhibitory learning approach, on the other hand, 
places the emphasis on facilitating a mismatch between patients’ expectations and experiences 
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during exposure trials.  Consequently, reductions in patients’ belief that an adverse outcome will 
occur would be a better indicator of when an exposure session should end than would reductions 
in fear.  Additionally, traditional fear habituation-based exposure procedures typically start by 
addressing a mildly to moderately anxiety-provoking item on a fear hierarchy.  Once habituation 
to this stimulus occurs, the next item up on the fear hierarchy is selected for exposure treatment, 
proceeding sequentially until habituation is achieved for all items on the fear hierarchy (Barlow 
& Cerny, 1988).  In contrast, an inhibitory learning approach suggests that it may be more 
beneficial to introduce greater variability during exposure trials, such as by conducting exposure 
to feared items in random order and by varying the stimuli present during exposure, the duration 
of exposure sessions, and the level of intensity of the exposure (Craske et al., 2014).  Consistent 
with this suggestion, increasing variability during exposure has been found to be beneficial in the 
long-term, despite lack of within-session habituation (Kircanski et al., 2012; Lang & Craske, 
2000). 
 Yet another model that attempts to explain the mechanisms of exposure treatment is 
social learning theory, which postulates that exposure is effective by modifying cognitive 
processes (Bandura, 1988).  In particular, the construct of self-efficacy, which refers to one’s 
perception of her or his ability to cope or perform a certain behavior (Bandura & Cervone, 1983), 
has been theorized to be critical for psychological change (Bandura, 1977).  A small body of 
research supports the importance of self-efficacy for behavior change in anxiety disorders.  In 
one study, participants with a phobia of heights and those with a phobia of driving who were 
randomly assigned to receive a mastery-oriented exposure treatment reported significantly 
improved behavioral functioning, self-efficacy, and anxiety ratings relative to participants who 
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received traditional exposure therapy (Williams, Dooseman, & Kleifield, 1984).  Moreover, 
perceived self-efficacy has been found to be a significantly better predictor of therapeutic 
outcome following exposure therapy than self-reported anxiety in participants with agoraphobia 
and fear of heights (Williams, Kinney, & Falbo, 1989; Williams, Turner, & Peer, 1985).  One 
study that investigated self-efficacy throughout the course of “guided imaginal coping” found 
that changes in self-efficacy predicted reductions in catastrophic thinking, but not in panic 
symptoms (Borden, Clum, & Salmon, 1991).   
 Eating disorder researchers have also suggested that improving self-efficacy may be a 
more important treatment target than extinguishing anxiety about food and eating-related 
activities (e.g., Wilson, 1988).  Indeed, self-efficacy has been found to be associated with 
reductions in binge eating and purging frequency in the treatment of BN using exposure with 
cognitive restructuring (Wilson, Rossiter, Kleifield, & Lindholm, 1986) and CBT (Schneider, 
O’Leary, and Agras, 1987).  Despite improvements in reported self-efficacy, Wilson et al. (1986) 
found no differences in participants’ heart rate, a physiological measure of fear, from pre-
treatment to post-treatment.  Like most research investigating self-efficacy ratings in response to 
exposure treatment for anxiety disorders, however, these studies assessed self-efficacy at the 
same time as other outcomes.  Thus, it may be that self-efficacy is merely correlated with 
positive treatment outcomes.  In view of these limited findings, more research incorporating 
indicators of both anxiety and self-efficacy over the course of exposure treatment is warranted. 
 Despite the apparent role of anxiety in eating disorders and extensive research supporting 
the efficacy of exposure therapy, therapist-assisted exposure is rarely conducted with eating 
disorder patients, and is absent from CBT manuals for eating disorders (e.g., Fairburn, 2008; 
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Waller et al., 2007).  The lack of therapist-assisted exposure in CBT protocols for eating 
disorders is somewhat surprising given that exposure is the most prominent cognitive-behavioral 
intervention for anxiety and avoidance.  In a sense, CBT protocols for eating disorders do 
involve exposure to feared eating and weight-related stimuli: therapists encourage their patients 
to eat regularly and eventually incorporate feared foods into their diets; discourage binge eating, 
purging, excessive exercise, and frequent weighing; and weigh patients in treatment sessions 
despite patient fears about this process (Fairburn, 2008; Waller et al., 2007).  Unlike CBT for 
many anxiety disorders, however, exposure is not an integrated feature of CBT for eating 
disorders and is rarely therapist-assisted.  With the exception of in-session weigh-ins, patients are 
expected to engage in “exposure” on their own. 
 Findings from exposure treatment for eating disorders.  Although therapist-assisted 
exposure is not currently a central component of CBT protocols, a number of studies have 
investigated the efficacy of exposure treatment for eating disorders.  Prior research has focused 
heavily on exposure and response prevention (ERP) procedures targeting binge eating (ERP-B) 
or purging (ERP-P) in BN.  Paralleling ERP treatment for obsessive-compulsive disorder (OCD), 
ERP-P exposes patients to cues that elicit vomiting (such as eating foods that typically lead to an 
urge to purge) and prevents patients from purging until their anxiety subsides.  Similarly, ERP-B 
procedures instruct patients to taste, smell, and touch foods that typically trigger a binge episode 
and concentrate on their fears and emotions, while being prevented from binge eating (Carter & 
Bulik, 1994).  As a stand-alone treatment, ERP has been shown to reduce eating disorder 
symptomatology in BN (Kennedy, Katz, Neitzert, Ralevski, & Mendlowitz, 1995; Leitenberg, 
Gross, Peterson, & Rosen, 1984; McIntosh, Carter, Bulik, Frampton, & Joyce 2011; Rosen & 
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Leitenberg, 1982; Schmidt & Marks, 1988), and may be superior to cognitive restructuring alone 
(Rossiter & Wilson, 1985; Wilson, Rossiter, Kleifield, & Lindholm, 1986) or self-control 
techniques (Jansen, Broekmate, & Heymans, 1992).  
 Despite these positive findings, research investigating the additive efficacy of ERP to 
CBT has provided mixed results.  While two studies found that the addition of ERP to CBT for 
BN resulted in improved treatment outcomes at six-month (Leitenberg, Rosen, Gross, Nudelman, 
& Vara, 1988) and five-year (McIntosh et al., 2011) follow-up, other studies indicated that the 
addition of ERP to CBT for BN failed to demonstrate any incremental benefits above and 
beyond CBT alone (Bulik, Sullivan, Carter, McIntosh, & Joyce 1998; Carter, McIntosh, Joyce, 
Sullivan, & Bulik, 2003; Wilson, Eldredge, Smith, & Niles, 1991), and may even have 
deleterious effects (Agras, Schneider, Arnow, Raeburn, & Telch, 1989).  Another study found 
that CBT for BN without exposure resulted in better outcomes than ERP without cognitive 
restructuring at one-year follow-up (Cooper & Steere, 1995).  Some researchers have concluded 
that the lack of strong, consistent findings supporting ERP as an additive intervention suggests 
that the time and effort ERP requires may not be warranted (Bulik et al., 1998). 
 Researchers have proposed a number of explanations for these inconsistent findings, 
including the variable duration and delivery of exposure across studies (Carter & Bulik, 1994).  
For example, while some ERP procedures avoided the use of any type of cognitive restructuring 
(e.g., Jansen et al., 1992), others encouraged the challenging of distorted thoughts during 
exposure (e.g., Rosen & Leitenberg, 1982).  In some protocols, the addition of exposure resulted 
in fewer sessions of CBT (e.g., Wilson et al., 1986; Wilson et al., 1991) or less time in sessions 
devoted to the non-exposure elements of CBT (e.g., Agras et al., 1989).  Additionally, exposure 
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sessions were often conducted in clinics or laboratories, and the beneficial effects of exposure 
might not generalize to the naturalistic settings where patients regularly eat such as restaurants 
(Koskina, Campbell, & Schmidt, 2013).  As noted earlier, CBT facilitates the consumption of 
regular meals, reintroduction of forbidden foods, and abstinence from binging and purging (e.g., 
Fairburn, 2008; Garner et al., 1997), which is essentially exposure between treatment sessions 
(Carter & Bulik, 1994).  By definition, individuals recovering from AN must be exposed to 
eating more food, gaining weight, and living in their heavier bodies (Murray et al., 2016; 
Vitousek, 2012).  Thus, the elements of exposure implicit in CBT may render more explicit 
exposure treatment, such as ERP for binge eating or purging, unnecessary for many patients.  
 In addition to the body of research testing ERP for BN, several studies have examined 
other exposure-based elements in the treatment of AN.  Two studies tested the effect of ERP as 
an adjunct to inpatient treatment targeting meal consumption in weight-restored patients with AN 
by exposing them to feared eating situations (e.g., holding and eating a sandwich) and preventing 
“anxiety-reducing” rituals (e.g., breaking the sandwich into small pieces; Steinglass et al., 2007; 
Steinglass et al., 2014).  ERP resulted in modest improvements in calorie intake and anxiety.  
Additionally, Family Behavior Therapy with exposure (FBT-E) has yielded encouraging results 
(Hildebrandt, Bacow, Greif, & Flores, 2013).  FBT-E incorporates exposure techniques into 
standard FBT for AN by creating a fear hierarchy of foods for the adolescent patient, instructing 
the patient’s parents to incorporate these foods into meals in a graduated fashion, preventing 
“rituals” such as weighing food or eating slowly, and monitoring distress ratings during meals.  
Despite these affirmative findings, it is unclear whether the addition of an exposure component 
to CBT or FBT for AN significantly improves outcomes.  
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 Exposure treatments designed to improve body image and related avoidance behaviors 
include mirror exposure (e.g., Hildebrandt et al., 2012), exposing patients to videos of 
themselves in the laboratory (e.g., Tuschen-Caffier, Voegele, Bracht, & Hilbert, 2003), and using 
virtual reality technology to manipulate body shape and weight (e.g., Marco, Perpiñá, & Botella, 
2013; Perpiñá et al., 1999).  Body image exposure has been found to improve behavioral, 
cognitive, and emotional indicators of body dissatisfaction, body avoidance, and other eating 
disorder symptoms in patients with BN (Delinsky & Wilson, 2010; Trentowska, Bender, & 
Tuschen-Caffier, 2013), AN (Key et al., 2002; Morgan, Lazarova, Schelhase, & Saeidi, 2014), 
BED (Hilbert, Tuschen-Caffier, & Vogele, 2002), and diagnostically diverse samples of eating 
disorder patients (Hildebrandt, Loeb, Troupe, & Delinsky, 2012; Trentowska, Svaldi, & 
Tuschen-Caffier, 2014; Trottier, Carter, MacDonald, McFarlane, & Olmsted, 2014; Vocks, 
Legenbauer, Wächter, Wucherer, & Ko, 2007).  Although body image exposure has been 
incorporated into CBT with positive outcomes, the additive efficacy of body image exposure to 
CBT has yet to be tested.  It may be the case that therapist-assisted exposure is unnecessary for 
many patients, particularly those who exhibit improved body image and reduced fear of foods 
from CBT alone. 
The Underuse of Exposure in the Treatment of Eating Disorders 
 The mixed findings from research investigating the additive efficacy of exposure may 
have contributed to the current absence of therapist-assisted exposure in CBT manuals for eating 
disorders (Koskina et al., 2013).  Moreover, there are a number of other likely reasons for the 
underuse of exposure in the eating disorder field, some of which are general to exposure 
treatments across disorders and some of which may be specific to this population. 
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 Reasons for the underuse of exposure across disorders.  Hesitancy to incorporate 
exposure into treatment is common to therapists treating the spectrum of anxiety disorders.  For 
example, a survey of therapists who treat post-traumatic stress disorder (PTSD) found that the 
vast majority never used exposure with their patients, despite strong evidence for its efficacy 
(Becker, Zayfert, & Anderson, 2004).  One practical barrier inherent in exposure treatment is that 
the intervention requires additional time and sometimes cost, and entails some logistical 
complications (Bulik et al., 1998).  If a psychosocial treatment without therapist-assisted 
exposure is effective in treating anxiety or eating disorders, then there may be no need for 
challenging exposure procedures.  
 Findings from a survey completed by PTSD clinicians suggest other reasons why 
therapists might choose to omit exposure treatment, including: inadequate training in exposure 
(Becker et al., 2004), perceptions that exposure is not a credible intervention (Devilly & Huther, 
2008), concerns that exposure will exacerbate symptoms (Frueh, Cusack, Grubaugh, Sauvageot, 
& Wells, 2006), and worries that exposure will increase the likelihood of treatment dropout 
(Cahill, Foa, Hembree, Marshall, & Nacash, 2006; Cook, Schnurr, & Foa, 2004).  In reality, 
research suggests that exposure for PTSD is not associated with high dropout or long-term 
symptom exacerbation, and appears comparably acceptable to patients relative to other 
psychological treatments (Olatunji, Deacon, Abramowitz, 2009). 
 Additionally, clinicians’ own anxieties about challenging patients may contribute to the 
underuse of exposure.  It has been suggested that therapists, including those with a cognitive-
behavioral orientation, have a tendency to avoid interventions that push for behavior change, 
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particularly if they elicit distress (Waller, 2009).  PTSD therapists, for instance, often note that 
exposure is more distressing to patients than other treatments, which contributes to their decision 
to omit the technique (Devilly & Huther, 2008).  Indeed, effective exposure requires patients to 
experience a temporary increase in distress.  As a result, well-meaning therapists may experience 
anxiety about their patients’ distress, and consequently avoid interventions that make their 
patients (and themselves) feel uncomfortable (Waller, 2009).  A therapist’s decision to avoid or 
attenuate treatment approaches that challenge patients will typically result in reduced distress for 
their patients (and the therapist) in the short-term, which serves to reinforce the therapist’s own 
avoidance behaviors.  In other words, anxiety on the part of the therapist may inadvertently lead 
to collusion with the patient at the expense of effective treatment (Waller, 2009).  
 Reasons for the underuse of exposure for eating disorders.  In addition to concerns 
that therapists have about using exposure in general, issues specific to eating disorders may also 
inhibit its application in this clinical population.  
 Normative discontent – the concept that most people are dissatisfied with their bodies 
(Rodin, Silberstein, & Striegel-Moore, 1984) – may contribute to clinicians’ avoidance of 
exposure when treating patients with eating disorders (Vitousek, 2012).  Results from the 1998 
National Health Interview Survey, a nationally representative sample of adults in the United 
States, found that 38% of women and 24% of men were trying to lose weight, with higher rates 
among individuals who are overweight or obese (Kruger, Galuska, Serdula, & Jones, 2004).  
Weight discrimination has increased since the 1990s (Andreyeva, Puhl, & Brownell, 2008) and 
messages recommending weight loss methods are pervasive, contributing to a multibillion dollar 
dieting industry (Atallah et al., 2014).  The prevalence of body dissatisfaction, weight 
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discrimination, dieting behavior, and messages about weight loss appear to have made concerns 
about weight gain normative across industrialized countries, and many people report 
experiencing some type of fear or guilt after eating certain foods.  Dieters in particular tend to 
categorize foods dichotomously as “guilt-inducing” versus “guilt free” (King, Herman, & Polivy, 
1987) and indicate experiencing greater levels of fear and/or guilt for foods that they perceive as 
higher in fat (Gonzalez & Vitousek, 2004).  Moreover, even non-restrained eaters report some 
fear and/or guilt about eating certain foods (Gonzalez & Vitousek, 2004; King et al., 1987).  It 
would be naive to think that eating disorder researchers and clinicians are immune from this 
normative discontent.  In fact, survey research indicates that eating disorder professionals are 
significantly more likely to have experienced an eating disorder than the general population 
(Barbarich, 2002; Johnston, Smethurst, & Gowers, 2005).  It may be the case that therapists 
resonate more with the fears reported by eating disorder patients (e.g., weight gain) than those 
expressed by anxiety disorder patients (e.g., fears of contamination, social rejection, panic 
attacks, heights, etc.).  In consequence, both normative discontent and personal eating disorder 
history may contribute to the avoidance of exposure treatment for eating disorders. 
 A number of other important features distinguish eating disorders from anxiety disorders.  
Experienced eating disorder researchers and practitioners may be familiar with these distinctive 
features and consequently view exposure as inappropriate for this clinical population.  One 
noteworthy distinction, especially for individuals with AN, is the functional role that fear plays 
in facilitating the highly valued goal of weight loss (Garner & Bemis, 1982).  Indeed, an intense 
fear of weight gain might be necessary for patients determined to resist their fierce hunger and 
maintain their weight loss trajectories.  As a result, many AN patients will intentionally cultivate 
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their fears related to eating and weight, and in turn value fear itself.  In contrast to those with 
anxiety or OCD, many individuals with AN exert effort to maintain their anxiety, obsessions, 
and/or compulsions.  For example, some individuals with AN memorize slogans to sustain their 
fear of weight gain.  The last line of the “Ana Psalm,” one of many motivational messages AN 
individuals might rehearse to preserve fear of weight gain, states: “I will dwell in the fear of the 
scales forever” (p. 46, Uca, 2004).  Explaining that exposure reduces fear is likely to increase 
treatment buy-in for patients with anxiety disorders; this rationale may have the opposite effect 
for those with AN (Garner & Bemis, 1982).  The uniquely functional role that fear plays for 
certain individuals with eating disorders requires attention, as it has implications for how 
exposure should be framed to patients and at what point in treatment it should be implemented. 
 Additionally, many of the behaviors that resemble anxiety-driven avoidance in AN may 
be attributable to the stereotyped effects of semi-starvation that occur in all starving people 
(Vitousek, 2012).  Prior researchers have used exposure to prevent the “anxiety-reducing rituals” 
of eating slowly or playing with food in patients with AN (Hildebrandt et al., 2014; Steinglass et 
al., 2014), and these behaviors are commonly prohibited in inpatient units for eating disorders.  
However, these behaviors occur across all starving people (Keys et al., 1950), not just those with 
AN.  Given that stereotyped starvation behaviors can persist for months following refeeding, it 
may be inappropriate to use exposure to treat these behaviors, particularly in the early phases of 
treatment.  
 Unlike most anxiety disorders, the fears associated with food and weight for individuals 
with eating disorders are often at least partially valid (Vitousek, 2012).  For patients who are 
maintaining their weight below their biological set point, eating regularly will lead to the feared 
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outcome of weight gain (Murray et al., 2016).  Additionally, binge eating and loss of control 
around eating are typical responses following a period of semi-starvation (Keys et al., 1950).  
Patients’ concerns that eating regularly will lead to out of control eating may be valid, 
particularly for patients with AN, and could call for the use of certain types of “safety signals” 
(e.g., eating no more than a predetermined amount of food) to prevent overeating during the 
process of recovery (Vitousek, 2012).  These distinctive features do not necessarily 
contraindicate the use of exposure when treating eating disorders, but should be considered when 
implementing exposure with this clinical population (Murray et al., 2016).  
The “Undershooting” of Exposure with Eating Disorders 
  In addition to the underuse of exposure for eating disorders relative to anxiety disorders, 
the way in which exposure has been conducted for eating disorders is relatively narrow in scope 
and conservative in approach (Vitousek, 2012).  Exposure treatment for anxiety disorders often 
involves overcorrection – exposure moves beyond simply “being around” the feared stimulus to 
even more challenging sessions where the patient’s specific fears are amplified or exaggerated 
(Huppert, Siev, & Kushner, 2007).  For example, in the treatment of social anxiety disorder, an 
exposure session might involve a patient making a public speech in front of an unknown 
audience.  An exposure session that overcorrects could do so by using a hostile, unreceptive 
audience during the patient’s speech (e.g., Pertaub, Slater, & Barker, 2002) in order to amplify 
the patient’s fear of negative evaluation.  A parallel example of overcorrecting might be used 
with a patient with OCD who says “God forbid” aloud as a ritual to prevent harmful things from 
happening to others.  As part of ERP, this patient might initially be asked to imagine a friend 
getting killed and be prevented from saying “God forbid.”  As exposure progressed, he might be 
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encouraged to shift to saying “God willing” out loud every time he imagines something terrible 
happening to a friend (Abramowitz, Franklin, & Cahill, 2004).  The use of overcorrection may 
strengthen the efficacy of exposure treatment by increasing patient confidence in the non-
occurrence of a feared consequence and reduce the likelihood of relapse (Huppert & Siev, 2010). 
 In contrast, exposure for eating disorders typically “undershoots,” and has seldom 
challenged patients to do more than eat feared foods or view themselves in a mirror for an 
extended period of time.  By adopting the principle of overcorrection sometimes employed in the 
treatment of anxiety disorders, therapists have the potential to use exposure in imaginative ways 
to address a wide range of situations related to eating, weight, and shape that patients fear and 
avoid.  There are some indications that scientist-practitioners are beginning to explore creative 
adaptations of exposure for eating disorders.  Levinson, Rapp, and Riley (2014) recently 
described using challenging imaginal exposure sessions to overcorrect for fear of becoming fat, 
Glasofer, Albano, Simpson, and Steinglass (2016) conducted exposure sessions targeting feared 
situations such as portioning food out of a larger container, and Trottier et al. (2015) encouraged 
patients to engage in challenging between-session exposures including eating a high energy food 
in front of a romantic interest.  These studies represent the most challenging adaptations of 
exposure in the eating disorder literature, yet none of them utilized the principle of 
“overcorrection” to the same degree as exposure treatment for anxiety disorders.  Examples of 
particularly challenging therapist-assisted exposure sessions for eating disorder patients desgined 
to overcorrect include a patient eating a regular-sized meal while a therapist orders a traditional 
“diet” meal (e.g., a small salad), or a therapist criticizing a patient’s meal (e.g., “I’m surprised 
that you are eating something that has so many calories”).  To date, no published study in the 
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eating disorder field has described or tested therapist-assisted exposure in this manner.  
Using Exposure to Support “Full Recovery” 
 A possible benefit of exposure for eating disorders is its potential to prevent relapse and 
support full recovery.  Estimates indicate that over one-third of women who recover from AN or 
BN subsequently relapse (e.g., Carter et al., 2012; Halmi et al., 2002; Keel, Dorer, Franko, 
Jackson, & Herzog, 2005).  During and after treatment, patients who are at higher risk for relapse 
have been found to exhibit: decreased motivation to recover, slower response to treatment, 
shorter periods of abstinence during treatment, increased body dissatisfaction, higher levels of 
preoccupation and ritualization of eating, more weight-related self-evaluation, increased residual 
symptoms (e.g., binging, vomiting, calorie restriction), and poorer psychosocial functioning 
(e.g., Carter et al., 2012; Freeman, Beach, Davis, & Solyom, 1985; Halmi et al., 2002; Keel et 
al., 2005; McFarlane, Olmsted, & Trottier, 2008; Olmsted, MacDonald, McFarlane, Trottier, & 
Colton, 2015).  In other words, patients who no longer meet diagnostic criteria for an eating 
disorder but continue to experience residual behavioral and/or cognitive symptoms appear to be 
at higher risk of relapse following treatment.   
 In addition to higher rates of relapse, patients who do not demonstrate full recovery from 
both the behavioral and cognitive features of eating disorders may continue to experience 
psychological difficulties.  Bardone-Cone et al. (2010) posit that: “full recovery is achieved 
when individuals with a history of an eating disorder appear indistinguishable from healthy 
controls (defined as having no history of an eating disorder) on indices reflecting behavioral and 
psychological aspects of eating disorders” (p. 195).  Bardone-Cone et al. (2010) operationally 
defined “full recovery” as scoring within one standard deviation of age-matched community 
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norms on the Restraint, Eating Concern, Weight Concern, and Shape Concern subscales of the 
Eating Disorder Examination-Questionnaire (Fairbrun & Beglin, 1994).  On all other domains, 
the fully recovered and partially recovered groups were defined in the same way: individuals in 
both groups no longer met diagnostic criteria for an eating disorder, maintained a Body Mass 
Index (BMI) of at least 18.5 kg/m2, and abstained from binge eating, purging, or fasting over the 
past three months.  Compared to the fully recovered group, individuals who achieved partial 
recovery reported more disordered eating cognitions, poorer body image, higher incidence of a 
mood disorder, and increased difficulties with psychosocial functioning in certain domains 
(Bardone-Cone et al., 2010).  It may be the case that CBT’s effectiveness is constrained by 
terminating treatment before patients have achieved a sufficient level of recovery and by an 
inadequate focus on the full spectrum of psychological symptoms experienced by patients with 
eating disorders.  Adding elements to CBT that better facilitate full recovery (e.g., normal levels 
of body satisfaction, restraint, eating behaviors, weight concerns, etc.) may be one of the keys to 
improving treatment for eating disorders.  
 Therapist-assisted exposure may provide therapists with an intervention that fosters full 
recovery, and may be particularly useful after patients have recovered from the behavioral 
symptoms of an eating disorder.  Exposure sessions occurring later in treatment might focus on a 
patient’s ritualized eating, body dissatisfaction, and weight-related self-evaluation.  Therapist-
assisted exposure might also reduce fear of social situations related to eating, weight, and shape, 
an understudied feature of eating disorders.  Even after patients improve, many experience 
difficulties in social situations related to eating, weight, and shape, which may predispose them 
to relapse.  Given that recovered patients will encounter a variety of eating-related social 
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situations after ending treatment, therapist-assisted exposure targeting highly distressing social 
situations may be effective in supporting full recovery from an eating disorder. 
 In summary, exposure can be used to target a wide range of issues that eating disorder 
patients frequently experience, including: binge eating, purging, fear and avoidance of certain 
foods and eating settings, body image, dietary rules and rituals, and social situations related to 
eating, weight, and shape.  As eating disorder patients across diagnostic categories can 
experience a number of these difficulties, the type of exposure sessions conducted will vary 
according to the specific characteristics of the patient.  In general, exposure sessions 
implemented earlier in treatment with BN patients are more likely to focus on eating foods that 
would typically trigger a binge or purge episode, earlier exposure sessions with BED patients are 
more likely to focus on foods that would trigger a binge episode, and earlier exposure sessions 
with restrictive AN patients are more likely to focus on feared and avoided foods.  On the other 
hand, eating disorder patients within the same diagnostic group improve at different rates across 
various domains.  The specific difficulties that a patient experiences throughout the course of 
treatment, rather than the patient’s diagnostic category, provide a better guide to the content of 
exposure sessions.  
Advantages of Single-Case Experimental Designs  
 No study to date has investigated the efficacy of therapist-assisted, in vivo exposure 
(IVE) for reducing anxiety or increasing self-efficacy about a range of eating-, weight-, and 
shape-related situations in patients with eating disorders.  IVE was designed as an intervention 
that may have added benefits to CBT, not as a stand-alone treatment for eating disorders.  Given 
the preliminary nature of this inquiry and the complexity of investigating the efficacy of an 
 25 
additive element to a larger treatment package, a single-case experimental design appears to be a 
fitting approach.  Single-case research involves the systematic and detailed investigation of a 
single subject, or small group of subjects, to study a specific phenomenon.  Through the 
controlled variation of a clearly specified independent variable and repeated assessment of the 
dependent variable(s), single-case experimental designs allow researchers to make inferences 
about the causal relationship between an intervention and certain outcomes (Nock, Michel, & 
Photos, 2008).  By exploring causality with a small sample, this methodological approach serves 
as a more affordable alternative to larger-scale between-group designs such as randomized 
controlled trials (RCTs; Kazdin, 2001), which may eventually be warranted to make more certain 
conclusions about the efficacy of IVE. 
The increased flexibility afforded by single-case experimental designs is another 
advantage (Nock et al., 2008) that makes this an appropriate methodological approach.  
Paralleling the flexible use of IVE in clinical practice, a single-case design allows the timing, 
frequency, and content of IVE sessions to be individualized to each participant, while 
simultaneously maintaining the scientific rigor needed to infer causality.  Attempting to establish 
pre-determined times when IVE sessions would occur (e.g., after five weeks of treatment, 
between sessions 10 and 11) is unnecessary to maintain the integrity of single-case experimental 
designs, and is inconsistent with clinical practice.  Eating disorder patients demonstrate 
substantial variation in the extent to which they reintroduce feared foods into their diet, eliminate 
self-imposed dietary rules and rituals, increase body satisfaction, and participate in anxiety-
provoking eating-related social situations and settings.  Accordingly, the timing of IVE sessions 
will also vary for each patient, in addition to the frequency, difficulty, and content of exposure. 
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Additionally, single-case experimental designs have the advantage of providing 
information about how and why individuals improve by evaluating changes in dependent 
variables over the course of treatment.  Change processes are more difficult to examine in RCTs, 
which collect data at limited time points, such as pre-treatment and post-treatment (Nock et al., 
2008).  Through the use of this time-series methodology, the efficacy of IVE as an additive 
element to CBT can be examined in specific ways that could not be done by conducting an RCT 
that, for example, compared outcomes of participants randomized to either a “CBT with IVE” or 
“CBT without IVE” condition.   
The Present Study 
The present study employed a multiple-baseline design across behaviors (Hayes, Barlow, 
& Nelson-Gray, 1999) to examine the relationship between IVE and self-reported distress about 
certain foods and eating, weight, and shape situations.  In addition to the primary outcome of 
self-reported distress, self-efficacy ratings in response to IVE were also examined, particularly in 
view of the hypothesis that self-efficacy may be more important for recovery than extinguishing 
anxiety (Wilson, 1988).  Participants were five patients receiving treatment services at the Center 
for Cognitive Behavior Therapy – Eating Disorders Clinic (CCBT-ED), an outpatient research 
and training clinic at the University of Hawai‘i at Mānoa that specializes in the treatment of 
eating disorders.  For each participant, IVE was introduced as clinically indicated at various time 
points throughout treatment.  IVE sessions targeted one or more specific anxiety-provoking 
stimuli.  According to the logic of a multiple-baseline design across behaviors, causality can be 
inferred if there is a change in the specified behavior and no change in other behaviors after 
introducing an intervention targeting the specified behavior (Nock et al., 2008).  
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As noted earlier, single-case experimental designs provide scientists and practitioners 
with a methodological approach that investigates cause-and-effect relationships without 
requiring significant modifications to clinical practice.  By using a multiple-baseline design 
across behaviors, the relationship between IVE and the outcomes of self-reported distress and 
self-efficacy about food and eating, weight, and shape situations was investigated by making 
relatively minor adjustments to treatment as usual at the CCBT-ED.  Indeed, the primary 
difference for eating disorder patients who consented to take part in the present study and 
patients who did not participate was the frequency of data collection: patients who participated 
were asked to provide data on a more frequent basis than those who did not.  
The present study also diverged slightly from typical treatment at the CCBT-ED by 
requiring a two-week delay between formulating and conducting IVE sessions for participants.  
It is worth noting, however, that the scheduling of IVE sessions, which involves planning the 
details of the session and identifying an available time and date for both the patient and IVE 
therapist, often results in a natural delay of one to two weeks.  Thus, the minimum delay of two 
weeks in the present study parallels the natural delay likely to occur in most instances. 
Additionally, ongoing data collection may have led therapists to more readily identify 
foods and/or situations that their patients reported as highly distressing.  As a result, therapists 
might have chosen to implement an IVE session targeting persistently high fear ratings for a 
specific variable, which may not have been salient in the absence of frequent assessment. 
Hypotheses 
The specific hypotheses of the present study included:   
1. Participants will report reduced distress for targeted foods and eating, weight, and 
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shape scenarios in the CBT sessions following each IVE session relative to the 
CBT sessions before each IVE 
2. Participants will not report reduced distress for unrelated foods and eating, 
weight, and shape scenarios in the CBT sessions following each IVE session 
relative to the CBT sessions before each IVE 
3. Participants will report increased self-efficacy for targeted foods and eating, 
weight, and shape scenarios in the CBT sessions following each IVE session 
relative to the CBT sessions before each IVE 
4. Participants will not report increased self-efficacy for unrelated foods and eating, 
weight, and shape scenarios in the CBT sessions following each IVE session 
relative to the CBT sessions before each IVE 
 In addition to testing these hypotheses, data from therapists and participants were used to 
conduct preliminary explorations of patterns of change in distress and self-efficacy ratings over 
time, of each participant’s reaction to IVE, and of the extent to which the effects of IVE for 
targeted domains generalize to other domains not targeted by exposure.  
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Method 
Measures 
 
CCBT-ED intake interview.  The CCBT-ED intake interview is a semi-structured 
interview developed by staff at the CCBT-ED.  The interview was designed to obtain a detailed 
history of the patient’s eating and weight concerns, the nature of the eating disorder and related 
symptoms that inform diagnosis according to DSM-5 criteria (American Psychiatric Association, 
2013), and relevant psychological, social, and physiological history.  The CCBT-ED intake 
interview assesses food restriction and avoidance, binge eating, purging, exercise, and other 
compensatory behaviors; history of eating and weight concerns; body image; frequency of self-
weighing; history of eating disorder-related medical complications; history of psychiatric 
difficulties, diagnoses, and/or hospitalizations; past and present suicidality; experiences with 
psychological treatment and medication; family circumstances, current living situation, and 
employment; and motivation for treatment.  
CCBT-ED background questionnaire.  The CCBT-ED background questionnaire is a 
10 page measure that assesses a number of demographic variables, including sex, ethnicity, age, 
religious affiliation, and marital status.  The questionnaire also asks participants to provide 
information about their living situation, family background, weight history, dieting history, 
exercise regimen, psychiatric history, drug use, sexual behaviors, medical issues, menstrual 
history, and professional background.  
 Food Phobia Survey (FPS).  The FPS is a 180-item questionnaire designed to facilitate 
the identification of foods that are desired but avoided by patients with eating disorders due to 
fear or guilt (Gonzalez & Vitousek, 2004; see Appendix A).  The measure asks participants to 
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indicate on a 5-point Likert scale the frequency within the last year with which they have eaten 
each food (from Never to Very Often), the extent to which they have feared and/or felt guilty 
about each food (from None to Very Strong), and how desirable or appealing they find each food 
independent from other considerations such as perceived healthfulness, dangerousness, and fat 
content (from Not At All to Extremely).  The FPS demonstrated high test-retest reliability for the 
number of foods designated as feared by female undergraduates, and discriminated between 
dieters and non-dieters (Gonzalez & Vitousek, 2004).  
Given that no published study has examined the psychometric properties of the FPS 
among individuals with eating disorders, a preliminary assessment of the scale’s validity was 
conducted for the present investigation.  Of 56 female patients who were administered the FPS 
while being assessed at the CCBT-ED, 53 also completed the EDI-2 and 25 were screened with 
the Eating Disorder Examination (EDE).  The sample was 76.1% Caucasian, 19.6% Asian, and 
19.6% mixed ethnicities, with a mean age of 25.0 (SD = 11.63) years.  Criterion-related validity 
was assessed by examining the extent to which the FPS was correlated with subscales from the 
EDE and the EDI-2 measuring similar constructs: the Restraint, Eating Concern, and Weight 
Concern subscales of the EDE, and the Drive for Thinness subscale of the EDI-2.  Construct 
validity was measured using the “known groups” method by comparing the mean number of 
avoided foods identified by the FPS in the present sample to the mean previously collected in a 
non-clinical sample.  Consistent with previous interpretations of the measure (Gonzalez & 
Vitousek, 2004), forbidden foods were defined as foods that were: (a) rated a 1 or 2 for 
frequency of consumption; (b) rated as a 4 or 5 for associated fear/guilt; and (c) rated as a 4 or 5 
for appeal.  
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As anticipated, the number of forbidden foods identified by the FPS was significantly 
correlated with the Restraint (r = .72, p < .001), Eating Concern (r = .45, p < .05), and Weight 
Concern (r = .55, p < .01) subscales of the EDE, and the Drive for Thinness (r = .52, p < .001) 
subscale of the EDI-2.  Additionally, the FPS identified a significantly greater number of 
forbidden foods in the eating disorder sample than in the non-clinical sample (t = 3.72, p < .001).  
These results provide preliminary psychometric evidence supporting the validity of the FPS in a 
sample of patients with eating disorders.  
IVE Scenarios Scale (IVESS).  The IVESS is a 29-item self-report questionnaire that 
was developed for the present study (see Appendix B).  Paralleling the format of fear hierarchies 
utilized in exposure treatment for anxiety (Wolpe & Lazarus, 1966), the IVESS asks participants 
to imagine a number of eating-, weight-, and shape-related scenarios and to rate how distressing 
each situation would be on a 100-point scale (with 0 representing no distress and 100 
representing the most distress imaginable).  Items include scenarios from four different domains: 
(1) eating settings, (2) eating-related social situations, (3) dietary rules and rituals, and (4) body 
image situations.  Participants were also able to write in other relevant feared scenarios not 
included on the IVESS.   
 The investigator and seven other graduate students working at the CCBT-ED under the 
supervision of Dr. Kelly Vitousek, the clinical researcher who developed this approach to IVE 
for eating disorders, initially generated a pool of prospective items for the IVESS.  Therapists 
were asked to describe all IVE sessions that they had conducted or remembered being discussed 
during clinical supervision.  The investigator compiled these items into a longer list of IVE 
scenarios and removed or revised redundant items.  Subsequently, Dr. Vitousek reviewed the list 
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and suggested the addition, removal, and modification of certain items.  Seven CCBT-ED staff 
members were then asked to evaluate the test instructions and items for breadth, quality, clarity, 
wording, and appropriateness for patients with eating disorders.  Written and verbal feedback 
from CCBT-ED staff members was used to make further decisions about the inclusion and 
wording of the items and instructions, ultimately resulting in a final version of the IVESS for the 
present study.   
 Subjective units of distress (SUDS) scale.  The SUDS scale (Wolpe & Lazarus, 1966) is 
a self-report measure that is commonly used to assess subjective distress in individuals with 
anxiety disorders, and has been used in exposure treatment for eating disorders (e.g., Gray & 
Hoage, 1990; Hildebrandt et al., 2013; Steinglass et al., 2014).  Typically, a therapist works with 
a patient to generate a list of distressing scenarios related to a feared domain.  The patient then 
rates each scenario on a scale from 0 to 100, with 0 representing no distress and 100 representing 
the maximum level of distress.  A number of these scenarios are then placed into a fear 
hierarchy, ordered from lowest to highest according to their anticipated SUDS rating.  SUDS 
have been found to be significantly associated with other self-report measures of anxiety such as 
the Multiple Affect Adjective Check List and the State-Trait Anxiety Inventory (Kaplan, Smith, 
& Coons, 1995), clinicians’ ratings of patients’ general functioning (Tanner, 2012), and 
physiological indicators of distress such as heart rate and digit temperature (Thyer, Papsdorf, 
Davis, & Val, 1984).   
 While some adult patients with social anxiety disorder exhibit relatively static reductions 
in SUDS during exposure sessions, others report substantial within-session variation in SUDS 
(Hayes, Hope, & Heimberg, 2008).  In two single-subject designs investigating exposure 
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treatment for children with choking phobia, patients exhibited moderately fixed reductions in 
distress ratings between treatment sessions when averaging SUDS across several different food 
items (Chorpita, Vitali, & Barlow, 1997; Scemes, Wielenska, Savoia, & Bernik, 2009).  A 
generally steady decreasing trend in SUDS between sessions was also found across four children 
in a multiple-baseline design evaluating parent-assisted ERP for OCD when averaging the items 
on fear hierarchies (Knox, Albano, & Barlow, 1996).  Similarly, relatively stable SUDS ratings 
have been observed during the baseline phase of a single-subject design evaluating flooding for 
an adult female with a phobia of public transportation (Hayes & Barlow, 1977).   
 A small number of studies suggest that individuals with eating disorders may exhibit 
greater variability in distress ratings over time relative to patients with anxiety disorders.  
Individuals with eating disorders commonly report higher SUDS during and after exposure 
sessions targeting feared foods (Boutelle, 1998; Carter, Bulik, McIntosh, & Joyce, 2002), which 
tend to progressively reduce over the two hours following the exposure (Gray & Hoage, 1990). 
 Self-efficacy ratings.  Similar to the self-efficacy scales developed by Bandura, Taylor, 
Williams, Mefford, and Barchas (1985), the present study measured self-efficacy by asking 
participants to rate how certain they were that they could handle eating particular foods or 
participating in certain situations on a scale from 0 (highly uncertain) to 100 (completely 
certain).  Self-efficacy ratings have been found to be associated with positive therapeutic 
outcome (Williams, 1992), reduced anxiety and avoidance (Jones & Menzies, 2000), better 
behavioral performance in exposure trials (Zoellner, Echiverri, Craske, 2000), reduced 
physiological indicators of stress (Bandura et al., 1985), and improvements in the immune 
system (Wiedenfeld et al., 1990). 
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 Eating Disorder Examination – Self-Report Questionnaire Version (EDE-Q).  The 
EDE-Q (Fairburn & Beglin, 2008) is a self-report version of the widely used EDE (Fairburn & 
Cooper, 1993).  The EDE-Q consists of 4 subscales measuring the cognitive features of eating 
disorders over the past 28 days: Restraint, Eating Concern, Shape Concern, and Weight Concern.  
In addition, the EDE-Q assesses the behavioral symptoms of eating disorders, including 
frequency of binge eating, self-induced vomiting, laxative use, and “compulsive” exercise.  Test-
retest reliability of the EDE-Q has been evaluated in a sample of undergraduate women (Luce & 
Crowther, 1999) and a sample of men and women seeking treatment for BED (Reas, Grilo, & 
Masheb, 2006).  With the exception of subjective binge episodes, test-retest coefficients ranged 
from 0.51 to 0.94 for the various subscales and behavioral frequency items (Berg, Peterson, 
Frazier, & Crow, 2012).  The EDE-Q has also demonstrated acceptable internal consistency 
across four studies, adequately detected differences between eating disorder and control groups 
in four studies, and converged with instruments measuring similar constructs and daily food 
records in three studies (Berg et al., 2012).  
 Body Shape Questionnaire – 8-Item Version (BSQ-8).  The BSQ-8 (Evans & Dolan, 
1993) is a shortened version of the lengthier 34-item self-report measure of body dissatisfaction 
developed by Cooper, Taylor, Cooper, and Fairburn (1987).  Four different versions of the BSQ-
8 demonstrated good internal consistency in a nonclinical female sample, with alpha values 
ranging from .87 to .92 (Evans & Dolan, 1993).  Additionally, the four versions of the BSQ-8 
exhibited virtually identical convergent and divergent validity as a 16-item version of the scale.  
One of the four versions of the BSQ-8 demonstrated the most sensitivity to change in a sample of 
BN patients who completed the measure before receiving therapy and after six weeks of CBT 
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(Pook, Tuschen-Caffier, & Brähler, 2008), and was the version selected for the present study.  
The BSQ has demonstrated: good concurrent and discriminant validity in a community sample of 
young women and in patients with BN (Cooper et al. 1987); good test-retest reliability, 
concurrent validity with other measure of body image, and criterion validity in a nonclinical 
sample of college students, obese individuals seeking weight reduction, and clinical subjects 
referred for body image difficulties (Rosen, Jones, Ramirez, & Waxman, 1996); and sensitivity 
to change in women receiving CBT for BN (Pook & Tuschen-Caffier, 2004). 
 Fear of Food Measure (FOFM).  The FOFM is a 23-item self-report instrument 
designed to assess changes in anxiety and avoidance behaviors in eating disorder patients 
following exposure treatment (Levinson & Byrne, 2014).  The FOFM has three subscales: (1) 
“Anxiety about Eating,” which was designed to measure trait level fear of food and anxiety about 
eating; (2) “Food Avoidance Behaviors,” which was designed to measure the anxiety-related 
avoidance behaviors commonly observed in individuals with eating disorders; and (3) “Feared 
Concerns,” which was designed to measure the maladaptive thoughts and core beliefs associated 
with food anxiety.  The FOFM exhibited a good three-factor structure and convergent and 
divergent validity in two samples consisting of undergraduate females and women in the 
community (Levinson & Byrne, 2014).  Individuals diagnosed with an eating disorder exhibited 
higher scores on the FOFM than matched controls.  Additionally, the FOFM was associated with 
food intake and anxiety during an exposure meal and significantly decreased over the course of 
four exposure sessions in a clinical sample of patients with eating disorders (Levinson & Byrne, 
2014). 
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IVE Feedback Form.  To obtain more global and open-ended information about 
participants’ experiences with IVE sessions, the IVE Feedback Form was created (see Appendix 
C).  This measure includes four Likert-type items asking participants to rate the utility of IVE 
sessions on a scale from 1 (strongly disagree) to 7 (strongly agree) and four open-ended 
questions about participants’ experiences with IVE.  This measure was administered several 
weeks after participants completed their final IVE session, typically at the end of treatment.   
 CCBT-ED Therapist Checklist.  To track the specific CBT interventions employed 
during each treatment session, a checklist delineating a number of different possible 
interventions was created for the present study (see Appendix D).  The CCBT-ED Therapist 
Checklist instructs therapists to endorse which interventions were implemented during each 
treatment session.  The specific interventions are organized into eight general categories: (1) 
Psychoeducation and Treatment Rationale, (2) Enhancing Motivation and Specific Strategic 
Techniques, (3) In-Session Weighing, (4) Self-Monitoring, Meal Planning, and Interrupting the 
Binge-Purge Cycle, (5) Cognitive Interventions Addressing Eating, Weight, and Shape 
Concerns, (6) Behavioral Interventions Addressing Eating, Weight, and Shape Concerns, (7) 
Cognitive and Behavioral Interventions Addressing Concerns other than Eating, Weight, and 
Shape, and (8) Relapse Prevention.  The CCBT-ED Therapist Checklist also directs therapists to 
document the patient’s weight and note the number of times the patient reported engaging in 
objective binges, subjective binges, and purging episodes since the last treatment session.  The 
CCBT-ED Therapist Checklist was created by the investigator and reviewed by the clinical 
supervisor and seven other graduate students at the CCBT-ED.  Ongoing feedback from CCBT-
ED staff resulted in additional revisions to the instrument.   
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 IVE Form.  To record the details of each IVE session, an IVE Form was created for the 
present study (see Appendix E).  The primary investigator completed the front side of each IVE 
Form when discussing details of an upcoming IVE session with the clinical supervisor and 
primary therapist(s).  The front side of each IVE Form was completed at least two weeks before 
the scheduled IVE session, and includes: the date when the IVE session was initially formulated, 
the specific item(s) on the participant’s fear hierarchies that the IVE aims to address, the foods 
and/or scenarios that might be expected to demonstrate generalization effects from the IVE, the 
foods and/or scenarios that are not expected to demonstrate generalization effects from the IVE, 
and a description of the decision-making process that occurred when setting up the IVE.  The 
IVE therapist completed the back side of this form after each IVE session.  The back of the IVE 
Form includes information about the date of the IVE session, the content and length of the IVE 
session, and the participant’s SUDS ratings before, during, and after the exposure.  The 
investigator obtained feedback about the measure from the clinical supervisor and seven other 
graduate students at the CCBT-ED and made revisions accordingly.  
Procedure 
Intake protocol.  Referrals to the CCBT-ED usually come from the university’s 
counseling and student development center, medical and mental health providers in the 
community, or by self-referral for individuals who become aware of the clinic through flyers, 
brochures, or the clinic’s website.  The CCBT-ED clinic typically has a caseload of 
approximately eight patients at any given time.  Unfortunately, the CCBT-ED had a lower 
patient census during the time of data collection for the present study, with a caseload of five 
patients or fewer throughout this period.  Consistent with past recruitment strategies at times of 
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low patient flow, the investigator placed flyers and/or brochures detailing the clinic’s services 
around the University of Hawai‘i at Mānoa’s campus and the city of Honolulu, and contacted 
high school counselors in Honolulu to provide information about the clinic’s services.  
Regrettably, these recruitment approaches did not contribute to the attainment of any additional 
study participants.  
Prior to scheduling an appointment with the CCBT-ED, all participants completed a 
phone screen conducted by one of the clinic’s therapists.  Therapists at the CCBT-ED were 
master’s or doctoral students in the Clinical Studies Program at the University of Hawai‘i at 
Mānoa who were enrolled in the CCBT-ED clinical practicum.  All interested patients who 
completed a phone screen during the time of the current evaluation were considered eligible for 
an assessment at the CCBT-ED.  After acquiring the patient’s consent, one to two CCBT-ED 
therapists conducted an assessment which included: administration of the CCBT-ED intake 
interview; measuring the patient’s height and weight; completion of the CCBT-ED background 
questionnaire, EDE-Q, BSQ-8, FOFM, FPS, IVESS, and other clinic measures; providing 
feedback to the patient about her condition, including any relevant DSM-5 diagnoses; and a 
discussion of treatment options.  Additionally, therapists obtained consent and discussed 
treatment options with the parents of the two patients who were below the age of 18. 
During the final assessment session, the therapist(s) who conducted the evaluation 
provided patients (and, for the two minors, their legal guardians) with information about the 
current investigation and reviewed an Institutional Review Board-approved consent form (see 
Appendix F and Appendix G).  An assent form was reviewed with and signed by the two 
participants under the age of 18 (see Appendix H).  All patients assessed at the CCBT-ED during 
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data collection were deemed eligible for treatment and consented to participate in the present 
study.  No patient refused to participate or dropped out of the study.  Assessment and treatment 
were provided at no cost to participants.   
CBT protocol.  CBT was provided by clinic therapists, who were graduate students who 
had received at least one year of specialized training in CBT and eating disorders.  This training 
is conducted by Dr. Vitousek and consists of attendance in clinical supervision at the CCBT-ED, 
participation in ongoing didactic presentations relevant to eating disorders, and completion of at 
least one university seminar course in CBT.  All clinic therapists received ongoing weekly 
supervision from Dr. Vitousek, who is an expert in the field of eating disorders and one of the 
first researchers to adapt CBT for AN (Garner & Bemis, 1982).  In contrast to clinical trials 
evaluating CBT for eating disorders (e.g., Fairburn, 2008), treatment at the CCBT-ED does not 
involve a pre-determined sequence of interventions or set number of sessions.  Paralleling the 
way that CBT is typically conducted in clinical practice, treatment entailed the flexible use of 
cognitive, behavioral, and motivational approaches.  Patients received an average of one to two 
CBT sessions per week.  
Rather than adhering to a specific treatment manual, therapists at the CCBT-ED treated 
patients using behavioral, cognitive, and motivational interventions as informed by manuals and 
articles describing CBT for eating disorder (e.g., Garner et al., 1997; Fairburn, 2008; Waller et 
al., 2007) under the supervision of Dr. Vitousek.  The specific cognitive-behavioral interventions 
implemented by therapists at the CCBT-ED fall under eight general domains: (1) 
Psychoeducation and Treatment Rationale, (2) Enhancing Motivation, (3) In-Session Weighing, 
(4) Self-Monitoring, Meal Planning, and Interrupting the Binge-Purge Cycle, (5) Cognitive 
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Interventions Addressing Concerns Related to Eating, Weight, and Shape, (6) Behavioral 
Interventions Addressing Concerns Related to Eating, Weight, and Shape, (7) Interventions for 
Comorbid Difficulties, and (8) Relapse Prevention.  The IVE Form (see Appendix E) includes a 
list of specific interventions within each of these eight domains.  Throughout all aspects of 
treatment, therapists also implemented basic CBT elements, including: setting and maintaining 
an agenda, Socratic questioning, identifying treatment goals, conducting joint reviews of 
progress, assigning homework, building a positive therapeutic alliance, being empathetic and 
validating, taking an experimental approach to treatment, and encouraging the patient to become 
her or his own therapist (Waller et al., 2007; Vitousek et al., 1998). 
IVE protocol.  IVE therapists were graduate students enrolled in the CCBT-ED 
practicum.  With the exception of Participant 4’s IVE session, all patients met with a different 
provider from their primary therapist for IVE sessions.  The frequency and timing of IVE 
sessions varied by patient, depending on when it was deemed clinically indicated to target a 
specified eating, weight, or shape scenario. 
Exposure therapists adhered to an IVE protocol created by Dr. Vitousek.  Each IVE 
session had a predetermined purpose that was apparent to both the therapist and patient.  In order 
to facilitate natural eating situations, all but one of the sessions occurred in real-world settings 
such as restaurants.  The specific details of each IVE were established collaboratively between 
the patient and therapist in prior CBT sessions.  After discussing the details and goals of the 
exposure session with the patient, the primary therapist communicated all relevant information to 
the IVE therapist.  
At the start of each exposure session, the IVE therapist confirmed the details of the 
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session with the patient, including where they would be going, what each would be eating, and 
other specifics relevant to the session.  IVE therapists also inquired about the patient’s 
predictions for how the session will go, and obtained SUDS ratings before, throughout, and after 
the IVE session.  In order to model appropriate social eating behavior while simultaneously 
encouraging the patient to persist through an anxiety-provoking situation, IVE therapists were 
trained to use an interactive style that is somewhere between social and conventionally 
therapeutic.  In general, discussions during IVE sessions are similar to conversations one might 
have with someone she or he recently met, and often involved a substantial amount of “small 
talk.” 
Duration varied across exposure sessions, with an average length of approximately 60 
minutes.  At the end of each session, the IVE therapist debriefed with the patient, which included 
a discussion of the accuracy of the predictions made before the exposure, aspects of the session 
that went particularly well or poorly, anticipated reactions over the next several hours, and 
confidence in ability to adhere to the meal plan for the rest of the day.  Additionally, the IVE 
therapist typically congratulated the patient on completing the exposure session.  A more detailed 
debriefing of the exposure session occurred with the primary therapist during the patient’s next 
CBT session.  
At some point before the first IVE, the primary therapist(s) and patient discussed 
strategies for maintaining confidentiality during the exposure session, and subsequently relayed 
this information to the IVE therapist.  Consistent with recommendations from other clinical 
psychologists (Olatunji et al., 2009), the primary therapist(s) and patient decided to implement 
one or more strategies to protect patient confidentiality during IVE sessions.  It is common for 
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patients to choose a “cover story” to explain their relationship with the IVE therapist in case 
either party encounters acquaintances during the exposure session.  For instance, the patient may 
ask the IVE therapist to introduce herself or himself to acquaintances as a friend, colleague, 
relative, or tutor.  The IVE therapist also works to be inconspicuous when doing anything that 
might “out” the patient or IVE therapist to others.  IVE therapists typically asked for SUDS 
ratings or checked on the patient’s anxiety in subtle ways that would not appear out of context to 
others in the setting.  The patient and IVE therapist sometimes developed “codes” for certain 
clinical questions and answers (e.g., asking “How are you feeling now?” rather than “What is 
your distress rating now?”).    
Assessment protocol.  Following the patient’s completion of the FPS during the 
assessment phase, the investigator identified all items on the measure that met criteria as a 
“forbidden food” (Gonzalez & Vitousek, 2004) and placed these foods on an extensive food 
hierarchy.  Before or shortly after her first CBT session, the patient was asked to complete this 
extensive food hierarchy by rating each food item on a scale from 0 (no distress) to 100 (most 
distress imaginable).  Patients were asked to complete the extensive food hierarchy and IVESS 
approximately every six weeks.  Through repeated administration of these two measures, all 
forbidden foods and eating, weight, and shape scenarios were assessed at regular intervals 
throughout treatment.  
Given that patients may provide inaccurate or incomplete information to clinicians, 
especially at the start of treatment, provisions were made in the protocol to allow for the re-
administration of the FPS as warranted.  Inaccurate self-reporting appears particularly likely 
among patients with AN, who may conceal and/or downplay their symptoms from others 
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(Vitousek, Daly, & Heiser, 1991), deny the severity of their symptoms to themselves (Vitousek 
& Strumpf, 2005), or over-represent what they are eating in their food records during treatment 
(Wilson & Vitousek, 1999); at low weight, some may also experience starvation-related 
impairment in thought content and abstraction (Keys et al., 1950).  Although typically less 
invested in maintaining their symptoms, some patients with BN value dieting and purging as 
methods of weight control (Vitousek et al., 1998) and may consequently conceal information 
from therapists.  BN individuals may also deny and/or underreport symptoms due to feelings of 
shame (Vitousek et al., 1991).  Although there is reason to doubt the accuracy of self-report data 
collected from at least one participant in the present study with an atypical AN diagnosis, there 
were no indications that patients were being dishonest about the severity of their symptoms at 
intake, and thus the FPS was not re-administered to any study participant.  
Several weeks before each participant’s first IVE session was scheduled to occur, the 
investigator, therapist, and clinical supervisor worked together to create two shorter fear 
hierarchies for each participant.  The short food hierarchy consisted of at least five items from 
the extensive food hierarchy (see Appendix I for a sample short food hierarchy), while the short 
scenario hierarchy consisted of at least five eating, weight, and shape scenarios from the IVESS 
(see Appendix J for a sample short scenario hierarchy).  For the short food hierarchy, the 
investigator, therapist, and clinical supervisor identified at least five foods from the extensive 
food hierarchy with some of the highest SUDS ratings that appeared to be potential targets for 
IVE.  Similarly, the five or more items selected from the IVESS for the short scenario hierarchy 
consisted of those rated as most distressing and address a broad range of scenarios, including 
eating settings, social situations, dietary rules and rituals, and body image situations.  
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For the several weeks before and after each IVE session, participants were given the short 
food hierarchy and the short scenario hierarchy at each CBT session and asked to rate each item.  
The SUDS and self-efficacy ratings of these items were tracked at a number of CBT sessions 
before and after each IVE session.  As IVE did not entail gradual exposure from the lowest 
feared items to the highest feared items, the foods and scenarios on the short fear hierarchies 
were placed in random order rather than being ordered by SUDS ratings.  
Ratings from fear hierarchies were obtained at the start of each CBT session to increase 
confidence that any changes in SUDS and self-efficacy were attributable to mechanisms initiated 
prior to the CBT session.  Additionally, the short fear hierarchies were administered during CBT 
sessions, rather than IVE sessions, to investigate long-term habituation.  Changes in SUDS 
ratings within IVE sessions were also assessed to explore the relationship between within-session 
reductions in anxiety and between-session habituation (Foa & Kozak, 1986).  IVE therapists 
tracked SUDS ratings at least once before, during, and after each IVE.  The IVE therapist 
documented these ratings on the IVE Form following each exposure session.  
In addition to the foods and scenarios tracked before the first IVE session, other items 
were added to the short fear hierarchies at later points.  Foods and scenarios that continued to be 
highly distressing as treatment proceeded were considered especially good candidates for IVE 
sessions.  Thus, at different points throughout treatment, food items from the extensive food 
hierarchy were added to the short food hierarchy and scenarios from the IVESS were added to 
the short scenario hierarchy. 
Following every CBT session, the primary therapist(s) completed the CCBT-ED therapist 
checklist indicating which CBT interventions were implemented.  To assess treatment integrity, 
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Perepletchikova and Kazdin (2005) recommend that multiple treatment sessions be randomly 
observed and analyzed from each phase of treatment.  Consistent with this guideline, the 
principal investigator randomly selected one audio recording from every ten CBT sessions for 
each participant.  One audio recording was randomly selected from CBT sessions 1 – 10, a 
second from CBT sessions 11 – 20, a third from CBT sessions 21 – 30, and so on until the final 
treatment session.  While listening to each audio recording, the principal investigator completed 
a CCBT-ED therapist checklist for the session.  These investigator-rated checklists were then 
compared to those completed by the primary therapist(s) to assess for interrater reliability.  The 
primary therapists also used the CCBT-ED therapist checklist to track the frequency of 
subjective binge, objective binge, and purging episodes reported by the participant at every 
session. 
Figure 1 provides a simplified illustration of the present study’s assessment protocol and 
design.  The graph represents SUDS for six variables as rated by one hypothetical participant 
throughout 40 sessions of CBT.  Three of these variables, labeled as letters, represent three 
feared foods.  The other three variables, labeled as numbers, represent three feared eating, 
weight, and shape scenarios.  The x-axis represents the number of days the participant has been 
receiving services at the CCBT-ED since completing the IVESS and/or extensive food hierarchy.  
The vertical dashed lines indicate when an IVE session occurred.  The boxes adjacent to the 
vertical lines specify the variable(s) that each IVE session targeted.  In this example, variable B 
was targeted during the first IVE session, variable 3 was targeted in the second IVE session, and 
variables A and 2 were targeted in the third IVE session. 
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Figure 1.  Illustration of data from a hypothetical participant in the present study. 
 
 
Figure 1 Note.  A, B, and C represent three hypothetical foods.  1, 2, and 3 represent three 
hypothetical eating, weight, and shape situations. 
SUDS = Subjective units of distress 
IVE = In vivo exposure 
 
As illustrated in Figure 1, the patient initially rated all six of these variables at day 1.  The 
three foods (variables A, B, and C) were identified as “forbidden” according to the patient’s FPS. 
The SUDS of the three scenarios (behaviors 1, 2, and 3) at day 1 correspond to the patient’s 
ratings of these three items on the IVESS that we completed during assessment.  On day 25, 
several weeks before the first IVE session, three variables were added to the short fear 
hierarchies and tracked at each following CBT session: variables A, B, and 1.  Variables A and B 
represent two food items that were identified for the short food hierarchy, and variable 1 
represents an eating, weight, and shape scenario included in the short scenario hierarchy.  
Additionally, three other variables were identified at later points in treatment: variable 2 was 
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added to the short scenario hierarchy at day 57, variable 3 was added to the short scenario 
hierarchy at day 71, and variable C was added to the short food hierarchy at day 95.  As shown in 
the figure, data for variables 2, 3, and C were also collected during day 1, and at every six weeks 
(i.e., at days 43 and 85).   
Participants 
 Participants consisted of five patients between the ages of 14 – 46 who received treatment 
at the CCBT-ED.  Two participants were Caucasian, two were mixed Caucasian and Asian, and 
one was mixed Caucasian, Asian, and Pacific Islander.  All five CCBT-ED patients who were 
offered participation in the present study consented.  Two additional patients provided consent 
but were excluded from the study as they did not receive IVE sessions.  One of these two 
patients dropped out of treatment before an IVE was scheduled, and the other reported virtually 
no distress and maximum self-efficacy for all foods and situations measured.   
 All participants were female and met criteria for OSFED.  While most patients who 
receive services at the CCBT-ED meet full criteria for AN, BN, or BED, there was an atypical 
absence of these groups of patients during the study period.  Moreover, additional information 
suggests that study participants exhibited less severe eating disorder psychopathology than the 
patients typically treated at the CCBT-ED: Participant 2 reported scores within one standard 
deviation of the normal range on the EDE-Q and BSQ-8 during intake, only Participants 4 and 5 
had multiple foods with SUDS ratings greater than 50, and Participants 2 and 4 had received 
treatment at another clinic before transitioning to the CCBT-ED.  Additional details about each 
participant are described in the Results section.  Information that could contribute to the 
identification of any participant was omitted and/or obscured.     
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Design 
A multiple-baseline design across behaviors with five participants was employed.  IVE 
was implemented at various time points throughout treatment to target one or more specific 
anxiety-provoking stimuli.  The SUDS and self-efficacy ratings for the variables targeted by IVE 
were monitored before and after the implementation of each IVE session (see Assessment 
Protocol).  Additionally, variables not targeted by IVE were also monitored throughout 
treatment.  If there is a reduction in SUDS and/or increase in self-efficacy ratings for a certain 
food following an IVE session targeting that food and no reductions in SUDS and/or increase in 
self-efficacy ratings for other foods or scenarios to which generalization is not anticipated, it can 
be inferred that the IVE session caused the change in the self-reported ratings.  The conclusion 
that IVE led to the hypothesized change would be further strengthened by the replication of 
treatment effects across different variables and participants.  
The multiple-baseline design employed for the current investigation is illustrated with the 
hypothetical data presented in Figure 1.  In this example, the first IVE session, occurring 
between days 36 and 39, targeted variable B, a specific food item.  SUDS for the item targeted 
by the first IVE session (variable B) and the items not explicitly targeted by this IVE session 
(variables A and 1) have been tracked since day 25.  Following the IVE session targeting 
variable B, there were substantial changes in the SUDS ratings for variable B and minimal to no 
changes for variables A and 1.  Thus, it could be inferred that the first IVE session caused a 
change in variable B.  In this example, the efficacy of IVE in reducing specified SUDS ratings is 
strengthened by the replication of treatment effects across different variables.  For example, 
following the second IVE session, which targeted variable 2, there were substantial reductions in 
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SUDS for variable 2, with little to no changes in variables A, B, 1, and 3, increasing confidence 
that IVE sessions led to reductions in SUDS for specified variables. 
IVE sessions were designed to address one or two primary variables.  For instance, 
Participant 3 ate a meal with an unfamiliar person (an IVE therapist she met for the first time) 
during her first IVE session, which focused on reducing anxiety in one domain: eating a meal 
with an unfamiliar person.  During her second IVE session, she ate a meal with a new IVE 
therapist who made critical comments about the high fat and calorie content of her meal.  This 
IVE session addressed two variables: eating a meal with an unfamiliar person and receiving 
critical comments about a meal she was eating.  
Prior to all IVE sessions, the one or two primary variables that the exposure aimed to 
address and the one variable that the exposure was considered unlikely to be affected by the 
exposure were documented on the IVE Form by the investigator.  If the specified primary 
variable(s) exhibited a change in the predicted direction following an IVE session, and there was 
no change in the variable identified as unrelated, it could be inferred that the IVE session led to 
the change in the target variable(s).  
Consonant with the flexible use of exposure at the CCBT-ED, the investigator, individual 
therapist, and clinical supervisor decided when each IVE session was implemented according to 
clinical judgment.  The investigator documented the decision-making process used to determine 
the timing and content of each IVE session at least two weeks before the exposure on the IVE 
Form. 
The data collected from repeated assessment were also used to assist in the determination 
of the content and timing of IVE sessions.  It is unnecessary to use an IVE session to target foods 
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and situations for which patients report improved ratings throughout the course of CBT, such as 
variable A in Figure 1.  Instead, IVE sessions targeted the specific foods and situations that 
participants continued to report as challenging, as indicated by SUDS and self-efficacy ratings on 
the short fear hierarchies.  Data collected from repeated assessment informed the number of IVE 
sessions that were employed to address different domains.  This data-driven approach 
complemented clinical judgment and the individual preferences of the patient to determine the 
timing, frequency, content, and difficulty of IVE sessions, all of which were documented by the 
investigator on the IVE Form.  
A potential limitation of this flexible approach was the confounding of time with 
investigator and participant bias, as IVE sessions could have inadvertently been implemented at 
times when participants would have improved regardless of whether or not they participated in 
an exposure session.  As an example, imagine that a participant in therapy reported increased 
confidence in her ability to eat anxiety-provoking foods, and that the therapist and patient 
collaboratively decided to set up an IVE session targeting one of these foods (e.g., lasagna) for 
the next week.  If the patient’s SUDS ratings for lasagna was significantly lower following the 
IVE, it would be unclear whether the participant’s change in SUDS was due to the IVE or to the 
opportune time selected by the therapist and participant to implement the IVE.  To address this 
potential confound, a delay of two weeks occurred between the time that the investigator and 
therapist (in collaboration with the patient) decided to set up an IVE session and when the IVE 
session was actually implemented.  The investigator documented the date at which each IVE 
session was planned on the IVE Form. 
Another concern with the present study’s design was the likelihood for generalization of 
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treatment effects across non-target variables.  With multiple-baseline designs across behaviors, 
causality is more convincingly demonstrated when there is no change in behaviors until the 
intervention targeting that behavior is applied (Nock et al., 2008).  In other words, if there are 
changes in variables A, B, and C following an IVE solely targeting variables A, confidence in 
the causal relationship between IVE and the change in variable A is reduced.  Changes in 
variables B and C following an IVE targeting variable A could be due to generalization effects, 
or others factors such as stressors in the patient’s life, timing, or non-exposure treatment 
elements.  In particular, it seems likely that an IVE targeting a food item (e.g., pizza) may lead to 
reductions in SUDS ratings for several other food items (e.g., pasta, white bread, grilled cheese 
sandwich).  It is also probable that IVE session targeting a specified eating, weight, or shape 
scenario (e.g., eating a meal with unknown calorie and nutritional properties) might lead to 
reductions in self-reported anxiety across a number of other scenarios (e.g., eating a larger meal 
than someone else), with some exceptions (e.g., receiving critical comments about a meal while 
eating).   
To address the issue of generalization, variables that appeared likely to yield 
generalization of treatment effects from IVE targeting other variables – heretofore referred to as 
related variables (RVs) – were identified and documented on the IVE Form prior to the 
implementation of each IVE session.  In order to maintain the logic of a multiple-baseline design 
across behaviors, changes in the target variable (TV) were compared to the changes (or lack 
thereof) in other behaviors.  However, the primary focus for comparison were behaviors not 
identified as being likely to experience generalization effects, or unrelated variables (UVs).  In 
other words, after introducing an IVE targeting a TV, causality can be inferred if there is a 
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change in the TV and no change in the UV.  While there were no specific hypotheses about the 
SUDS ratings of RVs, these variables were examined before and after each IVE session and 
described in a post-hoc, exploratory fashion. 
Data Analysis 
Visual inspection.  Interpretation of single-case experimental designs has traditionally 
relied on visual inspection of data (Hayes et al., 1999), rather than the inferential statistics used 
with group comparison designs.  While visual inspection of data has been criticized for 
permitting multiple interpretations of data, causal effects need to be strong enough and clinically 
significant in order to be detected via visual inspection (Nock et al., 2008).  As a result, visual 
inspection of data is less likely to result in a Type I error and tends to be a more conservative 
approach than inferential statistics for inferring causality.  Indeed, a limitation of visual 
inspection is that small but potentially meaningful effects can go unnoticed (Nock et al., 2008). 
 The study’s hypotheses were evaluated by graphing the data (see Figure 1 as an example) 
and inspecting patterns of change following the implementation of IVE sessions.  Kazdin (1982) 
delineated several principles to facilitate visual inspection of single-case experimental designs, 
three of which were employed in the present study: change in mean, change in level, and change 
in trend.  In the current investigation, a change in mean was demonstrated if there was a greater 
reduction in SUDS or increase in self-efficacy ratings for the specified TV than the UV 
following the IVE session.  Similarly, a change in level involved the inspection of ratings before 
and after an IVE session, but the focus was on the one session immediately before and after the 
IVE.  To investigate a change in trend, the slope of the data before and after each IVE session 
was examined.  
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 Statistical analyses.  Despite the advantages of visual inspection when interpreting 
results from single-case experimental designs, a growing number of researchers recommend the 
use of statistical analysis to supplement visual inspection (Parker & Brossart, 2003).  According 
to a panel of national experts on single-case designs, regression-based estimators appear to 
provide the best option for both technical and practical reasons: regression methods can model 
trends in data, require only a single case to determine an effect size, are familiar to researchers, 
and provide results that tend to be more easily understood (Kratochwill et al., 2010).  
 When compared to four other relatively common statistical analyses for single-case 
research, the regression technique known as Allison’s mean plus trend difference (ALLISON-
MT; Allison & Gorman, 1993; Faith et al., 1996) was found to have the best agreement with 
professional judgments of intervention effectiveness via visual inspection and strong statistical 
power to identify significant results (Brossart, Parker, Olson, & Mahadevan, 2006).  In view of 
these advantages, ALLISON-MT was used as the primary statistical approach in the present 
study.  The ALLISON-MT method involved creating two predictor variables: a dummy coded 
variable that represented treatment (e.g., 0 = baseline or pre-intervention phase, 1 = treatment or 
post-intervention phase) and a variable that represented time (e.g., number of days).  If the slope 
during the pre-intervention (i.e., baseline) phase was zero or in the opposite direction of the 
predicted trend following the implementation of the intervention, then a multiple regression was 
conducted with treatment and time as predictors and the time-series data (i.e., dependent 
variable) as the outcome.   
 On the other hand, if the slope during the pre-intervention phase was in the same 
direction as the predicted trend following the intervention, then a simple linear regression was 
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first conducted with time as a predictor variable and the time-series data from the pre-
intervention phase only as the outcome variable.  The residual scores from this regression were 
calculated, and the predicted values of the outcome variable were carried over through the post-
intervention phase.  These predicted values were subtracted from the actual post-intervention 
scores to obtain the post-intervention residuals.  The final multiple regression equation included 
the “detrended” time-series data (the residuals from the pre-intervention and post-intervention 
phases) as the outcome variable, and treatment and the time × treatment interaction as the 
predictor variables (Ross & Begeny, 2014).  Faith et al. (1996) recommend using adjusted R2 
rather than R2 as a measure of the effect size to account for the number of predictors. 
 ALLISON-MT was used in the present study to calculate the adjusted R2 value for the 
TV(s) targeted by each IVE session.  The adjusted R2 values for the UV and RVs of interest in 
response to each IVE were also computed and compared to the adjusted R2 value obtained for the 
TV(s).  The “baseline” or “pre-intervention” phase was examined as a “short phase” and “long 
phase.”  The pre-intervention short phase consisted of the three data points collected before the 
IVE session of interest, while the pre-intervention long phase included all data points since the 
prior IVE session up through the last data point before the IVE session of interest (for the first 
IVE session, this phase included all data points collected prior to the IVE).  Similarly, the 
“treatment” or “post-intervention” phase consisted of a short and long phase.  The post-
intervention short phase included the three data points after the IVE session of interest.  The 
post-intervention long phase was comprised of all the data points after the IVE session up 
through the last data point before the next IVE session (for the last IVE session, this phase 
included all data points obtained until the end of data collection). 
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 Despite the advantages of ALLISON-MT as a statistical approach for single-case 
experimental designs, it should be noted that ALLISON-MT has been found to be more sensitive 
to the effects of autocorrelation (i.e., the nonindependence of sequential observations) than some 
other approaches.  Due to limitations inherent in all statistical approaches evaluating single-case 
designs, experts have recommended conducting “sensitivity analyses” (Kratochwill et al., 2010).  
One way that this might be done is by calculating effect sizes from more than one statistical 
method and subsequently comparing the estimated effect sizes from these multiple methods.  An 
effect size that is particularly familiar to social scientists and relatively straightforward to 
compute for single-case experimental designs is Cohen’s d (Smith, 2012), which involves 
calculating the difference between data before and after a phase change and dividing this 
difference by some version of within-phase variance (Kratochwill et al., 2010).  Busk and Serlin 
(1992) define a within-subject effect size as the ratio of the control and treatment mean 
difference to the baseline standard deviation.  If the baseline standard deviation is zero, then a 
pooled standard deviation from the baseline phase and treatment phase is used as the 
denominator.  This statistical approach does not assume that there is a normal distribution or 
equal variances and intercorrelations across pre-treatment and post-treatment phases.  Although 
calculating a within-subject effect size in this way has been criticized for not adequately 
addressing the issue of autocorrelation, it provides an accessible approach that might supplement 
other visual and statistical analyses (Smith, 2012).  The Cohen’s d values obtained using this 
method can only be compared to the d values from single-subject designs using a comparable 
approach.  In other words, the d values can be compared within each subject and between the 
subjects in the present study, but not to effect sizes from other single-case designs using this 
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statistical approach (e.g., Nakamura et al., 2014) or to the standard effect size benchmarks for 
between-group studies (Cohen, 1992). 
 In sum, four different effect sizes were obtained for all TVs and UVs assessed at CBT 
sessions before and after each IVE session.  The first effect size, adjusted R2, was calculated 
using ALLISON-MT during both short and long phases.  The second effect size, Cohen’s d, was 
computed using the within-subject effect size procedures developed by Busk and Serlin (1992), 
and also examined using criteria for both short and long phases.  These statistically derived effect 
sizes complimented visual inspection of data, which focused on changes in mean, level, and 
trend. 
 Interrater agreement.  The principal investigator listened to a random selection of audio 
sessions from each participant in the present study and completed a CCBT-ED therapist checklist 
for each of these sessions.  These checklists were compared to those completed by the primary 
therapist to determine interrater agreement.  Cohen’s kappa coefficient (κ) was used to measure 
interrater agreement, which accounts for agreement that might occur by chance (Cohen, 1960).  
To determine the interrater agreement between the principal investigator and primary therapist 
on each CCBT-ED therapist checklist, the number of items that both the principal investigator 
and primary therapist endorsed as occurring during the session were counted.  Additionally, the 
number of items that these two raters both left blank were tallied.  These two totals were summed 
and then divided by the total number of items on the measure to determine the relative observed 
agreement among raters (po).  To determine the probability of random agreement between raters 
(pe), the percentage of items endorsed by the principal investigator and primary therapist were 
calculated and multiplied.  Similarly, the percentage of items left blank by the principal 
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investigator and primary therapist were calculated and multiplied.  These two products were 
summed to generate the probability of random agreement.  Cohen’s kappa coefficient was 
calculated using the formula: (po – pe)/(1 – pe).  According to Landis and Koch (1977), a kappa 
coefficient less than 0.0 indicates poor agreement, between 0.0 and 0.2 indicates slight 
agreement, between 0.21 and 0.40 indicates fair agreement, between 0.41 and 0.60 indicates 
moderate agreement, between 0.61 and 0.80 indicates substantial agreement, and between 0.81 
and 1.0 indicates almost perfect agreement. 
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Results 
Participant 1 
 Demographics and clinical characteristics.  Participant 1 was an adolescent referred to 
the CCBT-ED clinic by her mother, who had concerns about the participant’s significant food 
avoidance, calorie restriction, and instances of self-induced vomiting.  Participant 1 received a 
diagnosis of OSFED, atypical AN from the CCBT-ED.  Her BMI during intake was 18.3; at her 
current height, her highest BMI was 19.2 and her lowest was 18.0.  In view of her weight history, 
Participant 1’s BMI at the time of assessment did not meet criteria for “significantly low body 
weight,” precluding a diagnosis of AN.   
 Participant 1 exhibited significant calorie restriction to maintain a low body weight, and 
reported engaging in an average of one binge-eating and one purging episode per week, with 
infrequent laxative abuse.  Participant 1 stated that she began dieting at age 14 years, which 
progressively evolved into more extreme calorie restriction.  The participant’s calorie restriction 
and drive for thinness were further reinforced by her involvement in an activity that required her 
to maintain a low body weight.  Participant 1 also reported experiencing symptoms of depression 
and anxiety since middle school.  She indicated taking antidepressant medication for the last 
several years, which she discontinued within the first month of treatment.   
 Participant 1 initially reported a global EDE-Q score of 4.73, which is greater than two 
standard deviations above the mean of a normative sample of young adult women (Mond, Hay, 
Rodgers, & Owen, 2006) and between the 60th and 70th percentiles for treatment-seeking females 
with eating disorders (Aardoom, Dingemans, Slof Op’t Landt, & Van Furth, 2012). Participant 
1’s initial BSQ-8 score of 45 was greater than two standard deviations above the mean of a 
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normative sample of young adult Swedish women (Welch, Lagerstrom, & Ghaderi, 2012).  
Participant 1 did not complete the FOFM at intake.  She rated almost all of the scenarios on the 
IVESS with a SUDS of 50 or greater. 
 CBT interventions and treatment outcomes.  Participant 1 received a total of 30 CBT 
sessions and one IVE over a period of 215 days, before moving to a different country and 
terminating treatment.  As noted in Table 1, 71% of Participant 1’s CBT sessions included 
interventions aimed at enhancing motivation to recover and maintaining engagement in 
treatment.  The participant indicated that she was primarily interested in eliminating her binge 
eating and purging and reducing her preoccupation with food, but did not want to gain weight, 
particularly because weight gain would jeopardize her participation in an activity that required 
her to maintain a low body weight.  Consequently, treatment focused heavily on exploring the 
incompatible relationship between the participant’s involvement in this activity and her eating 
disorder symptoms.   
 In addition to interventions aimed at enhancing motivation, the majority of CBT sessions 
also included self-monitoring and meal planning, in-session weighing, and psychoeducation (see 
Table 1).  Consistent with CBT protocols for eating disorders (e.g., Garner et al., 1997; Fairburn, 
2008; Waller et al., 2007), Participant 1 completed daily food records documenting her eating 
behaviors, collaboratively planned the foods she would eat between treatment sessions, and was 
weighed in session once per week.  Most of the psychoeducation included in Participant 1’s CBT 
sessions involved providing her with accurate information about nutrition, regular eating, and 
strict dieting.   
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All of Participant 1’s self-report measures indicated that she improved substantially over 
the course of treatment.  According to her food records and information discussed with her 
therapist, Participant 1 progressively increased her calorie intake, reduced her avoidance of 
feared foods, ate a normal range and amount of food, and eliminated binge eating and purging.  
Participant 1’s mother also shared her perspective that the patient improved across these 
domains.  By the end of treatment, Participant 1’s EDE-Q global score of 0.68 was within one 
standard deviation of the mean of a community sample of young adult women and below the 5th 
percentile for women with eating disorders.  Similarly, her final BSQ-8 score of 15 was within 
one standard deviation of the mean of a normative sample of young adult women.  Participant 
1’s scores on all three subscales of the FOFM also indicated low levels of food anxiety: she 
received a final score of 9 on the Anxiety about Eating subscale (which is within one standard 
deviation of the mean of a small sample of health controls; Levinson & Byrne, 2014), 8 on the 
 
 
Table 1. The percentage of each participant’s CBT sessions that included at least one 
intervention from eight broader categories. 
 Percentage of CBT Sessions Using 
Intervention from Category Intervention Category 
 P1  P2  P3  P4  P5 
           
Psychoeducation   57%  13%  22%  55%  91% 
           
Enhancing Motivation  71%  2%  47%  18%  74% 
           
In-Session Weighing  71%  76%  56%  64%  76% 
           
Self-Monitoring and Meal Planning  79%  16%  75%  95%  88% 
           
Cognitive Interventions for ED Concerns  43%  60%  56%  41%  81% 
           
Behavioral Interventions for ED Concerns  18%  49%  44%  50%  45% 
           
CBT for non-ED Concerns  14%  87%  31%  95%  81% 
           
Relapse Prevention  18%  4%  16%  18%  9% 
Table 1 Note.  P1 = Participant 1; P2 = Participant 2; P3 = Participant 3; P4 = Participant 4;  
P5 = Participant 5 
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Food Avoidance Behaviors subscale (below one standard deviation of the mean of healthy 
controls), and 16 on the Feared Concerns subscale (within one standard deviation of the mean of 
health controls). 
 Despite these encouraging indicators of improvement, Participant 1’s weight remained 
stable throughout treatment.  Given that the patient denied ever experiencing a period of frequent 
binge eating or overeating in her past, her lifetime high BMI of 19.2 was likely a more accurate 
approximation of her weight when eating in an unrestrained manner than the BMI of 
approximately 18.3 that she maintained over the course of treatment.  The possible inconsistency 
between her slightly suppressed weight and self-report of unrestricted eating suggest that she 
remained interested in keeping her weight at a level consistent with participation in the activity 
she valued. 
 IVE and related outcomes.  Due in part to Participant 1’s report that she was 
successfully incorporating previously avoided foods into her diet and her relatively low SUDS 
ratings on the IVESS, IVE sessions targeting food or eating were not considered clinically 
indicated.  After five months of treatment, the patient reported that she did not find any of the 
eating, weight, and shape situations listed on the IVESS particularly anxiety-provoking, 
assigning most a SUDS rating of 10 or lower, and none a rating over 50.  At this point, however, 
she did express some anxiety and avoidance related to eating and being physically active while 
wearing a bathing suit, and an IVE targeting these domains was developed collaboratively by the 
participant and her therapist.   
 As planned, Participant 1 and an IVE therapist met at a beach.  Wearing a bathing suit, 
Participant 1 ate a sandwich with tortilla chips while talking to the IVE therapist, who wore a t-
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shirt and shorts.  The participant and IVE therapist then engaged in some light physical activity 
together, including kicking a soccer ball back and forth and jogging.  Participant 1 reported a 
SUDS rating of 20 when she started eating in her bathing suit, which reduced to a SUDS of 10 
and then increased again to a SUDS of 20.  Her SUDS rating increased to 40 during the soccer 
ball activity, then reduced to a SUDS rating of 10 within several minutes.  After starting to jog, 
the patient reported SUDS ratings of 60, 80, and 70, reducing to a rating of 30 several minutes 
after jogging stopped and to 10 an hour later. 
 
Figure 2.  Participant 1’s SUDS ratings of three situations over the course of treatment: (1) eating 
a meal in a bathing suit, (2) being active in a bathing suit, and (3) eating a meal when not hungry. 
Figure 2 Note.  Higher ratings indicate more distress.  Ratings were obtained at the start of each 
CBT session.  The vertical dashed line represents when the patient participated in an IVE 
session, which targeted anxiety related to eating a meal in a bathing suit and being active in a 
bathing suit. 
SUDS = Subjective units of distress 
IVE = In vivo exposure 
 
Visual inspection of SUDS.  Figure 2 illustrates Participant 1’s SUDS ratings of the two 
TVs (eating a meal in a bathing suit and being active in a bathing suit) and one UV (eating when 
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not hungry) collected during CBT sessions before and after the IVE.  Visual inspection of the 
several data points before and after the IVE indicated that both TVs exhibited a decrease in mean 
following the IVE; however, the mean UV rating also decreased, precluding conclusions that the 
IVE was responsible for reductions in the TVs.  Visual inspection of level (i.e., the one data 
point before and after the IVE) supported the study’s hypothesis: both TVs exhibited a decrease 
in SUDS after the IVE, while the UV increased slightly.  On the other hand, Participant 1 
provided a very low SUDS rating of 5 for the UV in the session before the IVE, such that a floor 
effect likely curtailed further decreases.  Visual inspection of trend did not support the study’s 
hypotheses, as the TVs exhibited a sharper negative slope prior to the IVE than they did 
afterwards.  Floor effects may have prevented any decreases in trend in the TVs.  Due to floor 
effects and decreasing trends across all variables before the IVE, no conclusions can be made 
about the efficacy of this IVE for Participant 1.   
 Statistical analyses of SUDS.  Table 2 presents adjusted R2 values from ALLISON-MT 
and within-subject Cohen’s d effect sizes of the change in SUDS before and after IVE within 
both “short” and “long” phases.  Effect sizes for the long phases were not calculated for 
Participant 1, as her SUDS ratings of TVs were obtained at only three time points before and 
after the IVE.  Consistent with the study’s hypotheses, ALLISON-MT yielded a positive (albeit 
small) effect for the TV of being physically active in a bathing suit, and a negative effect for the 
UV of eating a meal when not hungry.  Inconsistent with the study’s hypotheses, a negative 
effect was obtained for the TV of eating a meal in a bathing suit.  While positive within-subject 
Cohen’s d effect sizes were calculated for the two TVs, a positive d was also obtained for the 
UV.  
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Table 2. Results from statistical analyses investigating changes in subjective units of 
distress after exposure sessions. 
Participant  Target Variable(s)  Unrelated Variable 
          
1 
 Meal in 
Bathing Suit 
 Active in Bathing 
Suit 
 Eating Not 
Hungry 
 IVE 1       
  Short Phases       
   Adjusted R2  -0.51  0.05  -0.75 
   Cohen’s d  1.15  1.96  0.77 
  Long Phases       
   Adjusted R2  --  --  -- 
   Cohen’s d  --  --  -- 
          
2 
 Critical Comments  Gym Around Others 
 IVE 1       
  Short Phases       
   Adjusted R2  0.04  0.03 
   Cohen’s d  4.33  2.84 
  Long Phases       
   Adjusted R2  0.00  0.00 
   Cohen’s d  0.86  1.24 
 IVE 2       
  Short Phases       
   Adjusted R2  0.73  0.82 
   Cohen’s d  0.92  1.31 
  Long Phases       
   Adjusted R2  0.97  0.41 
   Cohen’s d  1.34  1.68 
          
3 
 Unfamiliar 
Person  Critical Comments  
Eating Not 
Hungry 
 IVE 1       
  Short Phases       
   Adjusted R2  0.00    0.00 
   Cohen’s d  -1.15    0.33 
  Long Phases       
   Adjusted R2  -0.57    0.00 
   Cohen’s d  0.30    3.57 
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Table 2 (cont.). Results from statistical analyses investigating changes in subjective 
units of distress after exposure sessions. 
 
   Unfamiliar 
Person  Critical Comments  
Eating Not 
Hungry 
 IVE 2       
  Short Phases       
   Adjusted R2  0.00  0.00  0.00 
   Cohen’s d  1.29  0.58  -0.87 
  Long Phases       
   Adjusted R2  0.14  -0.39  0.34 
   Cohen’s d  1.75  3.00  0.08 
          
4 
 Noisy Eating  Critical Comments 
 IVE 1       
  Short Phases       
   Adjusted R2  0.00  0.00 
   Cohen’s d  1.15  1.20 
  Long Phases       
   Adjusted R2  0.00  0.51 
   Cohen’s d  0.91  2.04 
          
5 
 Vegan Pizza  Eating More than Other Person  Tight Clothing 
 IVE 1       
  Short Phases       
   Adjusted R2  0.78  0.74  -- 
   Cohen’s d  8.66  4.04  -- 
  Long Phases       
   Adjusted R2  0.70  0.01  0.04 
   Cohen’s d  8.66  0.43  -0.46 
Table 2 Note.  Larger positive values suggest greater decreases in distress ratings 
following an exposure session.  Negative values suggest increases in distress ratings 
following an exposure session.  The study’s primary hypothesis is supported when 
the value of a target variable is greater than the value of an unrelated variable. 
IVE = In vivo exposure 
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Visual inspection of self-efficacy ratings.  Figure 3 presents Participant 1’s self-efficacy 
ratings assessed at CBT sessions before and after her IVE.  According to visual inspection of 
mean and level, both TVs increased as hypothesized; however, the UV also demonstrated an 
increase in mean and level following the IVE.  The TVs and UV exhibited sharper increases in 
the trend of self-efficacy ratings prior to the IVE relative to afterwards, likely because of a 
ceiling effect.  Similar patterns across variables preclude conclusions about whether IVE 
contributed to any of these changes. 
 
Figure 3.  Participant 1176’s self-efficacy ratings of three situations over the course of treatment: 
(1) eating a meal in a bathing suit, (2) being active in a bathing suit, and (3) eating a meal when 
not hungry. 
 
Figure 3 Note.  Higher ratings indicate greater self-efficacy.  Ratings were obtained at the start of 
each CBT session.  The vertical dashed line represents when the patient participated in an IVE 
session, which targeted self-efficacy related to eating a meal in a bathing suit and being active in 
a bathing suit. 
IVE = In vivo exposure 
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Table 3. Results from statistical analyses investigating changes in self-efficacy 
ratings after exposure sessions. 
Participant  Target Variable(s)  Unrelated Variable 
          
1 
 Meal in 
Bathing Suit 
 Active in Bathing 
Suit 
 Eating Not 
Hungry 
 IVE 1       
  Short Phases       
   Adjusted R2  0.00  0.00  -0.28 
   Cohen’s d  1.33  2.31  0.94 
  Long Phases       
   Adjusted R2  --  --  -- 
   Cohen’s d  --  --  -- 
          
2 
 Critical Comments  Gym Around Others 
 IVE 1       
  Short Phases       
   Adjusted R2  -0.07  0.00 
   Cohen’s d  -0.87  0.58 
  Long Phases       
   Adjusted R2  -0.51  -0.82 
   Cohen’s d  0.77  0.72 
 IVE 2       
  Short Phases       
   Adjusted R2  -0.45  0.17 
   Cohen’s d  0.87  1.00 
  Long Phases       
   Adjusted R2  0.96  0.86 
   Cohen’s d  1.64  1.38 
          
3 
 Unfamiliar 
Person  Critical Comments  
Eating Not 
Hungry 
 IVE 1       
  Short Phases       
   Adjusted R2  -0.90    0.00 
   Cohen’s d  0.98    0.72 
  Long Phases       
   Adjusted R2  0.00    0.09 
   Cohen’s d  0.86    0.60 
 IVE 2       
  Short Phases       
   Adjusted R2  0.00  0.00  -0.41 
   Cohen’s d  -1.15  1.73  -1.15 
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Table 3 (cont.). Results from statistical analyses investigating changes in self-efficacy 
ratings after exposure sessions. 
         
    Unfamiliar 
Person  Critical Comments  
Eating Not 
Hungry 
  Long Phases       
   Adjusted R2  -0.13  0.00  -0.73 
   Cohen’s d  -0.47  1.47  -0.52 
          
4 
 Noisy Eating  Critical Comments 
 IVE 1       
  Short Phases       
   Adjusted R2  -0.83  -0.34 
   Cohen’s d  -0.29  0.10 
  Long Phases       
   Adjusted R2  -0.98  -0.83 
   Cohen’s d  -0.42  0.25 
          
5 
 Vegan Pizza  Eating More than Other Person  Tight Clothing 
 IVE 1       
  Short Phases       
   Adjusted R2  0.00  -0.84  -- 
   Cohen’s d  1.44  0.83  -- 
  Long Phases       
   Adjusted R2  0.92  -0.23  0.00 
   Cohen’s d  -1.59  1.15  -0.31 
Table 3 Note.  Larger positive values suggest greater increases in self-efficacy ratings 
following an exposure session.  Negative values suggest decreases in self-efficacy 
ratings following an exposure session.  The study’s primary hypothesis is supported 
when the value of a target variable is greater than the value of an unrelated variable. 
IVE = In vivo exposure 
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 Statistical analyses of self-efficacy ratings.  Adjusted R2 values from ALLISON-MT and 
within-subject Cohen’s d effect seizes for Participant 1 are noted in Table 3.  Inconsistent with 
the present study’s hypotheses, adjusted R2 values of 0 were calculated for both TVs.  Although 
positive within-subject Cohen’s d effect sizes were obtained for the two TVs, a positive d was 
also calculated for the UV.  
 Satisfaction with IVE.  Although Participant 1 reported to her therapist that the IVE 
session was valuable, the participant did not complete an IVE Feedback Form, despite multiple 
attempts to obtain this information from her.    
Participant 2 
 Demographics and clinical characteristics.  Participant 2 was a young adult who 
received a diagnosis of OSFED, BED of low frequency from the CCBT-ED.  Her BMI at 
assessment was 26.0, with a reported high BMI of 29.2 and low BMI of 20.9 at her present 
height.  Participant 2 indicated that she began significantly restricting her calorie intake in an 
effort to lose weight approximately two years prior to her assessment, which soon led to the 
onset of binge eating at an average frequency of two times per week.  Approximately two 
months before being assessed at the CCBT-ED, the participant entered inpatient treatment for 
OCD and binge-eating disorder.  She noted that treatment included exposure therapy to address 
both OCD and binge eating.   
 Participant 2 sought outpatient services from the CCBT-ED with the goals of maintaining 
her gains from inpatient treatment and reducing her anxiety about a range of social situations 
related to eating.  At intake with the CCBT-ED, the participant stated that she was experiencing 
distressing episodes of overeating less than once per week.  She denied objective binge episodes, 
 70 
loss of control while eating, purging, or laxative abuse.  The participant reported a history of 
intermittent symptoms of OCD and depression since adolescence, and received prior individual 
psychotherapy for more than seven years to address these difficulties.  Participant 2 had been 
taking antidepressant medication for over three years, which she continued to take as a 
participant in the present study.  
 At assessment, Participant 2 reported a global EDE-Q score of 1.80, which is within one 
standard deviation of the mean based on a sample of healthy women and between the 5th and 10th 
percentiles of treatment-seeking females with eating disorders.  Her initial BSQ-8 score of 24 
was also within one standard deviation of the mean of a community sample of women.  Relative 
to a small sample of healthy controls, Participant 2’s score of 15 on the Anxiety about Eating 
subscale and 20 on the Feared Concerns subscale of the FOFM were both greater than one 
standard deviation above the mean.  Her score of 7 on the Food Avoidance Behaviors subscale of 
the FOFM was less than one standard deviation below the mean.  Despite relatively low scores 
across the EDE-Q, BSQ-8, and FOFM, the participant reported a SUDS rating of 50 or greater 
on all but three items on the IVESS at intake, suggesting that she continued to exhibit moderate 
to high levels of anxiety about a range of situations related to eating, weight, and shape. 
 CBT interventions and treatment outcomes.  Participant 2 continues to receive 
treatment from the CCBT-ED.  The present study includes data from 52 CBT and two IVE 
sessions over 434 days.  As noted in Table 1, 87% of Participant 2’s CBT sessions included 
cognitive and behavioral interventions for concerns that were not directly related to eating 
behaviors.  A substantial number of the participant’s CBT sessions focused on supporting her 
with building autonomy from her family, effectively handling ongoing conflict with her 
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significant other, and developing appropriate distress tolerance and emotion regulation skills.  As 
Participant 2 did not exhibit symptoms of significant calorie restriction, binge eating, or purging, 
only 16% of CBT sessions included self-monitoring and meal planning, all of which occurred 
during her first two months in treatment.  More than half of the participant’s CBT sessions 
involved cognitive approaches to address eating disorder concerns, including identifying and 
challenging anxious thoughts about eating-related social situations. 
 Participant 2’s relatively low scores on the EDE-Q, BSQ-8, and FOFM subscales reduced 
further over the course of treatment.  Scores from the last administration of these measures were 
all below the means obtained in samples of healthy controls.  Participant 2 lost 5 lbs. within the 
first three months of treatment, perhaps due to her continued abstinence from binge eating.  She 
maintained a BMI of approximately 25 and denied having any binge-eating or purging episodes 
throughout the course of treatment at the CCBT-ED. 
 IVE and related outcomes.  From the start of treatment at the CCBT-ED, Participant 2 
expressed significant concern about other people’s judgment of her food choices and exhibited 
difficulties being assertive with others in eating-related situations.  She often avoided eating 
certain foods in public due to fears of negative evaluation, modified her food choices to match 
what she thought others perceived as acceptable, and endorsed other people’s stated beliefs about 
dieting and thinness despite having divergent views herself.  During her third month of treatment 
at the CCBT-ED, the participant and her primary therapists began planning an IVE to address 
these concerns.  She expressed anxiety but also a high level of interest in planning and 
participating in challenging IVE sessions to practice assertiveness skills, reduce her apprehension 
and avoidance of eating around others, reinforce her pro-recovery values, and increase her ability 
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to tolerate eating in a wide range of potentially difficult social situations.  
 For her first IVE session, Participant 2 met an IVE therapist at a casual restaurant.  The 
IVE therapist reviewed the plan that the participant had previously worked out with her primary 
therapists, which involved purchasing and eating a cheeseburger and fries with an IVE therapist 
who ate a veggie burger.  During three blocks of time lasting approximately ten minutes each, 
the IVE therapist role-played different characters representing people in the participant’s life, 
including a parent concerned about whether the participant is making the healthiest food choices 
and a friend bragging about her own recent weight loss and willpower to adhere to a strict diet.  
The challenge of these critical comments generally increased over the course of the IVE.  
Participant 2 reported a SUDS of 50 at the start of the IVE session, with subsequent levels 
fluctuating between a low rating of 35 and high rating of 60.  She endorsed a SUDS rating of 20 
ten minutes after the end of the exposure, which reduced to a 10 over the next hour.  
 During CBT sessions following the IVE, Participant 2 indicated that the exposure was 
helpful, but that the IVE therapist’s frequent transitions in and out of character contributed some 
artificiality to the session.  The participant expressed an interest in planning a more challenging 
IVE with a new IVE therapist who stays in character throughout the entire session.  A second 
IVE was scheduled two months later.  During this session, the participant met a new IVE 
therapist at a food court in a mall.  The participant chose to eat a calorie-rich pasta while the IVE 
therapist ate a lighter pasta.  Consistent with the participant’s goal to make this second IVE 
session particularly challenging, the IVE therapist frequently made exceptionally critical and 
rude comments about the participant’s meal (e.g., “That’s what you decided to eat?!”, “Aren’t 
you worried that you’ll become fat and lose your boyfriend?”).  Despite the therapist’s attempts 
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to make this IVE session as challenging as she could, the participant’s SUDS never exceeded the 
rating of 50 she reported at the start of the exposure.  Her ratings fluctuated between 30 and 50 
throughout, with a rating of 30 at the end of the IVE and ten minutes after the session had ended. 
 Visual inspection of SUDS.  Figure 4 displays Participant 2’s SUDS ratings of the 
identified TV (receiving critical comments about a meal she is eating) and UV (working out at 
the gym around other people) throughout treatment.  Visual inspection of mean was consistent 
with the study’s hypothesis, as SUDS exhibited a decrease in the several CBT sessions following 
the first and second IVE sessions.  Notably, Participant 2’s SUDS rating of the TV after the first 
IVE reduced from 85 to 60, her lowest rating for this item since starting treatment.  The SUDS 
decreased further to a rating of 40 in the subsequent CBT session.  On the other hand, the 
participant’s SUDS ratings of the UV exhibited similar reductions following the first IVE 
session, and even greater reductions following the second IVE, precluding the conclusion that 
the exposure sessions contributed to reduction in SUDS ratings.   
 Similarly, visual inspection of level indicated a reduction in the one SUDS rating directly 
before and after the first IVE session for both the TV and UV.  The participant reported the same 
SUDS rating of the TV before and after the second IVE, while the SUDS rating of the UV 
decreased.  Visual inspection of trend indicated an increase in both the TV and UV following the 
first IVE, and a decrease in trend in the TV and UV after the second IVE. 
 Statistical analyses of SUDS.  When examining changes in SUDS of the TV in the short 
phases, ALLISON-MT produced adjusted R2 values of similar magnitudes for the TV and UV 
following both IVE sessions, as noted in Table 2.  ALLISON-MT revealed an adjusted R2 of zero 
for SUDS of both the TV and UV during the long phases for the first IVE, indicating that this  
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Figure 4. Participant 2’s SUDS ratings of two situations over the course of treatment: (1) 
receiving critical comments about a meal that she is eating and (2) working out at the gym 
around other people. 
 
 
Figure 4 Note.  Higher ratings indicate more distress.  Ratings were obtained at the start of each 
CBT session.  The vertical dashed lines represent when the patient participated in her first and 
second IVE session, both of which targeted anxiety related to receiving critical comments about 
a meal that she was eating. 
SUDS = Subjective units of distress 
IVE = In vivo exposure 
 
IVE session did not impact the change in SUDS over time.  For the second IVE in the long 
phases, positive adjusted R2 values were obtained for both the TV and UV.  
 In both the short and long phases, within-subject Cohen’s ds of similar magnitudes were 
found for the TV and UV following the first and second IVE sessions.   
 Visual inspection of self-efficacy ratings.  Figure 5 presents Participant 2’s self-efficacy 
ratings assessed at CBT sessions before and after her first and second IVE.  According to visual 
inspection of mean, self-efficacy ratings of both the TV and UV were higher in the several  
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Figure 5. Participant 2’s self-efficacy ratings of two situations over the course of treatment: (1) 
receiving critical comments about a meal that she is eating and (2) working out at the gym 
around other people. 
 
Figure 5 Note.  Higher ratings indicate greater self-efficacy.  Ratings were obtained at the start of 
each CBT session.  The vertical dashed lines represent when the patient participated in her first 
and second IVE session, both of which targeted self-efficacy related to receiving critical 
comments about a meal that she was eating. 
IVE = In vivo exposure 
 
sessions after the first and second IVEs relative to the ratings before these two exposure sessions.  
Inconsistent with the study’s hypotheses, there was a decrease in self-efficacy level of the TV 
and increase in level of the UV after the first IVE.  Following the second IVE, there was an 
increase in level for both the TV and UV.   
 Participant 2’s self-efficacy ratings exhibited greater increases toward the beginning of 
treatment.  Although her ratings continued to increase over the course of treatment, the 
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magnitude of this increase reduced over time, likely due to ceiling effects.  After the second IVE, 
Participant 2 reported a maximum self-efficacy rating of 100 for both TV and UV, and 
maintained this rating for almost all of her subsequent CBT sessions.  As a result, visual 
inspection of trend indicated decreases in trend of self-efficacy ratings following both IVEs.  
 Statistical analyses of self-efficacy ratings.  In the short phases, negative adjusted R2 
values were calculated for changes in self-efficacy ratings of the TV following the first and 
second IVEs, suggesting that the trend in self-efficacy became less positive following exposure 
sessions (see Table 3).  During the long phases, negative adjusted R2 values were found for both 
the TV and UV following the first IVE, while both variables received positive values after the 
second IVE.   
 In the short phases before and after the first IVE, a negative within-subject Cohen’s d was 
calculated for the TV.  For the second IVE, positive values of similar magnitude were obtained 
for the TV and UV.  All ds calculated during the long phases were positive, with similar values 
yielded for the TV and UV. 
 Satisfaction with IVE.  Participant 2 indicated satisfaction with IVE according to her 
responses on the IVE Feedback Form, which she completed several months after her second IVE 
session.  On a scale from 1 to 7, the participant assigned a 6 to the item asking about the extent to 
which exposure added to the effectiveness of therapy, a 5 to whether it added to the efficiency of 
therapy, and a 6 to the extent to which it increased her confidence to handle a variety of 
situations.  She also indicated that the challenging nature of IVE was valuable, assigning a 7 to 
the statement: “The most helpful in vivo exposure sessions have been the ones that challenged 
me the most.” 
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 In response to the open-ended questions on the IVE Feedback Form, Participant 2 
reported appreciating the naturalistic quality of the IVE sessions, such as involving IVE 
therapists she had not met prior to the exposure, and individualizing the critical comments she 
received to be relevant to the situations and people she encountered in her life.  The participant 
indicated that her IVEs provided a “safe space” to practice responses, categorized her fears into 
manageable treatment targets, and made difficult situations easier to handle. 
Participant 3  
 Demographics and clinical characteristics.  Participant 3 was a young adult who 
received a diagnosis of OSFED, atypical AN from the CCBT-ED.  Her BMI at intake was 21.5, 
with a reported high BMI of 24.1 and low adult BMI of 18.8.  Although Participant 3 did not 
meet criteria for AN, her significant calorie restriction at the time warranted a diagnosis of 
OSFED, atypical AN.  In addition to skipping meals, avoiding foods, and limiting portions, 
Participant 3 reported subjective binge eating episodes one to two times per week, with no 
history of objective binge eating, purging, or laxative abuse, and described significant body 
image dissatisfaction.  Participant 3 stated that she began skipping meals in high school, and had 
since vacillated between periods of extreme restriction and more moderate dieting.  She indicated 
that her restrictive eating was reinforced by her participation in an appearance-focused activity 
throughout her childhood and young adulthood.  Participant 3 reported experiencing symptoms 
of depression and anxiety on an intermittent basis over the last three years.  She received 
outpatient treatment from a university counseling center for several weeks before being referred 
to the CCBT-ED for more specialized eating disorder treatment.  Her goals included reducing 
preoccupation with food, eliminating subjective binge eating, and improving body image. 
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 At intake, Participant 3 obtained a score of 4.08 on the EDE-Q, more than one standard 
deviation above the normative mean and between the 40th and 50th percentiles of patients with 
eating disorders.  Her BSQ-8 score of 36 was also one standard deviation above the mean of a 
community sample.  Relative to a small sample of eating disorder patients, Participant 3’s score 
of 39 on the Anxiety about Eating subscale of the FOFM was just under one standard deviation 
below the mean, while her score of 53 on the Feared Concerns subscale matched the clinical 
sample mean.  Her score of 20 on the Food Avoidance Behaviors subscale was within one 
standard deviation of the mean of a small sample of healthy controls.  The participant rated all of 
the scenarios on the IVESS at SUDS levels of 60 or greater. 
 CBT interventions and treatment outcomes.  Participant 3 received a total of 34 CBT 
and two IVE sessions over a period of 187 days before moving to a different city.  Following her 
move, she participated in three brief phone sessions.  Consistent with CBT protocols for eating 
disorders, food record reviews and in-session weight checks were included in the majority of the 
participant’s treatment sessions (see Table 1).  These interventions explored and addressed 
Participant 3’s beliefs about the relationship between regular eating and weight gain.  Over half 
of the participant’s CBT sessions also involved cognitive interventions for concerns related to 
her eating disorder, particularly her fear of negative judgment from others about her eating 
behaviors and her avoidance of eating in social situations.  Additionally, Participant 3 indicated 
that the appearance-related activity in which she participated was an important aspect of her 
identity, and expressed ongoing ambivalence about giving up calorie restriction and gaining even 
a small amount of weight to achieve full recovery from her eating disorder.  As a result of this 
ambivalence, most of the participant’s CBT sessions included interventions that focused on 
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enhancing her motivation for change, such as exploring the benefits and drawbacks of her eating 
disorder symptoms. 
 Participant 3’s weight fluctuated within a range of 10 lbs. throughout the course of 
treatment.  During her final in-person CBT session, the participant was 2 lbs. heavier than her 
weight at intake.  Although Participant 3’s BMI of 21.8 at discharge was within a healthy weight 
range, she continued to consume a moderately restrictive diet.  The participant’s primary 
therapists believed that she would have benefited from additional treatment at the CCBT-ED to 
help her achieve full recovery, which would have likely required some weight gain.  
 The participant did not report objective binge eating, subjective binge eating, or purging 
while receiving services from the CCBT-ED.  Her scores on the EDE-Q progressively reduced 
over the course of treatment, reaching 2.53 at the time of termination, which is one standard 
deviation of the mean of healthy women.  Her BSQ-8 score of 35 at discharge was similar to her 
score at intake.  Her scores on the three FOFM subscales were lower at discharge relative to 
intake: she received a 25 on the Anxiety about Eating subscale, a 34 on the Feared Concerns 
subscale, and a 15 on the Food Avoidance Behaviors subscale. 
 Participant 3 also completed the EDE-Q and BSQ-8 approximately three months after her 
final in-person session at the CCBT-ED.  At three-month follow-up, she obtained a score of 2.36 
on the EDE-Q and 27 on the BSQ-8, both of which were within one standard deviation of the 
mean of healthy women.   
 IVE and related outcomes.  Throughout treatment, Participant 3 expressed significant 
anxiety about eating in social situations and avoided eating in front of other people.  For 
example, she reported concerns that others would judge her negatively if she ate foods that others 
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might consider unhealthy or fattening.  She also exhibited fear of violating standards for polite 
eating, such as offending others by eating in a messy or noisy way.  When discussing possible 
scenarios for her first IVE, Participant 3 was reluctant to target concerns about improper eating, 
and requested that a less challenging exposure be planned.  For her first IVE, the participant 
agreed to eat lunch with an unfamiliar person whom she was meeting for the first time.   
 During this IVE, the participant purchased a sandwich for lunch, met an IVE therapist on 
the university’s campus, and ate her lunch while conversing with the IVE therapist who was not 
eating anything.  The IVE therapist was instructed to maintain a friendly demeanor during the 
exposure.  Participant 3 reported a SUDS of 80 at the start of the IVE session, which reduced to a 
50 by the end of the exposure and a 40 five minutes after completing the IVE. 
 Following this first IVE, the participant expressed increased willingness to set up a more 
challenging exposure session to increase her self-efficacy for eating non-diet foods in front of 
other people.  She agreed to participate in a difficult IVE designed to amplify these fears by 
meeting an unfamiliar IVE therapist who would make critical comments about a calorie-dense 
food item that the patient was eating.  During multiple CBT sessions prior to this second IVE, 
Participant 3’s primary therapists reviewed the rationale for this challenging exposure, practiced 
alternative ways of responding to critical comments, and highlighted connections between the 
patient’s ability to take on difficult situations and her personal values and goals.  
 For her second exposure session, the participant met a new IVE therapist for lunch at an 
outdoor table located on campus.  After the details of the session were reviewed, Participant 3 
purchased and ate a burrito as planned, while the IVE therapist did not eat anything.  As they 
conversed, the IVE therapist made intermittent comments about the calorie and fat content of the 
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burrito (e.g., “Wow, that looks like it has a lot of sour cream in it!” “I wonder how many calories 
are in one burrito?”) and about the participant’s choice to eat a calorie-dense food in view of her 
success in an appearance-focused activity (e.g., “I’m surprised that someone [involved in X] 
would feel comfortable eating food like that”).  Participant 3 reported a SUDS of 90 at the start 
of the exposure session, which progressively reduced to a rating of 65 by the end and increased 
slightly to 70 five minutes later.  When debriefing with the IVE therapist, the participant 
indicated that the exposure was more challenging that she had expected.  She agreed to adhere to 
her meal plan for the rest of the day and discuss her thoughts about the IVE in more detail with 
her primary therapists.    
 During her next CBT session, Participant 3 expressed that she had been ruminating for 
several days about the comments made during the IVE, and reported uncertainty about whether 
the exposure session was helpful.  Participant 3 and her primary therapists reviewed the rationale 
of the IVE and general importance of reducing anxiety and increasing self-efficacy in eating-
related social situations.  The primary therapists hypothesized that additional IVE sessions 
targeting the participant’s concerns in social situations would be valuable.  Unfortunately, soon 
after the second IVE, Participant 3 terminated treatment when she moved to a different city. 
 Visual inspection of SUDS.  Figure 6 presents Participant 3’s SUDS ratings of two TVs 
(eating a meal with an unfamiliar person and receiving critical comments about a meal) and one 
UV (eating when not hungry) throughout treatment.  According to visual inspection of mean, the 
SUDS ratings of TVs reduced following both IVE sessions.  The mean SUDS rating of the TV of 
eating a meal with an unfamiliar person was slightly lower following the first IVE relative to the 
mean SUDS in the session before this IVE.  Similarly, both TVs exhibited lower mean SUDS  
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Figure 6. Participant 3’s SUDS ratings of three situations over the course of treatment: (1) eating 
a meal with an unfamiliar person, (2) receiving critical comments about a meal that she is eating, 
and (3) eating a meal when not hungry. 
 
 
Figure 6 Note.  Higher ratings indicate more distress.  Ratings were obtained at the start of each 
CBT session.  The vertical dashed lines represent when the patient participated in her first and 
second IVE session.  The first IVE session targeted anxiety related to eating a meal with an 
unfamiliar person.  The second IVE targeted anxiety related to both eating a meal with an 
unfamiliar person and receiving critical comments about a meal that she was eating. 
SUDS = Subjective units of distress 
IVE = In vivo exposure 
 
scores following the second IVE when compared to the mean SUDS before this exposure 
session.  The UV also exhibited a decrease in mean SUDS following the first IVE.  After the 
second IVE, the overall mean SUDS of the UV was slightly higher than the mean SUDS from 
the several sessions before the second IVE.  
 Inconsistent with the study’s hypothesis, there was an increase in SUDS level of the TV 
following the first IVE.  Additionally, one of the TVs – receiving critical comments about a meal 
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– demonstrated an increase in SUDS following the second IVE.  The other TV – eating a meal 
with an unfamiliar person – exhibited a decrease in level following the second IVE.  There was 
an increase in the SUDS of the UV in the session after both IVEs.  Both the TV and UV 
demonstrated an increase in trend following the first IVE, while both TVs and the UV exhibited 
a decrease in trend after the second IVE.  Given the inconsistent changes in SUDS following 
IVE sessions and the overall reduction in all three variables over time, it cannot be concluded 
that exposure led to reductions in SUDS of TVs. 
 Statistical analyses of SUDS.  When exploring changes within the short phases before 
and after the first IVE, ALLISON-MT produced an adjusted R2 of zero for both the TV and UV 
(see Table 2).  In the long phases, a negative adjusted R2 was obtained for the TV, while a value 
of zero was calculated for the UV.  For the second IVE, all variables examined within short and 
long phases using ALLISON-MT yielded adjusted R2 values of zero. 
 As noted in Table 2, a negative within-subjects Cohen’s d was obtained for the TV when 
focused on the short phases before and after the first IVE.  In the long phases, a larger positive 
within-subjects Cohen’s d was found for the UV than the TV.  Consistent with the study’s 
hypotheses, both TVs exhibited positive effect sizes while the UV had a negative effect size 
when examining SUDS before and after the second IVE.  
 Visual inspection of self-efficacy ratings.  Figure 7 illustrates Participant 2’s self-
efficacy ratings throughout her treatment at the CCBT-ED.  Although the TV exhibited an 
increase in mean self-efficacy following the first IVE, mean self-efficacy ratings of the UV also 
increased.  While her mean self-efficacy ratings of one TV (receiving critical comments) 
increased following the second IVE, the other TV (eating with an unfamiliar person) exhibited a 
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Figure 7. Participant 3’s self-efficacy ratings of three situations over the course of treatment: (1) 
eating a meal with an unfamiliar person, (2) receiving critical comments about a meal that she is 
eating, and (3) eating a meal when not hungry. 
 
 
Figure 7 Note.  Higher ratings indicate greater self-efficacy.  Ratings were obtained at the start of 
each CBT session.  The vertical dashed lines represent when the patient participated in her first 
and second IVE session.  The first IVE session targeted self-efficacy related to eating a meal 
with an unfamiliar person.  The second IVE targeted self-efficacy related to both eating a meal 
with an unfamiliar person and receiving critical comments about a meal that she was eating. 
IVE = In vivo exposure 
 
decrease in mean self-efficacy ratings, which appears related to the considerable reduction in 
self-efficacy in the CBT session after her IVE.  Although the lack of an increase in mean self-
efficacy ratings of the UV following the second IVE is consistent with the study’s hypothesis, 
this could be due to a ceiling effect.  
 Visual inspection of level yielded inconsistent results.  Self-efficacy ratings of the TV 
decreased in the session after the first IVE.  There was no change in the self-efficacy ratings of 
the UV following the first IVE.  While the TV of receiving critical comments exhibited an 
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increase in self-efficacy level after the second IVE, the TV of eating a meal with an unfamiliar 
person illustrated a decrease in self-efficacy level.  Participant 3’s self-efficacy rating of the UV 
decreased from the CBT session before to the CBT session after her second IVE. 
 Results from visual inspection of trend generally did not support the study’s hypotheses.  
Following the first IVE, the slope of self-efficacy ratings increased for the TV and decreased for 
the UV.  After the second IVE, the participant’s slope of self-efficacy ratings of one TV (eating 
with an unfamiliar person) increased while the slope of the other TV (receiving critical 
comments) decreased.  The self-efficacy slope of the UV increased following the second IVE.  
Overall, visual inspection of changes in mean, level, and slope of self-efficacy ratings did not 
support the study’s hypotheses, as there were inconsistent changes across all variables.  
 Statistical analyses of self-efficacy ratings.  As shown in Table 3, ALLISON-MT 
yielded adjusted R2 values near, at, or below zero for all variables when investigating effects of 
the first and second IVE in both the short and long phases. 
 The TV and UV examined before and after the first IVE yielded positive within-subject 
Cohen’s d effect sizes of similar magnitude within the short and long phases (see Table 3).  
Consistent with results from visual inspection of the mean before and after the second IVE, 
positive within-subject Cohen’s d effect sizes were obtained for the TV of receiving critical 
comments about a meal, while negative ds were found for the TV of eating a meal with an 
unfamiliar person.  For the UV during the second IVE, negative within-subjects Cohen’s ds were 
found.  
 Satisfaction with IVE.  Participant 3 completed an IVE Feedback Form by her 
therapists’ request approximately three months after moving away and ending treatment with the 
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CCBT-ED.  Despite her reported uncertainty about the value of exposure following her second 
IVE, the participant reported general satisfaction with exposure on her IVE Feedback Form.  She 
indicated that IVE sessions added to the effectiveness and efficiency of treatment (with 6 out of 7 
ratings for both items), and that she is more confident in her ability to handle a variety of eating 
and weight-related situations because of IVE (with a rating of 7).  Her rating of 5 suggests 
modest agreement to the statement that the most challenging IVE sessions were the most helpful. 
 Participant 3’s responses to the open-ended questions indicated that she appreciated the 
collaborative process of developing exposure sessions, having the opportunity to address her 
fears in a more controlled environment, and debriefing following IVE sessions.  The participant 
reported that exposure sessions were challenging and pushed her to address situations she was 
avoiding.  She described the second IVE session as “too much too soon,” noting that the 
exposure was more challenging that she had expected and that she was unprepared for the 
thoughts and emotions she experienced afterwards.  Participant 3 indicated that she “absolutely” 
thinks future clients should participate in exposure sessions. 
Participant 4 
 Demographics and clinical characteristics.  Approximately four months before starting 
treatment at the CCBT-ED, Participant 4 sought outpatient treatment for objective binge eating at 
a medical center, and received treatment from a therapist who worked simultaneously at the 
CCBT-ED.  When assessed by this therapist at the medical center, Participant 4 received 
diagnoses of BED, generalized anxiety disorder, and social anxiety disorder.  Additionally, her 
BMI was approximately 49.0, the patient indicated that this was her highest weight ever, and 
expressed interest in receiving support with weight management.  After more than one month of 
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treatment at the medical center, she had steadily lost weight and successfully stopped objective 
binge eating, but continued to report significant anxiety about situations related to eating, weight, 
and shape, as well as impairment related to social anxiety.  After the medical center abruptly 
discontinued their eating disorders program, both the participant and her therapist decided to 
transition her outpatient treatment to the CCBT-ED clinic. 
 When assessed at the CCBT-ED, Participant 4 received a diagnosis of BED, in full 
remission, generalized anxiety disorder, and social anxiety disorder.  She was an adult patient 
with a BMI of 47.0 at intake, with a reported low BMI of 19.8 at her present height.  Although 
she was no longer experiencing objective binge eating, she was interested in continuing 
treatment to maintain her treatment gains, get further support with weight management, and 
address subjective binge eating, discomfort and avoidance of eating around other people, and 
significant body dissatisfaction.  She denied ever purging or using laxatives.  Participant 4 
reported receiving prior psychotherapy for depression and social anxiety. 
 At the time of assessment at the CCBT-ED, Participant 4 obtained a score of 3.34 on the 
EDE-Q, which was between one and two standard deviations above the mean of healthy controls 
and between the 20th and 30th percentiles of patients with eating disorders.  Her score of 40 on 
the BSQ-8 was precisely two standard deviations above the mean of a normative sample of 
women, suggesting significant body dissatisfaction.  Compared to a small sample of healthy 
controls, her score of 9 on the Feared Concerns subscale of the FOFM was less than one standard 
deviation below the mean.  Her score of 21 on the Anxiety about Eating subscale and 27 on the 
Food Avoidance Behaviors subscale were greater than two standard deviations above the mean 
of a healthy sample, and less than two standard deviations below the mean of a small clinical 
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sample.  She rated just over half of the various eating, weight, and shape situations listed on the 
IVESS with a SUDS rating of 50 or greater, and nine scenarios received a SUDS rating of 100. 
 CBT interventions and treatment outcomes.  Participant 4 received a total of 34 CBT 
and one IVE session at the CCBT-ED before moving to another state.  Almost all of her CBT 
sessions included interventions related to self-monitoring and meal planning, and more than half 
incorporated psychoeducation and in-session weigh-ins (see Table 1).  The participant regularly 
completed food records and planned meals with her primary therapist in CBT sessions.  
Psychoeducation about regular eating and healthy approaches to dieting often accompanied meal 
planning, as the therapist helped the participant develop a balanced diet that supported weight 
management while simultaneously reducing her susceptibility to binge eating.  The 41% of CBT 
sessions including cognitive interventions and 50% including behavioral interventions for ED 
concerns often focused on Participant 3’s anxiety about eating in social situations, such as 
challenging negative predictions about eating situations and attempts to set up exposure sessions 
targeting these concerns.  Additionally, almost all of Participant 4’s CBT sessions included 
cognitive and behavioral interventions for concerns other than her eating disorder, which 
typically addressed social anxiety, generalized anxiety, and emotion regulation. 
 Over the course of her treatment at the CCBT-ED, the participant lost and then regained 
approximately 15 lbs., remaining below her high lifetime BMI of 49.0.  Participant 4 reported 
experiencing just one subjective binge-eating episode and denied ever engaging in objective 
binge eating while receiving treatment.  Although her score on the EDE-Q reduced by 1.06 
points on the second administration of this measure 90 days into treatment, her score 
progressively increased on the third and fourth administrations, which occurred 139 and 159 
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days into treatment, respectively.  Her fourth (and final) EDE-Q score of 3.37 was almost 
identical to her intake score of 3.34.  Similarly, the participant’s score on the BSQ-8 exhibited a 
reduction on the second administration, followed by a progressive increase on the third and 
fourth administrations.  Her final BSQ-8 score of 43 was three points higher than her initial score 
on this instrument.  Participant 4 received a final score of 29 on the Anxiety about Eating 
subscale, 32 on the Feared Concerns subscale, and 8 on the Food Avoidance Behaviors subscale.  
The participant’s initial improvement on self-report measures, particularly the BSQ-8, may be 
related to her weight loss during the first three months of treatment.  Similarly, subsequent 
weight regain may have contributed to worsening scores on these measures. 
 IVE and related outcomes.  Participant 4 reported significant fear about eating in front 
of other people, and avoided going to social events where she would be expected to eat.  She 
expressed concerns that other people monitor and negatively judge her eating behaviors, and 
worried about eating foods that might draw attention (e.g., eating food that is messy or noisy).  
Two months after starting treatment at the CCBT-ED, the participant’s primary therapist 
introduced the idea of IVE to address her anxiety and avoidance of eating in social situations.  
The participant reported that she was very anxious about participating in exposure treatment, and 
was resistant to even relatively straightforward IVEs such as eating while having a friendly 
conversation with an unfamiliar IVE therapist.  After reviewing the rationale for exposure, 
attempting to increase the participant’s motivation to participate, and discussing various 
possibilities for an IVE, Participant 4 agreed to an IVE in which she would eat a noisy food item 
while having a casual conversation with her primary therapist.  It was expected that this would 
be the first of several exposure sessions that would increase in difficulty over time.  
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 As planned, this IVE took place in a treatment room at the clinic with Participant 4 
bringing a bag of crackers to the session.  After reviewing goals, the participant began eating 
while carrying on a casual conversation with the primary therapist.  Participant 4 reported a 
SUDS rating of 65 at the start of the IVE, which increased to a high of 82 during the IVE.  At the 
end of the IVE, she reported a SUDS rating of 80, decreasing to 50 when assessed 15 minutes 
after the session had ended.  When debriefing with her therapist afterwards, the participant stated 
that the IVE was even more anxiety-provoking than she had anticipated.  Although the 
participant reported that she disliked the IVE, the significant difficulty she had with the IVE 
indicated to the primary therapist that additional exposure sessions would be particularly 
desirable for this patient.  Unfortunately, the participant abruptly relocated to a different state for 
occupational reasons, ending treatment with the CCBT-ED before additional IVEs could be 
conducted. 
 Visual inspection of SUDS.  Figure 8 presents Participant 4’s SUDS ratings for the TV 
(noisy eating) and UV (receiving critical comments about a meal) throughout her treatment at the 
CCBT-ED.  The final SUDS collected on day 187 were obtained during a final phone check-in 
with the participant almost one month after her last in-person CBT session.  Overall, there were 
minimal changes in SUDS ratings of both the TV and UV over the course of treatment.  Visual 
inspection of mean indicated that SUDS of both the TV and UV were slightly lower in the 
several sessions following the IVE.  Similarly, both the TV and UV exhibited a slight reduction 
in SUDS ratings in level after the IVE.  Visual inspection of slope indicated that SUDS of the 
TV changed from a small positive slope before the IVE to a small negative slope after the 
exposure session.  In contrast, the slope of the UV changed from a small negative slope before 
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the IVE to a small positive slope after the exposure.  Overall, similar reduction in SUDS ratings 
of the TV and UV precludes making any conclusions about the efficacy of this IVE at reducing 
Participant 4’s SUDS ratings of the TV. 
 
Figure 8.  Participant 4’s SUDS ratings of two situations over the course of treatment: (1) eating 
food in a noisy way and (2) receiving critical comments about a meal that she is eating. 
 
 
 
Figure 8 Note.  Higher ratings indicate more distress.  Ratings were obtained at the start of each 
CBT session.  The vertical dashed line represents when the patient participated in an IVE 
session, which targeted anxiety related to eating food in a noisy way. 
SUDS = Subjective units of distress 
IVE = In vivo exposure 
 
 Statistical analyses of SUDS.  Consistent with the small changes in slope observed using 
visual inspection, ALLISON-MT analyses resulted in adjusted R2 values of zero for both the TV 
and UV when employing the short phase criteria (see Table 2).  In the long phases, an adjusted 
R2 value of zero was calculated for the TV and a positive value for the UV.   
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 Due to the lower SUDS ratings of variables in the phase after the IVE relative to the 
phase before the exposure, positive within-subject Cohen’s d effect sizes were found for both 
variables within the short and long phases. 
  Visual inspection of self-efficacy ratings.  Figure 9 presents Participant 4’s self-efficacy 
ratings of the TV and UV.  In the CBT session immediately before the IVE, the participant 
reported a substantial increase in self-efficacy ratings for both variables.  In contrast to stable 
baselines, this sharp positive trend just before the implementation of the IVE complicates the 
interpretation of changes in self-efficacy following the IVE.  It is unclear whether reductions in 
self-efficacy following the IVE were due to the effects of the exposure session or a natural return 
to her baseline ratings.  Visual inspection of mean, level, and trend did not support the 
hypothesis that the IVE resulted in an increase in self-efficacy ratings of the TV, as self-efficacy 
ratings of the TV decreased according to these three approaches.  Moreover, the UV exhibited an 
increase in level and slight increase in mean self-efficacy ratings.  Like the TV, the UV changed 
from a positive slope in the phase before the IVE to a negative slope in the phase after the 
exposure session. 
 Statistical analyses of self-efficacy ratings.  As noted in Table 3, ALLISON-MT 
produced negative adjusted R2 values for the TV and UV within the short and long phases. 
 Consistent with results from visual inspection of the mean, within-subjects Cohen’s d 
effect sizes were negative for the TV and positive for the UV within both the short and long 
phases. 
 Satisfaction with IVE.  According to her responses on the IVE Feedback Form, 
Participant 4 indicated dissatisfaction with the exposure session.  She responded to all Likert  
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Figure 9.  Participant 4’s self-efficacy ratings of two situations over the course of treatment: (1) 
eating food in a noisy way and (2) receiving critical comments about a meal that she is eating. 
Figure 9 Note.  Higher ratings indicate greater self-efficacy.  Ratings were obtained at the start of 
each CBT session.  The vertical dashed line represents when the patient participated in an IVE 
session, which targeted self-efficacy related to eating food in a noisy way. 
IVE = In vivo exposure 
 
items with a rating of 1, suggesting that she strongly disagreed with the assertion that IVE added 
to the effectiveness of treatment, increased the efficiency of treatment, or helped increase her 
confidence in being able to handle a variety of situations related to eating, weight, and shape.  In 
her responses to the open-ended questions, the participant described the exposure session as 
“fairly awful” and indicated that she “failed” the IVE.  She noted that the IVE was too 
challenging, highlighted that her social eating issues are “deeply rooted,” and led to “regressive 
binge-eating behavior.”  On the other hand, the participant also reported on the IVE Feedback 
Form that she understands the potential value of IVEs and thought that other patients could 
benefit from them. 
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Participant 5 
 Demographics and clinical characteristics.  Participant 5 was an adolescent who 
received a diagnosis of OSFED, BN of low frequency from the CCBT-ED.  Her BMI at intake 
was 22.8.  She reported uncertainty about her highest or lowest weight, but denied ever 
experiencing significant weight fluctuations.  She reported objective binge eating and purging an 
average of once every two weeks over the past two years.  The participant noted that she had 
stopped purging approximately two months before her evaluation at the CCBT-ED and had not 
had an objective binge-eating episode in two weeks.  The participant endorsed subjective binge-
eating episodes, a strong desire to purge after eating certain meals, and significant fear and 
avoidance of foods she considered fattening or unhealthy.  She reported sub-clinical symptoms 
of social anxiety and depression.   
 Participant 5 reported a global EDE-Q score of 1.54 at intake, which is within one 
standard deviation of the mean of a normative sample of young adult women and between the 5th 
and 10th percentiles of treatment-seeking females with eating disorders.  Participant 5’s initial 
BSQ-8 score of 20 matched the mean of a normative sample of young adult women.  Her score 
of 18 on the Feared Concerns subscale and 15 on the Anxiety about Eating subscale of the 
FOFM were greater than one standard deviation above the mean of a small sample of healthy 
controls, and less than two standard deviations below the mean of a clinical sample.  Her score of 
8 on the Food Avoidance Behaviors subscale was less than one standard deviation below the 
mean of a healthy sample.  She endorsed a SUDS greater than 50 for just over half of the 29 
scenarios on the IVESS. 
 
 95 
 CBT interventions and treatment outcomes.  Participant 5 continues to receive 
treatment from the CCBT-ED.  The present study includes data from one IVE and 53 CBT 
sessions over 337 days.  As noted in Table 1, over half of her CBT sessions included 
interventions related to psychoeducation, enhancing motivation, in-session weighing, self-
monitoring and meal planning, cognitive interventions addressing disordered eating, and CBT 
for concerns other than her eating disorder.  Many of these interventions worked in conjunction 
to explore and challenge the participant’s beliefs about the relationship between the consumption 
of feared foods and weight gain, as well as to facilitate the reintroduction of foods she perceived 
as unhealthy into her diet.  Treatment also targeted her fears of eating in social situations, 
investment in treatment, and completion of food and thought records between treatment sessions.  
CBT interventions that were unrelated to the participant’s eating disorder often focused on 
thoughts, behaviors, and emotions related to life stressors, depressed mood, and social anxiety.   
 Participant 5 reported one purging episode within the first month of treatment, and no 
purging afterwards.  Over the course of treatment, the participant indicated experiencing 22 
subjective binge-eating episodes, but no objective binge eating.  Participant 5 used inconsistent 
criteria to define a subjective binge-eating episode, and included eating accompanied by any 
feeling of loss of control, eating a meal that she considered large, and/or consuming food that she 
felt was too high in fat or calories.  She gained approximately 9 lbs. during the first three months 
of treatment, and has maintained a BMI of 24.4 since that time. 
 Similar to her score at the time of assessment, Participant 5’s most recent EDE-Q score of 
2.44 was within one standard deviation of the mean of a healthy sample, and between the 10th 
and 15th percentiles of treatment-seeking females.  Her BSQ-8 score also remained relatively 
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stable throughout treatment; her final score on this measure was 23.  Participant 5’s scores on the 
three subscales of the FOFM increased slightly from intake, although all were more than two 
standard deviations below the mean of a small sample of patients with eating disorders.  She 
received a score of 23 on the Anxiety about Eating subscale, 15 on the Food Avoidance 
Behaviors subscale, and 26 on the Feared Concerns subscale.  While it is possible that the slight 
increases in Participant 5’s scores on the EDE-Q, BSQ-8, and FOFM subscales indicate 
worsening eating disorder symptoms over time, these small changes may instead reflect 
regression to the mean, mild fluctuations in the severity of her eating disorder symptoms, 
increased awareness of her symptoms, and/or improved understanding of the constructs 
measured by these questionnaires. 
 IVE and related outcomes.  Despite Participant 5’s sustained abstinence of purging and 
objective binge eating throughout the first few months of treatment, she continued to express 
significant fear and disordered thinking related to eating foods that violated certain dietary rules 
and/or health guidelines, as well as eating in front of other people.  Approximately six months 
into treatment at the CCBT-ED, the participant and her primary therapists began planning what 
they anticipated to be the first of several IVE sessions targeting these concerns.  Participant 5 
stated that she was very anxious about eating with someone she had never met before, and 
requested that the first IVE include a food item that was not too challenging.  The participant and 
her primary therapists collaboratively decided that she would eat a large slice of vegan pizza, 
which she rated with a SUDS of 65.  They also agreed to target the participant’s fear of eating a 
meal that is larger and/or higher in calories and fat than a meal being eaten by another person.  
To address this issue, Participant 5 and her primary therapists decided that the IVE therapist 
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would bring a relatively small portion of food to eat for herself.  
 During the IVE, Participant 5 purchased a slice of vegan pizza for lunch from a grocery 
store with an eatery, and sat at a table with an IVE therapist she was meeting for the first time.  
The IVE therapist brought one breadstick for herself to eat.  Participant 5 and the IVE therapist 
had a friendly conversation, and the IVE therapist noted that the participant appeared to become 
more relaxed over the course of the 30-minute session.  The participant’s SUDS rating reduced 
from 60 five minutes before the start of the IVE to 50 by the beginning of the exposure session, 
remained at 50 for the rest of the IVE, and reduced to 40 seven minutes after the end of the IVE.  
 In the following CBT session, the participant indicated to her primary therapists that the 
IVE was not as difficult as she had expected, although she was uncertain if the IVE contributed 
to any changes in her anxiety or self-efficacy about eating in social situations.  While discussing 
potential foods and scenarios to target in a second IVE session, the participant exhibited 
difficulty identifying what thoughts contributed to her anxiety.  The primary therapists thus 
shifted focus in CBT sessions to help Participant 5 better understand her thoughts and beliefs 
about food, dietary rules, and eating in social situations, and decided to hold off on conducting 
additional IVE sessions until the participant developed improved insight into her own cognitions. 
 Visual inspection of SUDS.  Figure 10 presents Participant 5’s SUDS ratings for two 
TVs (vegan pizza and eating a larger meal than another person) and one UV (wearing tight 
clothing around others).  Visual inspection of mean and level were consistent with the present 
study’s hypotheses, as both TVs exhibited decreases in SUDS in the CBT session immediately 
after the IVE and during the multiple CBT sessions following the IVE, while SUDS of the UV 
remained relatively stable before and after the IVE.  Ratings for vegan pizza exhibited a decrease 
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in slope in SUDS following the IVE, while the slope in SUDS ratings for eating a larger meal 
than another person was roughly the same before and after the IVE.  The generally stable pattern 
of SUDS of the UV before the IVE did not change following the IVE. 
 
Figure 10.  Participant 5’s SUDS ratings of one food and two situations over the course of 
treatment: (1) vegan pizza, (2) eating a larger meal than someone else she was eating with, and 
(3) trying on tight clothing around others. 
 
Figure 10 Note.  Higher ratings indicate more distress.  Ratings were obtained at the start of each 
CBT session.  The vertical dashed line represents when the patient participated in an IVE 
session, which targeted anxiety related to eating vegan pizza and eating a larger meal than 
another person she was eating with. 
SUDS = Subjective units of distress 
IVE = In vivo exposure 
  
 Statistical analyses of SUDS.  For the TV of vegan pizza, ALLISON-MT analyses 
exploring changes within the short and long phases produced some of the largest positive 
adjusted R2 values in present study (see Table 2).  Increasing confidence that the IVE contributed 
to changes in the TVs are the small adjusted R2 values obtained for the UV (a value for the UV 
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from the short phase could not be calculated due to the lack of variability in SUDS). 
 Relatively large positive Cohen’s d values were obtained for the two TVs within the short 
and long phases (see Table 2).  As hypothesized, the UV did not exhibit a reduction in mean 
SUDS following the IVE, resulting in a negative d within the long phases. 
 
Figure 11.  Participant 5’s self-efficacy ratings of one food and two situations over the course of 
treatment: (1) vegan pizza, (2) eating a larger meal than someone else she was eating with, and 
(3) trying on tight clothing around others. 
 
Figure 11 Note.  Higher ratings indicate greater self-efficacy.  Ratings were obtained at the start 
of each CBT session.  The vertical dashed line represents when the patient participated in an IVE 
session, which targeted self-efficacy related to eating vegan pizza and eating a larger meal than 
another person she was eating with. 
IVE = In vivo exposure 
   
 Visual inspection of self-efficacy ratings.  Figure 11 illustrates Participant 5’s self-
efficacy ratings of the two TVs and one UV.  Visual inspection of the mean indicated minimal 
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increases in self-efficacy ratings of both TVs, which may be due to ceiling effects: both TVs 
were rated with a self-efficacy score greater than 80 in the CBT session before the IVE.  Visual 
inspection of level indicated an increase in self-efficacy level for the TV of vegan pizza, but not 
the TV of eating more than another person.  The self-efficacy score of 50 for the UV remained 
the same during the several CBT sessions before and after the IVE.  Visual inspection of trend of 
Participant 5’s self-efficacy data did not support the present study’s hypotheses.  Perhaps due to 
ceiling effects, slopes of the TVs did not increase following the IVE. 
 Statistical analyses of self-efficacy ratings.  Results form ALLISONT-MT for 
Participant 5 generally did not support the study’s hypotheses.  As noted in Table 3, ALLISON-
MT often produced values at or below zero for the two TVs.   
 In contrast, results from within-subject Cohen’s d effect sizes tended to support the 
present study’s hypotheses.  Although a negative d was found for the TV of vegan pizza within 
the long phases, this negative value appeared to be due to temporary decreases in the 
participant’s self-efficacy score several sessions after the IVE (see Figure 11).  A positive d was 
found for the vegan pizza variable within the short phases.  Positive Cohen’s ds were calculated 
for the TV of eating more than another person within the short and long phases, while a negative 
d was found for the UV within the long phases (a d could not be calculated for the short phases). 
 Satisfaction with IVE.  Participant 5’s responses on the IVE Feedback Form indicated 
that she did not find the IVE session to be particularly helpful.  She responded to the Likert items 
with a rating of 4, suggesting that she neither agreed nor disagreed with the statement that IVE 
added to the effectiveness of treatment, increased the efficiency of treatment, or helped increase 
her confidence in being able to handle a variety of eating-related situations.  She noted in 
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response to open-ended questions that the IVE went better than she had expected, and had 
appreciated that her therapists worked with her to choose an exposure situation that was not too 
challenging for her first session.  On the other hand, she also expressed that the IVE session may 
not have been challenging enough, and indicated that she could not completely remember the 
purpose of the IVE.  While Participant 5 stated that she does not feel passionately about whether 
future patients should participate in IVE sessions, she noted that IVE sessions seem to have the 
benefit of committing patients to actually making a change or partaking in a challenging situation 
that they could otherwise choose to avoid.   
Results Across All Participants 
 In addition to results investigating each participant’s ratings following IVE sessions, 
supplementary analyses explored findings across all five participants, including: (1) the 
relationship between TVs, UVs, and RVs, and (2) inter-rater reliability on the CCBT Checklist. 
 Exploring relationships between variables.  In addition to changes in SUDS and self-
efficacy ratings of TVs and UVs, participants’ ratings of RVs were also examined via visual 
inspection to explore potential patterns of change over the course of treatment and in response to 
IVE sessions.  Paralleling the data from TVs and UVs (see Figures 2 – 11), RVs typically 
exhibited a progressive decrease in SUDS and increase in self-efficacy ratings over time across 
the five participants.  Moreover, RVs demonstrated a similar pattern as the TV(s): RVs typically 
increased when the TV(s) increased, and decreased when the TV(s) decreased.  In other words, 
SUDS and self-efficacy data from TVs and RVs appeared correlated.   
 Table 4 presents Pearson’s correlation coefficients (r) representing the relationship 
between SUDS of TVs, RVs, and UVs.  For each TV, three correlation coefficients were  
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Table 4. Pearson’s correlation coefficients (r) representing the relationship between distress ratings of target, 
unrelated, and related variables. 
  Target Variable  Unrelated Variable  Related Variables 
      Lowest r  Highest r 
Participant 1         
 Item  Meal in Bathing Suit  Eating Not Hungry  
Critical Comments 
Weight  
Critical Comments 
Meal 
 Pearson’s r    0.89  0.63  0.94 
          
 Item  Active in Bathing Suit  Eating Not Hungry  
Critical Comments 
Meal  
Critical Comments 
Weight 
 Pearson’s r    0.35  0.24  0.76 
          
Participant 2         
 Item  Critical Comments Meal  
Gym Around 
Others  Cake  
Eating More than 
Other Person 
 Pearson’s r    0.94  0.38  0.94 
          
Participant 3         
 Item  Unfamiliar Person  Eating Not Hungry  
Gym Around 
Others  
Fast-Food 
Restaurant 
 Pearson’s r    0.41  0.43  0.66 
          
 Item  Critical Comments Meal  Eating Not Hungry  Fried Rice  
Flatbread 
Sandwich 
 Pearson’s r    0.61  0.13  0.71 
          
Participant 4         
 Item  Noisy Eating  Critical Comments Weight  
Other Person Not 
Eating  
Critical Comments 
Meal 
 Pearson’s r    0.46  0.49  0.62 
          
Participant 5         
 Item  Vegan Pizza  Tight Clothing Around Others 
 Milkshake  Waffles 
 Pearson’s r    --  -0.04  0.39 
          
 Item  Eating More than Other Person 
 Tight Clothing 
Around Others 
 Milkshake  Eating Large Meal 
 Pearson’s r    -0.12  0.02  0.36 
Table 4 Note.  An r representing the correlation between vegan pizza and wearing tight clothing around others 
for Participant 5 could not be calculated due to lack of variability in the ratings of the latter variable. 
r = Pearson’s correlation coefficient 
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calculated, which represent the relationship between the SUDS of the TV and the: (1) UV, (2) 
RV with the lowest r, and (3) RV with the highest r.  The considerable differences between the 
lowest and highest correlation coefficients within each participant except Participant 5 indicated 
that the extent to which RVs were correlated with the TV varied substantially.  Moreover, UVs 
often exhibited a stronger correlation with the TV than some of the RVs.  For example, 
Participant 2’s SUDS of the TV (receiving critical comments about a meal she was eating) were 
highly correlated with her SUDS of the UV (working out at the gym around other people) (r = 
0.94), despite the expectation that ratings of these two variables would not be closely related 
(Figure 4 provides a visual representation of this correlation).  This correlation coefficient was 
similar to those obtained when analyzing the relationship between Participant 2’s SUDS ratings 
of the TV and potentially related scenarios (e.g., eating a bigger meal than someone else, r = 
0.94), and greater than those exploring the relationship between her SUDS of the TV and 
potentially related foods (e.g., cake, r = 0.38). 
 In general, each participant’s SUDS and self-efficacy ratings of scenarios appeared to be 
more highly correlated with the TVs (all of which were also scenarios except for one of 
Participant 5’s TVs) than their ratings of foods.  After collapsing RVs and UVs into the same 
category, Pearson’s correlation coefficients were calculated between the SUDS of each scenario  
TV and all other foods, and between each scenario TV and all other scenarios, for the four 
participants who provided SUDS for both foods and scenarios (Participant 4 only reported 
distress related to scenarios during treatment, and thus was not asked to provide SUDS ratings 
for foods).  Mean scenario correlation coefficients were then calculated: r = 0.63 for Participant 
1, r = 0.94 for Participant 2, r = 0.56 for Participant 3, and r = 0.08 for Participant 5.  Mean food  
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Figure 12. Participant 2’s mean SUDS ratings for all foods and scenarios measured over the 
course of treatment. 
 
Figure 12 Note.  Ratings were obtained at the start of each CBT session.  The vertical dashed 
lines represent when the patient participated in her first and second IVE session. 
SUDS = Subjective units of distress 
IVE = In vivo exposure 
 
correlation coefficients were derived using the same approach: r = 0.71 for Participant 1, r = 0.49 
for Participant 2, r = 0.34 for Participant 3, and r = 0.20 for Participant 5.  These results suggest 
that SUDS of TVs, all of which were scenarios, were more highly correlated with SUDS of other 
scenarios than SUDS of foods, with the exception of Participant 5.  On the other hand, distress 
ratings of foods still yielded a moderate correlation with ratings of target scenarios. 
 To explore session-to-session variability in participants’ ratings, a mean food SUDS 
rating was calculated at each CBT session by averaging SUDS ratings of all foods on each 
participant’s short food hierarchy.  A mean scenario SUDS rating from each CBT session was   
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Figure 13. Participant 2’s mean self-efficacy ratings for all foods and scenarios measured over 
the course of treatment. 
 
Figure 13 Note.  Ratings were obtained at the start of each CBT session.  The vertical dashed 
lines represent when the patient participated in her first and second IVE session. 
IVE = In vivo exposure 
  
also calculated by averaging all scenarios on the short scenario hierarchy.  Additionally, mean 
food and scenario self-efficacy ratings were obtained using the same procedures.  Figures 
displaying these mean scores were created for each participant and analyzed visually.  Figures 12 
and 13 present the results for Participant 2.  Similar to the pattern observed in SUDS and self-
efficacy ratings of specific scenarios over time (see Figures 2 – 11), the overall food and scenario 
ratings demonstrated variability from session to session.  However, this variability was more 
modest when looking at mean scores rather than individual items.  For example, while Figure 12 
demonstrates that Participant 2 sometimes reported greater than 25-point changes in SUDS in 
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consecutive CBT sessions, the decreasing trend in SUDS over time appears steadier than the 
pattern of Participant 2’s SUDS ratings of the individual variables illustrated in Figure 4. 
Interrater reliability of CBT interventions.  A Cohen’s kappa coefficient (κ) of 0.63 
was computed between the checklists completed by the primary investigator and therapists 
(when excluding the “other” option), indicating substantial agreement (Landis & Koch, 1977).  A 
second Cohen’s κ was calculated to evaluate interrater agreement related to whether or not at 
least one intervention from each category was employed in the CBT session.  A κ of 0.66 was 
calculated when focusing on the inclusion of interventions from the broader categories, also 
suggesting substantial agreement. 
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Discussion 
 Exposure therapy has been evaluated as a treatment for eating disorders since the early 
1980s (e.g., Rosen & Leitenberg, 1982), with most studies focusing on ERP for BN.  More 
recently, scientist-practitioners have explored the efficacy of exposure for patients with other 
eating disorder diagnoses (e.g., Hildebrandt et al., 2013; Steinglass et al., 2014) and additional 
symptom patterns such as body dissatisfaction (e.g., Hildebrandt et al., 2012; Morgan et al., 
2014; Trentowska et al., 2014).  None of these investigations, however, have fully applied the 
principle of “overcorrection” when developing exposure sessions, with the exception of a case 
study describing imaginal exposure for AN (Levinson et al., 2014).  The present study is the first 
to explore the impact of challenging therapist-assisted IVE sessions that address a wide range of 
eating, weight, and shape situations designed to amplify or exaggerate patients’ fears.    
 Unfortunately, limitations related to the study’s design and sample prohibit making 
conclusions about the efficacy of IVE, particularly due to the challenge of identifying 
comparison variables that are simultaneously relevant to eating disorder treatment and unrelated 
to the domains being targeted by IVE.  Nevertheless, systematic and detailed information 
collected from each participant provided some clues about the utility and potential complications 
of adapting exposure treatment for this clinical population.  Results suggest that at least some 
participants perceived challenging exposure sessions as valuable, which may encourage further 
research evaluating the efficacy of IVE for this population.  Preliminary findings from the 
present study may also inform future research that could better answer whether IVE is an 
effective additive element to CBT for eating disorders. 
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Findings from the Multiple-Baseline Design 
 Changes in SUDS following IVE.  The present study’s primary hypothesis predicted a 
decrease in SUDS of a TV and no change or an increase in SUDS of a UV.  With the exception 
of Participant 5’s results, visual inspection and statistical analyses of SUDS did not support this 
hypothesis: while SUDS ratings of TVs often reduced following exposure, similar changes 
tended to occur in the UVs.  Although the frequent reductions in SUDS ratings following IVE 
sessions may indicate that exposure is effective in reducing anxiety, the similar decreases in 
SUDS for variables that were presumed to be unrelated preclude conclusions about whether any 
changes were related to IVE.  Decreases across all variables could be attributable to other 
factors, such as the non-exposure elements of CBT, time, regression to the mean, or individual 
patient variables unrelated to treatment. 
 In general, results from analyses using ALLISON-MT paralleled the findings from visual 
inspection of trend, both of which provided the least support for the present study’s hypotheses.  
Visual inspection of trend examined the slope of the SUDS data before and after each exposure 
session.  To support the study’s primary hypothesis, the trend line following the IVE needed to 
exhibit a greater negative slope than the trend line prior to the IVE.  However, participants were 
more likely to exhibit a greater negative reduction in SUDS toward the beginning of treatment, 
often creating sharper negative slopes prior to the first IVE session relative to the post-IVE 
slopes.  Similarly, ALLISON-MT controls for decreasing trends in the pre-intervention phase 
when calculating an adjusted R2 value.  To demonstrate an effect, the data in the post-
intervention phase must exhibit a greater decreasing trend than the pre-intervention phase trend.  
It appears likely that the decreasing trend in SUDS data over the course of CBT, particularly 
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toward the start of treatment, is at least partially responsible for the limited support of the study’s 
primary alternative hypothesis via ALLISON-MT and visual inspection of trend.   
 Similar to the parallel between visual inspection of trend and results from ALLISON-
MT, findings from visual inspection of mean converged with within-subject Cohen’s d effect 
sizes.  The convergence between these two approaches is likely due to the fact that both focus on 
change in mean scores of ratings before and after an IVE.  Given that all variables tended to 
exhibit reductions over time, mean scores of SUDS of TVs and UVs were typically lower in the 
phase following an IVE than the phase before an IVE.  
 As general reductions in SUDS ratings over time make it difficult to interpret results from 
visual inspection of trend (along with ALLISON-MT) and mean (along with within-subject 
Cohen’s d), visual inspection of level may be the most valuable measure of change following 
each IVE session.  As inspection of level focused solely on the SUDS rating obtained in the CBT 
session before and after the IVE, results should be less susceptible to attenuation (as was the case 
with inspection of trend) or inflation (as was the case with inspection of mean).  Consistent with 
this premise, participants were less likely to report reductions in SUDS and more likely to report 
increases or no change in SUDS from session to session before the first IVE occurred (see 
Figures 2 – 11).  However, reductions in SUDS level of TVs following IVEs did not appear to 
occur more often than what might be expected by chance.  Moreover, UVs exhibited decreases in 
SUDS level at a similar rate as TVs for all but Participant 5.  Unfortunately, the lack of a clear 
distinction between changes in level of the TVs versus UVs for Participants 1 – 4 precludes 
making cause-and-effect conclusions about the efficacy of IVE at affecting SUDS ratings.   
 The most convincing evidence for the additive efficacy of IVE was observed with 
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Participant 5, who reported decreases in SUDS ratings of two TVs immediately after her IVE 
and relatively stable ratings of the UV.  Interestingly, Participant 5 also exhibited the smallest 
correlations between TVs and other variables (see Table 4), which may indicate that this 
participant viewed the TVs as distinct from the UV, while the other four participants may not 
have differentiated distress about TVs from the selected UV.  While Participant 5’s SUDS data 
provide support of the primary hypothesis, it cannot be ruled out that these results are due to 
chance or other factors.  The lack of replication of Participant 5’s results across participants 
prohibits concluding that IVE contributes to reductions in SUDS ratings about various eating, 
weight, and shape situations.  
 Changes in self-efficacy ratings following IVE.  Similar to the results from SUDS data, 
analysis of self-efficacy ratings using visual inspection of trend paralleled findings from 
ALLISON-MT, and visual inspection of mean converged with within-subject Cohen’s d effect 
sizes.  Overall, changes in self-efficacy ratings following IVE sessions were more modest than 
changes in SUDS.  Visual inspection of trend and adjusted R2 values from ALLISON-MT rarely 
supported the alternative hypothesis.  While visual inspection of the mean and Cohen’s d effect 
sizes often found that self-efficacy of TVs increased in the several following sessions following 
IVE, UVs also demonstrated greater post-IVE mean scores.  Changes in the level of self-efficacy 
ratings of TVs following IVEs are similar to what would be expected by chance.  Overall, the 
present study failed to provide convincing evidence that IVE sessions led to increases in self-
efficacy for TVs.  
 Relationship between variables.  The logic of the present study’s multiple-baseline 
design depended on IVE specifically affecting TVs and not impacting UVs that were deemed 
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unlikely to be influenced by the IVE.  For example, it was predicted that an IVE designed to 
address a participant’s fear of receiving critical comments about a meal she was eating would not 
likely impact anxiety or self-efficacy about working out at the gym around others.  In reality, 
most of the variables selected as “unrelated,” as well as “related” items that were not targeted by 
IVE, exhibited modest to strong correlations with TVs (see Table 4).  In general, SUDS ratings 
of TVs and UVs appeared to exhibit similar patterns over the course of CBT: as SUDS for one 
variable increased, SUDS for the other variables also tended to increase, and vice versa. 
The correlation between TVs, UVs, and RVs may indicate that most participants 
perceived these different variables as part of the same broader construct.  If this is the case, 
factors that impact one of these variables would be likely to affect the others.  Alternatively, the 
therapeutic effects of IVE (and/or other aspects of treatment) may have generalized to a wide 
range of variables, impacting participants’ ratings of all items on the short fear hierarchies.  For 
example, an exposure session that decreased a participant’s anxiety about people commenting on 
her food choices may have had cascading effects that led to reduced distress about eating feared 
foods, breaking dietary rituals, and participating in previously avoided activities due to body 
dissatisfaction.  It may also be the case that patients are not sensitive to differences between their 
emotional responses to distinct eating, weight, and shape situations.  Participants’ ratings on the 
short fear hierarchies could represent broader feelings of anxiety and self-efficacy, such that 
greater anxiety and disordered thoughts and behaviors in general translates to higher SUDS and 
lower self-efficacy ratings across all items assessed on the fear hierarchies.  Regardless of the 
specific reason(s), the correlations between TVs and UVs indicate that the selection of different 
types of eating, weight, and shape scenarios as comparison behaviors was a poor choice for the 
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present study’s multiple-baseline design across behaviors, at least for four of the five 
participants. 
 Conclusions about the efficacy of IVE.  In view of the limited support achieved for the 
primary hypothesis, it appears reasonable to conclude that IVE did not contribute to the efficacy 
of CBT for most participants.  Patients tended to improve across all measures, including SUDS 
and self-efficacy ratings, throughout the course of treatment, and neither visual inspection nor 
statistical analyses provided convincing evidence that IVEs had a noticeable impact on this trend 
for Participants 1 – 4.  
 On the other hand, several alternative explanations should be considered.  As noted 
earlier, the effects of IVE sessions may generalize to variables not specifically targeted by 
exposure, resulting in changes to both TVs and UVs.  It is also conceivable that other factors, 
such as stressors in the participants’ lives or other components of CBT, may have affected 
participants’ ratings and obscured the effects of IVE sessions.  Alternatively, IVE sessions may 
have delayed effects that could not be discerned from the changes occurring from CBT.  It is also 
feasible that IVE might contribute to change in ways not captured by SUDS or self-efficacy 
ratings, such as by building resistance to relapse in the future.  As each participant received only 
one to two IVE sessions, it is possible that a larger number of exposure sessions must be 
administered for IVE to demonstrate significant effects.   
 Taken together, the present study’s inconsistent findings preclude conclusions about 
whether or not IVE is an effective treatment element of CBT for eating disorders.  Additional 
research that better controls for confounding variables is necessary to draw more certain 
conclusions about the efficacy of IVE. 
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Other Findings Relevant to the Application of IVE for Patients with Eating Disorders 
 In addition to exploring the efficacy of IVE as an additive element to CBT for eating 
disorders, the present study provided a systematic, fine-grained look at how IVEs were 
conducted for five patients at the CCBT-ED.  While results from the multiple-baseline design 
failed to support any clear conclusions about the efficacy of IVE, other pieces of information 
were obtained from the close examination of CBT with challenging exposure sessions across the 
study’s five participants.  Although small sample size precludes drawing any general conclusions 
from these exploratory findings, patterns in the data warrant comment and may inform future 
research.         
 Variability in SUDS and self-efficacy ratings.  Participants demonstrated different 
degrees of variability in SUDS and self-efficacy ratings over the course of CBT.  While some 
participants’ ratings remained relatively stable, others’ exhibited substantial fluctuations.  
Additionally, distinct patterns in SUDS and self-efficacy ratings were observed within each 
participant.  For example, in the three CBT sessions prior to her second IVE, Participant 2’s 
SUDS ratings of the TV of receiving critical comments changed from a 60 to 95 to 50 (see 
Figure 4).  In contrast, her self-efficacy ratings for the TV during these three sessions were 85, 
95, and 95 (see Figure 5).  In other words, her self-efficacy ratings maintained a positive and 
stable trend even as her anxiety ratings fluctuated.  These results suggest that Participant 2 
experienced variable anxiety about certain situations while maintaining high confidence in her 
ability to handle these situations.  Interestingly, the opposite pattern emerged with Participants 3 
and 4, both of whom reported greater variability in self-efficacy than distress ratings.   
 The divergent patterns that often emerged between SUDS and self-efficacy ratings 
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suggest that distress and self-efficacy are distinct constructs.  The possibility that self-efficacy 
ratings may provide information about treatment progress above and beyond SUDS should 
encourage researchers to measure self-efficacy as a treatment outcome in the future.  Additional 
research might also explore whether changes in either distress or self-efficacy have a greater 
impact on treatment outcomes, as it is currently unclear if one of these two constructs is more 
important to target in treatment.  
 Overall, ratings were more stable when averaging across various items (see Figures 12 
and 13), but still appeared to exhibit somewhat greater variability than SUDS ratings of items 
reported over time in children and adults with anxiety in other studies (e.g., Chorpita et al., 1997; 
Hayes & Barlow, 1977; Knox et al., 1996; Scemes et al., 2009).  Further research is necessary to 
determine whether patients with eating disorders indeed exhibit more variability in SUDS ratings 
over the course of treatment than those with anxiety disorders.   
 The five participants also reported variable within-session SUDS ratings during exposure. 
For example, SUDS for Participants 1 and 4 increased substantially from their initial ratings at 
the start of the IVE, while Participants 3 and 5 reported their highest SUDS at the start of the 
exposure.  Participant 2’s SUDS ratings also reduced from the start to the end of her two IVEs, 
but demonstrated a fluctuating pattern during the exposure sessions.  The varied changes in 
SUDS observed across the five participants within IVE sessions is consistent with the diverse 
patterns reported by adults with social anxiety disorder during exposure (Hayes et al., 2008).  It 
remains unclear whether within-session habituation is a predictor of between-session progress 
when targeting feared situations in patients with eating disorders. 
 It should be reiterated that some of the distinctive features of eating disorders, 
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particularly AN, add complexity to the use of SUDS and self-efficacy ratings as measures of 
treatment progress.  As described earlier, SUDS ratings have been found to increase during and 
immediately following exposure sessions that involve the consumption of feared foods in 
patients with eating disorders (Boutelle, 1998; Carter et al., 2001).  This increase in anxiety is 
consistent with the observation that the primary fear of most patients with eating disorders – 
weight gain – is a longer-term consequence that cannot be challenged adequately in a brief 
exposure session (Murray et al., 2016), as the impact of exposure is expected to interact with 
changes in weight.  If a patient’s weight remains stable over time despite eating feared foods and 
abstaining from compensatory behavior, one might expect progressive reductions in SUDS.  
However, if a patient weighs 2 lbs. more in a CBT session following exposure to a feared food, 
the patient may attribute this weight increase to the food consumed and experience increased 
anxiety about the food.  Moreover, weight gain is a requirement of treatment for patients with 
AN.  Indeed, the belief held by patients with AN that increasing food consumption will lead to 
weight gain is an accurate one.  As a result, some have suggested that exposure to feared foods 
during the weight restoration phase of treatment for AN may inadvertently reinforce the belief 
that consumption of feared foods results in weight gain (Murray et al., 2016).   
 On the other hand, patients often overestimate the amount of weight gain they will 
experience after eating feared foods.  For these patients, exposure to feared foods may still be 
useful while they gain weight in treatment, as exposure treatment followed by weight gain that is 
less than expected could still reduce distress about these foods.  Patients with AN can also have 
idiosyncratic beliefs about certain foods, such as avoiding sweets but eating other foods that have 
the same caloric value.  In these cases, exposure to feared foods may help patients with AN learn 
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that, in general, the magnitude of weight gain is no greater when eating feared foods than non-
feared foods of the same caloric value.  Even if exposure therapy is helpful in reducing distress 
about feared foods in these ways, the complex relationship between food consumption and 
longer-term fears of weight gain is likely to produce variable SUDS and self-efficacy ratings 
over the course of treatment.   
 Further complicating this picture is the functional role that fear plays for many patients 
with AN (Garner & Bemis, 1982), as these individuals often exert effort to maintain their fear of 
food.  It may be the case that patients’ SUDS and self-efficacy ratings in response to exposure 
will be impacted by their motivation to recover and interest in reducing this fear.  Given 
observations that patients with eating disorders exhibit ongoing fluctuations in motivation 
(Vitousek et al., 1998), it would be reasonable to expect their ratings on outcome measures to 
follow this variable pattern.  It is also possible that patients may experience an increase in 
anxiety as they begin to contemplate taking on fear and avoidance.  Additional research is 
warranted to try to disentangle the complex interaction of factors that may impact patients’ 
response to exposure therapy, explore how weight changes may affect variability in SUDS and 
self-efficacy ratings following exposure, and identify potential differences between exposure to 
feared foods and feared situations in patients with eating disorders.   
 The potential value of targeting eating, weight, and shape situations.  In general, 
participants reported relatively high SUDS and low self-efficacy ratings throughout treatment, 
even as other measures indicated improvement.  For instance, Participant 2 obtained low scores 
on the EDE-Q, BSQ-8, and FOFM at intake with the CCBT-ED, and reported that she was no 
longer engaging in binge eating.  Based on this information, one might conclude that this 
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participant did not need to receive specialized treatment for her eating disorder.  On the other 
hand, she reported SUDS ratings of 50 or greater on all but three items on the IVESS, suggesting 
that she continued to experienced distress about a wide variety of situations related to eating, 
weight, and shape that may be important to address in treatment.  Given preliminary evidence 
that at least some patients with eating disorders report high SUDS and low self-efficacy ratings 
even when improving on other measures of eating disorder symptoms, it may be the case that 
distress and self-efficacy related to eating, weight, and shape situations represent unique 
constructs that provide information above and beyond the concepts measured by the EDE-Q, 
BSQ-8, and FOFM.   
 One measure that may overlap with the situations included in the IVESS is the Eating 
Disorder Recovery Self-Efficacy Questionnaire (EDRSQ; Pinto, Guarda, Heinberg, & 
DiClemente, 2006).  The EDRSQ assesses self-reported confidence to engage in behaviors that 
are incompatible with having an eating disorder such as eating without thinking about calories 
and looking in a mirror without thinking about weight loss.  The EDRSQ has demonstrated some 
discriminant validity by yielding small to moderate correlations with the constructs of maturity 
fears and awareness of society’s standards of thinness (Pinto et al., 2006), and significantly 
predicted length of hospital stay in inpatient and partial hospital programs (Pinto, Heinberg, 
Coughlin, Fava, & Guarda, 2008).  On the other hand, it is unclear whether the EDRSQ provides 
any additional information above and beyond the EDE-Q and/or BSQ-8.  Although the EDRSQ 
and IVESS both intend to capture constructs related to normative eating, the IVESS consists of a 
number of very challenging scenarios that have yet to be included in any published measure of 
recovery from an eating disorder.  In view of preliminary data form the present study that there 
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may be value in measuring and targeting challenging eating, weight, and shape situations, future 
researchers might consider developing and testing assessment tools that evaluate distress and 
self-efficacy in these situations.  It would also be interesting to administer such a measure to a 
large sample of individuals in the community to better understand normative levels of distress 
and self-efficacy in these situations. 
 Diverse preferences and reactions to IVE.  The five participants in the present study 
demonstrated dramatic variability in their interest in IVE and response to challenging exposure 
sessions.  For example, Participant 2 indicated that the check-in at the start of her first IVE made 
the exposure feel more artificial, requested that a second IVE be conducted with a new IVE 
therapist who would stay in character for the entire exposure session, and expressed interest in 
increasing the difficulty level of the second IVE.  In contrast, Participant 3 noted that she really 
valued the check-ins and debriefing as part of her IVEs, found the IVE in which she received 
some critical comments more difficult than she had expected, and expressed some regret that she 
agreed to participate in such a challenging IVE.    
 In sharp contrast to the difficult IVEs completed by Participant 2 was the session 
designed for Participant 4, which was the least challenging exposure conducted over the course 
of the present study.  Compared to the other participants, Participant 4 appeared to have the most 
difficulty with her IVE, which simply involved eating crackers while having a friendly 
conversation with her therapist in the clinic.  Interestingly, Participants 2 and 4 both presented to 
the CCBT-ED in remission from BED, suggesting that patients with the same diagnostic profile 
can exhibit substantially different responses to IVE.  While the results from the present study’s 
five participants suggest that patients with eating disorders exhibit diverse preferences and 
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reactions to IVE, this supposition needs to be explored by research using a larger sample of 
patients with eating disorders. 
Implications 
 Although the present study’s results do not allow for any conclusions about the efficacy 
of IVE, evidence that challenging IVE sessions were perceived as valuable by at least some of 
the study’s participants may have some useful implications.  It is worth noting that the 
satisfaction with IVE endorsed by at least three study participants is consistent with the anecdotal 
impressions of past therapists and the supervisor at the CCBT-ED.  More than 100 patients with 
eating disorders have been treated at the CCBT-ED during the past two decades, at least one-
third of whom received challenging IVE sessions.  Although these patients’ responses to IVE 
were not systematically measured, neither the supervisor nor prior CCBT-ED therapists recall 
any exposure sessions that appeared to cause sustained distress, symptom exacerbation, relapse, 
or treatment drop-out.  A few patients have been persistently reluctant to engage in IVE sessions, 
and some of these patients dropped out of treatment prematurely; however, such reluctance was 
typically associated with other indices of poor treatment engagement and compliance such as not 
keeping food records or failing to engage in behavioral experiments at home, so it is not clear 
that unwillingness to participate in IVE was specifically linked to treatment termination.  Almost 
all prior CCBT-ED patients reported to their therapists that they perceived IVE as valuable in 
some way, albeit to varying degrees and at different points throughout treatment. 
  Despite evidence to the contrary, therapists in both the eating and anxiety disorder fields 
express concerns that patients will be more likely to drop out of treatment that includes aspects 
of exposure therapy (Waller, 2009).  In view of these concerns with standard exposure protocols, 
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it would be reasonable to expect that therapists may be even more reluctant to conduct the 
challenging types of IVE sessions included in the present study, most of which were designed to 
“overcorrect” by amplifying feared stimuli.  The overall findings from this study are inconsistent 
with the belief that most patients will dislike IVE sessions or drop out of treatment.  If future 
research with larger sample sizes confirms that most patients find challenging IVE sessions 
valuable, then some reluctant therapists may consider incorporating exposure into treatment. 
 Additionally, it is hoped that therapists and researchers who already utilize exposure and 
related interventions for patients with eating disorders will consider implementing and evaluating 
more challenging exposure sessions that can be applied flexibly to a wide range of eating, 
weight, and shape situations.  Recent studies indicate movement toward testing more challenging 
and varied types of exposure sessions.  For example, Steinglass et al. (2014) evaluated ERP for 
eating-related situations that appeared to apply the principle of “overcorrection,” such as by 
having a patient keep her hand in a bag of chips for an extended period of time, while the body 
image exposures tested by Trottier et al. (2015) included patients eating a high energy food item 
in front of a romantic interest and trying on tight fitted jeans in a store.  Moving to more 
challenging IVEs may be a logical next step for exposure-oriented researchers and clinicians, and 
could be a particularly useful intervention later in treatment when many patients report reduced 
anxiety about less challenging eating, weight, and shape situations. 
Limitations and Future Directions 
 Limitations related to study design.  The primary limitation of the current project was 
the failure to identify appropriate comparison variables, at least for four of the five participants, 
which is required in order to make cause-and-effect conclusions when using a multiple-baseline 
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design across behaviors.  Unfortunately, ratings of variables designated as “unrelated” were 
usually correlated with ratings of the TV(s), which leaves the primary research questions 
unanswered.   
   Furthermore, multiple-baseline designs are more convincing when the data are relatively 
stable prior to the initiation of an intervention.  In the present study, however, ratings of TVs 
often exhibited substantial variability.  For example, Participant 2’s SUDS ratings frequently 
increased or decreased from session to session, and sometimes exhibited a change of more than 
40 points (see Figure 4), complicating interpretation of data following IVE sessions.  
Additionally, in the session before Participant 4’s IVE, her self-efficacy rating of the TV 
increased 40 points from the prior session (see Figure 9), which makes the reduction in the 
session after the IVE difficult to interpret.  An alternative design could have postponed the 
implementation of IVEs until a more stable baseline emerged for the TV.  This approach would 
have served as a logistical challenge in the present study, as IVEs at the CCBT-ED clinic are 
typically scheduled several weeks in advance and require ongoing planning between the primary 
therapist, patient, and IVE therapist.  Moreover, some participants may never exhibit stable 
SUDS or self-efficacy ratings throughout the course of treatment. 
 To reduce the complication of testing the efficacy of IVE when delivered as an additive 
element to CBT, future multiple-baseline designs could consider providing IVE without CBT.  
Another alternative would be to conduct a multiple-baseline design across participants with 
clearly defined “CBT only” and “CBT + IVE” phases.  In this type of design, the frequency of 
IVE might occur on a more frequent basis (e.g., at least one IVE session per week).  If 
participants received the CBT + IVE phase at different pre-determined time points, and each 
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exhibited consistent improvements on outcome measures in the CBT + IVE phase relative to the 
CBT only phase, then support would be provided for the conclusion that adding IVE to CBT 
increases overall efficacy.  A multiple-baseline design across participants would also circumvent 
the difficulty involved in identifying variables that are relevant yet uncorrelated to TVs. 
 While these alternative designs may increase internal validity, they are inconsistent with 
one of the goals of the present study: to identify the efficacy of IVE without substantially 
modifying the way in which treatment is conducted at the CCBT-ED.  Single-subject research 
has been proposed as a practical and flexible approach to treatment research without requiring 
major modifications to the way in which treatment is conducted in clinical practice (Nock et al., 
2008).  However, results from the present study suggest that more substantial changes to 
treatment delivery would have been necessary to generate conclusion about whether an additive 
element (e.g., IVE) increased the overall efficacy of a larger treatment package (e.g., CBT).  
Without making more substantial modifications, it appears that all of the following criteria would 
have needed to be met to support the study’s primary alternative hypothesis: an eating disorder 
target that is specifically affected by IVE is identified and tracked at every session; a variable 
that is affected by CBT but not IVE is identified and tracked at every session; the effects of IVE 
are robust to factors unrelated to treatment (e.g., stressors in the participant’s life); IVE is 
implemented only after ratings of the target variable exhibit stability over time; the effects of 
IVE are powerful enough to impact the target variable to a noticeably greater extent than CBT; 
and the effects of IVE on the target variable occur quickly or are so robust that they continue to 
impact the target variable for several subsequent sessions.  Overall, it appears that a multiple-
baseline design across behaviors designed to explore the efficacy of an additive element to a 
 123 
larger treatment package may be untenable without substantially modifying clinical practice, 
unless the additive element is predicted to have an extremely powerful, immediate, and robust 
effect on a specific variable without affecting another pre-identified relevant comparison 
variable. 
 More commonly, the efficacy of an additive component to a larger treatment package is 
evaluated using larger sample sizes.  Despite avoiding the limitations inherent in smaller sample 
designs, it is worth noting that group designs have a number of problems as well.  In particular, 
researchers must decide whether the addition of a new treatment component will replace content 
included in the larger treatment package, shorten the time allocated to some treatment elements, 
or be added to the treatment package, increasing the total amount of treatment offered.  The 
former two options may dilute treatment and mask any beneficial effects of the added treatment, 
while the latter confounds the content of the additive treatment with the increased quantity of 
treatment provided.  Additionally, group designs require especially large sample sizes to detect 
the efficacy of additive treatment elements (Bell, Marcus, & Goodlad, 2013), and can be 
expensive and time consuming (Kazdin, 1982).  
 Limitations related to study sample.  Moreover, any conclusions about the efficacy of 
IVE are limited to the types of patients obtained in the present study’s small sample.  It seems 
particularly noteworthy that the five participants presented with less severe psychopathology 
than the patients typically treated at the CCBT-ED: no participant met full criteria for AN, BN, 
or BED; three participants did not report high SUDS ratings for foods; and two participants had 
recently curtailed binge eating at another clinic before initiating services at the CCBT-ED.  
Although IVE is assumed to be valuable at addressing a diverse range of eating disorder 
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symptoms, the intervention was initially designed for more severe patients with AN or BN.  It is 
common for the CCBT-ED to treat patients with AN who are unwilling to introduce feared foods 
into their diets on their own, as well as patients with BN who predictably binge and/or purge 
after eating certain foods.  For many of these patients, IVE sessions that target feared foods early 
in treatment are hypothesized to be an important element of CBT to disrupt long-standing 
behavioral patterns.  None of the five participants matched the diagnostic and clinical profile of 
the patients for whom IVE was initially developed.  
 Exposure sessions are also hypothesized to be especially indicated for patients who 
appear “stuck” on certain issues or exhibit minimal improvements in anxiety and self-efficacy 
about certain foods and eating, weight, and/or shape concerns.  Conversely, IVE does not appear 
necessary for other patients, such as those who are able to reintroduce feared foods into their 
diets, abstain from binge eating and purging, give up disordered dietary rules and rituals, and 
become confident in a wide range of eating settings and situations without participating in IVE 
sessions.  Indeed, one patient who consented to participate in the present study did not receive 
any IVE sessions precisely because she achieved these improvements through CBT without 
therapist-assisted exposure.  While the IVE sessions conducted in the present study were 
predicted to be valuable, they did not seem essential to break through an important issue for most 
of the participants.  For example, both Participants 1 and 2 endorsed self-efficacy ratings greater 
than 70 for TVs before participating in an IVE session, and indicated in CBT sessions that they 
were improving in these domains.  Although the IVEs conducted for these two participants were 
relevant to issues brought up during treatment, exposure was likely not an imperative 
intervention for either participant to exhibit continued improvements.   
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 Interestingly, the study participant for whom IVE may have been the most indicated was 
also the patient who was most resistant to and least satisfied with IVE.  Participant 4 reported 
that eating a noisy food (i.e., crackers) with her therapist during her one IVE session was much 
more challenging than she had anticipated and led to “regressive binge-eating behavior.”  The 
significant difficulty that Participant 4 experienced with this relatively easy IVE suggested that 
eating in social situations was an issue that she was indeed “stuck” on.  While other CBT 
interventions may have been valuable in addressing this concern – such as cognitive 
restructuring or encouraging the patient to eat at social events on her own (i.e., between-session 
exposure without therapist assistance) – conducting therapist-assisted IVE may have been a 
particularly valuable approach for this individual.  Future research could investigate the impact 
of IVE on patients with other eating disorder diagnoses and presentations, the effects of more 
frequent IVE sessions, and how various patient characteristics predict responses to IVE. 
 It may also be valuable to explore how various patient characteristics and treatment 
elements moderate the efficacy of exposure therapy.  Despite the widely held belief that 
corrective learning is the key mechanism through which exposure therapy works, little is known 
about how and when cognitions change in response to the treatment.  Research from the anxiety 
disorder literature suggests that attentional bias toward threatening stimuli and greater emotional 
variability during exposure sessions are associated with improved outcomes (Culver, Stoyanova, 
& Craske, 2012; Niles, Mesri, Burkland, Lieberman, & Craske, 2013; Price, Tone, & Anderson, 
2011; Waters, Mogg, & Bradley, 2012).  Additionally, a study with anxious children found that 
debriefing after an exposure session (e.g., discussing the experience, reviewing SUDS ratings) 
predicted longer-term improvement, while preparing for the exposure session beforehand (e.g., 
 126 
reviewing the rationale, role-playing with the therapist) did not (Tiwari, Kendall, Hoff, Harrison, 
& Fizur, 2013).  Further research investigating these questions may provide important 
information about how to modify exposure therapy to maximize corrective learning, both for 
patients with eating disorders and those with other psychological conditions.  
 Limitations related to defining CBT sessions.  CBT sessions did not follow a specific 
protocol and included a diverse assortment of interventions.  While this approach is consistent 
with clinical practice at the CCBT-ED, it makes it difficult to define the treatment that each 
participant received.  While convergence on the study’s CCBT Checklists is encouraging, the 
lack of stronger kappa coefficients indicates that there were some inconsistencies between the 
therapist(s) and primary investigator’s ratings of CBT sessions.   
 There are several potential explanations for these discrepancies.  First, therapists made 
ratings from memory after conducting CBT sessions while the primary investigator completed 
checklists while listening to audio recordings.  Second, overlap between intervention domains 
may have contributed to uncertainty when categorizing some treatment approaches.  Third, 
participating therapists may have distinct approaches to classifying the diverse content of CBT 
into various interventions and categories.  As process ratings were not a central focus of the 
present study, therapists had received only brief instruction in coding of treatment interventions.  
More extensive training may have improved inter-rater reliability between therapists and the 
primary investigator.  Despite these limitations, the substantial agreement between study 
therapists and the primary investigator suggests that the former provided relatively accurate 
descriptions of the content of CBT sessions. 
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Conclusion 
 Overall, the results of the present study are inconclusive.  Although variables targeted by 
IVE often exhibited predicted changes in mean and level following IVE sessions, similar patterns 
were observed in variables not targeted by exposure.  Moreover, visual inspection of trend and 
findings from ALLISON-MT did not indicate that the rate of change increased or decreased in 
the predicted direction in response to IVE sessions, likely because greater changes in trend 
generally occurred toward the beginning of the treatment course, and IVE sessions were more 
often implemented later in treatment.  Taken together, it is unclear whether improvements in TVs 
are related to IVE, CBT, time, patient characteristics, regression to the mean, or other factors.  At 
the very least, the present study provides preliminary evidence that challenging exposure 
sessions can be acceptable to some patients with eating disorders.  Consistent with the CCBT-ED 
clinic’s impression of patients’ response to IVE over the past two decades, most study 
participants reported satisfaction with IVE, recommended that other patients with eating 
disorders receive IVE, and did not drop out of treatment because of challenging exposure 
sessions.  It is hoped that these results will encourage further clinical research evaluating the 
utility of challenging exposure sessions designed to “overcorrect” by intentionally amplifying 
patient’s fears of a wide range of scenarios related to eating, weight, and shape. 
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Appendix A: Food Phobia Survey 
           ID # _____________ 
FOOD SURVEY: I 
 
Please rate each of the foods on the following pages according to: 
 
 - how frequently, on average, you have eaten that food over the past year  
  If you have been hospitalized at any point during the past year, rate each item according to 
    how frequently you have eaten it when you were not in the hospital.   
 
 - how much you have feared eating or felt guilty about eating that food over the past year 
  Please rate this item independently from how often you have eaten the food and from how 
  much you like the food: 
       - for example, if you never eat spinach because you don't like spinach, but you would not feel  
   at all fearful or guilty about eating spinach, you would assign a "1" for frequency and a  
   "1" for fear/guilt in rating that item. 
       - for example, if you never eat fudge because you feel very fearful about eating it or would 
feel very guilty if you ate it, you would assign a "1" for frequency and a "5" for fear/ 
guilt in rating that item. 
 
Interpreting food items 
 Note that some of the items specify the type of food very precisely - for example, the questionnaire asks 
   separately about whole milk, 2% milk, and skim milk.  Other items are not specific about particular 
   characteristics of the food.  In these cases, you should assume that you are being asked about the most 
   usual or typical version of the food.   
- for example, if the item simply says "hot dog," you should assume that the meat consists of 
   beef and pork, since that is the most "typical" kind of hot dog. 
  - for example, if the item says "tuna sandwich," you should assume that the sandwich is made 
   of 2 pieces of regular bread and is filled with tuna mixed with mayonnaise, since that 
   is the most "usual" kind of tuna sandwich. 
 You should also assume that the items refer to usual or typical portion sizes. 
 
Please check one of the following categories to describe yourself: 
 
   1. ____ non-vegetarian  (I eat a range of foods that includes a variety of meats) 
  Please check this category if you are someone who eats meat infrequently, but who does eat 
meat occasionally;  the categories below should be endorsed only by people who never eat meat or 
almost never (no more than once or twice a year) eat meat. 
   2. ____ poultry/fish only  (I eat poultry and fish, but do not eat other meats) 
   3. ____ fish only  (I eat fish, but do not eat poultry or other meats) 
   4. ____ lacto-ovo vegetarian  (I eat dairy products and eggs, but do not eat any meat or fish) 
   5. ____ vegan  (I do not eat animal products of any kind, including dairy products or eggs) 
   6. ____ other  (please explain) 
   ________________________________________________________________________ 
    NOTE:  If you are a vegetarian or partial vegetarian, please do not include any ethical concerns in making 
the "fear/guilt" ratings on the following pages - rate the items according to the fear/guilt (if any) that you 
feel or would feel about eating specific foods for other reasons. 
 
Please list below any foods to which you have an established allergic response:  
   (you do not need to list foods that upset your stomach - only those foods to which you have a known allergy) 
 
 ______________________________________________________________________________________ 
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        Food Survey p. 2  ID # _______________ 
 
 
Please use these scales in rating each item for frequency and fear/guilt, circling one number in both columns: 
 
  Frequency:              never              rarely          occasionally      often             very often 
   1                    2                    3                    4                    5 
  Fear/guilt:                none              slight             moderate         strong           very strong 
 
          Frequency     Fear/Guilt 
 
 1.  regular cheese (e.g., cheddar, Swiss, Monterey jack) 1   2   3   4   5  1   2   3   4   5      ____  
 2.  oatmeal (plain)     1   2   3   4   5  1   2   3   4   5     ____ 
 3.  fried rice      1   2   3   4   5   1   2   3   4   5      ____ 
 4.  potato chips (low fat)     1   2   3   4   5  1   2   3   4   5     ____ 
 5.  baked chicken breast     1   2   3   4   5  1   2   3   4   5     ____ 
 6.  bacon      1   2   3   4   5  1   2   3   4   5     ____ 
 7.  grilled chicken sandwich    1   2   3   4   5  1   2   3   4   5     ____ 
 8.  spaghetti with meat sauce    1   2   3   4   5  1   2   3   4   5     ____ 
 9.  garden burger      1   2   3   4   5  1   2   3   4   5     ____ 
10.  tomato or cucumber salad    1   2   3   4   5  1   2   3   4   5     ____ 
 
11.  saimin      1   2   3   4   5  1   2   3   4   5     ____ 
12.  snow peas (Chinese pea pods)    1   2   3   4   5  1   2   3   4   5     ____ 
13.  candied yams     1   2   3   4   5  1   2   3   4   5     ____ 
14.  avocado      1   2   3   4   5  1   2   3   4   5     ____ 
15.  tomato juice or V-8 juice    1   2   3   4   5  1   2   3   4   5     ____ 
16.  butterscotch or vanilla pudding (regular)  1   2   3   4   5  1   2   3   4   5     ____ 
17.  ketchup      1   2   3   4   5  1   2   3   4   5     ____ 
18.  carrot cake with cream cheese frosting   1   2   3   4   5  1   2   3   4   5     ____ 
19.  corn      1   2   3   4   5  1   2   3   4   5     ____ 
20.  turkey sandwich     1   2   3   4   5  1   2   3   4   5     ____ 
 
21.  rice cake      1   2   3   4   5  1   2   3   4   5     ____ 
22.  2% milk      1   2   3   4   5  1   2   3   4   5     ____ 
23.  pretzels      1   2   3   4   5  1   2   3   4   5     ____ 
24.  caramel-coated popcorn (regular)   1   2   3   4   5  1   2   3   4   5     ____ 
25.  taco with shredded beef    1   2   3   4   5  1   2   3   4   5     ____ 
26.  tomato soup      1   2   3   4   5  1   2   3   4   5     ____ 
27.  cappucino or cocoa (low fat)    1   2   3   4   5  1   2   3   4   5     ____ 
28.  chocolate chip cookies    1   2   3   4   5  1   2   3   4   5     ____ 
29.  frozen yogurt     1   2   3   4   5  1   2   3   4   5     ____ 
30.  apple      1   2   3   4   5  1   2   3   4   5     ____ 
 
31.  taco salad      1   2   3   4   5  1   2   3   4   5     ____ 
32.  sushi      1   2   3   4   5  1   2   3   4   5     ____ 
33.  power bar or cereal bar    1   2   3   4   5  1   2   3   4   5     ____ 
34.  skim milk      1   2   3   4   5  1   2   3   4   5     ____ 
35.  soft or semi-soft cheese (e.g., brie, camembert)  1   2   3   4   5  1   2   3   4   5     ____ 
36.  hamburger      1   2   3   4   5  1   2   3   4   5     ____ 
37.  green salad with regular salad dressing   1   2   3   4   5  1   2   3   4   5     ____ 
38.  tea or iced tea     1   2   3   4   5  1   2   3   4   5     ____ 
39.  fudgesicle (low fat)     1   2   3   4   5  1   2   3   4   5     ____ 
40.  cantaloupe or honeydew melon    1   2   3   4   5  1   2   3   4   5     ____ 
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        Food Survey p. 3  ID # _______________ 
 
 
  Frequency:               never             rarely        occasionally       often           very often 
   1                    2                    3                    4                    5 
  Fear/guilt:                none              slight           moderate         strong          very strong 
 
 
          Frequency     Fear/Guilt 
 
41.  milkshake      1   2   3   4   5  1   2   3   4   5     ____ 
42.  cheese lasagna     1   2   3   4   5  1   2   3   4   5     ____ 
43.  muffin (blueberry or cranberry)   1   2   3   4   5  1   2   3   4   5     ____ 
44.  white rice      1   2   3   4   5  1   2   3   4   5     ____ 
45.  omelet made with egg whites or low-fat egg substitute 1   2   3   4   5  1   2   3   4   5     ____ 
46.  dried vegetable chips     1   2   3   4   5  1   2   3   4   5     ____ 
47.  fried calamari     1   2   3   4   5  1   2   3   4   5     ____ 
48.  steak      1   2   3   4   5  1   2   3   4   5     ____ 
49.  tuna sandwich     1   2   3   4   5  1   2   3   4   5     ____ 
50.  cheese/veggie wrap or pita    1   2   3   4   5  1   2   3   4   5     ____ 
 
51.  miso soup      1   2   3   4   5  1   2   3   4   5     ____ 
52.  mixed vegetables with butter sauce   1   2   3   4   5  1   2   3   4   5     ____ 
53.  baked potato      1   2   3   4   5  1   2   3   4   5     ____ 
54.  grapes      1   2   3   4   5  1   2   3   4   5     ____ 
55.  cappucino or cocoa (regular milk)   1   2   3   4   5  1   2   3   4   5     ____ 
56.  fruit juice popsicle     1   2   3   4   5  1   2   3   4   5     ____ 
57.  mustard      1   2   3   4   5  1   2   3   4   5     ____ 
58.  berries with cream, whipped cream, or sour cream 1   2   3   4   5  1   2   3   4   5     ____ 
59.  macaroni salad     1   2   3   4   5  1   2   3   4   5     ____ 
60.  meatless chili and rice     1   2   3   4   5  1   2   3   4   5     ____ 
 
61.  fruit yogurt      1   2   3   4   5  1   2   3   4   5     ____ 
62.  cereal      1   2   3   4   5  1   2   3   4   5     ____  
63.  doughnut      1   2   3   4   5  1   2   3   4   5     ____ 
64.  potato chips (regular)     1   2   3   4   5  1   2   3   4   5     ____ 
65.  plate lunch with teriyaki beef    1   2   3   4   5  1   2   3   4   5     ____ 
66.  asparagus      1   2   3   4   5  1   2   3   4   5     ____ 
67.  french fries      1   2   3   4   5  1   2   3   4   5     ____ 
68.  fruit juice (apple, orange, guava, passion fruit)  1   2   3   4   5  1   2   3   4   5     ____ 
69.  hot fudge sundae     1   2   3   4   5  1   2   3   4   5     ____ 
70.  snack cakes (e.g., Twinkies, HoHos, Ding Dongs) 1   2   3   4   5  1   2   3   4   5     ____ 
 
71.  margarine (regular)     1   2   3   4   5  1   2   3   4   5     ____ 
72.  green salad with vinegar or lemon juice   1   2   3   4   5  1   2   3   4   5     ____ 
73.  grilled mahi burger     1   2   3   4   5  1   2   3   4   5     ____ 
74.  bean burrito      1   2   3   4   5  1   2   3   4   5     ____ 
75.  soy milk or rice dream    1   2   3   4   5  1   2   3   4   5     ____ 
76.  cheese omelet (whole eggs, regular cheese)  1   2   3   4   5  1   2   3   4   5     ____ 
77.  whole wheat bread     1   2   3   4   5  1   2   3   4   5     ____ 
78.  scone      1   2   3   4   5  1   2   3   4   5     ____ 
79.  popcorn (plain, air-popped)    1   2   3   4   5  1   2   3   4   5     ____ 
80.  pastrami or corned beef sandwich   1   2   3   4   5  1   2   3   4   5     ____ 
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        Food Survey p. 4  ID # _______________ 
 
 
  Frequency:              never               rarely      occasionally         often          very often 
   1                    2                    3                    4                    5 
  Fear/guilt:               none                slight          moderate          strong         very strong 
 
          Frequency     Fear/Guilt 
 
 81.  fettucine alfredo     1   2   3   4   5  1   2   3   4   5     ____ 
 82.  green beans      1   2   3   4   5  1   2   3   4   5     ____ 
 83.  mango or papaya     1   2   3   4   5  1   2   3   4   5     ____ 
 84.  protein drink     1   2   3   4   5  1   2   3   4   5     ____ 
 85.  beer      1   2   3   4   5  1   2   3   4   5     ____ 
 86.  brownies      1   2   3   4   5  1   2   3   4   5     ____ 
 87.  tabasco or chili sauce     1   2   3   4   5  1   2   3   4   5     ____ 
 88.  strawberries      1   2   3   4   5  1   2   3   4   5     ____ 
 89.  peas      1   2   3   4   5  1   2   3   4   5     ____ 
 90.  manapua (steamed, with pork filling)   1   2   3   4   5  1   2   3   4   5     ____ 
 
 91.  cottage cheese (low fat)    1   2   3   4   5  1   2   3   4   5     ____ 
 92.  brown rice      1   2   3   4   5  1   2   3   4   5     ____ 
 93.  cinnamon roll     1   2   3   4   5  1   2   3   4   5     ____ 
 94.  crackers (e.g., saltines, soda crackers)   1   2   3   4   5  1   2   3   4   5     ____ 
 95.  turkey (white meat)     1   2   3   4   5  1   2   3   4   5     ____ 
 96.  fried fish      1   2   3   4   5  1   2   3   4   5     ____ 
 97.  spam      1   2   3   4   5  1   2   3   4   5     ____ 
 98.  macaroni and cheese     1   2   3   4   5  1   2   3   4   5     ____ 
 99.  chicken noodle soup     1   2   3   4   5  1   2   3   4   5     ____ 
100.  jello (diet)      1   2   3   4   5  1   2   3   4   5     ____ 
 
101.  fruit smoothie     1   2   3   4   5  1   2   3   4   5     ____ 
102.  hot dog and bun     1   2   3   4   5  1   2   3   4   5     ____ 
103.  sun chips or wheat chips    1   2   3   4   5  1   2   3   4   5     ____ 
104.  trail mix (nuts, sunflower seeds, dried fruit)  1   2   3   4   5  1   2   3   4   5     ____ 
105.  pork or beef chow mein with noodles   1   2   3   4   5  1   2   3   4   5     ____ 
106.  potato salad      1   2   3   4   5  1   2   3   4   5     ____ 
107.  coffee or iced coffee     1   2   3   4   5  1   2   3   4   5     ____ 
108.  oatmeal cookies     1   2   3   4   5  1   2   3   4   5     ____ 
109.  margarine (low fat)     1   2   3   4   5  1   2   3   4   5     ____ 
110.  tofu with vegetables     1   2   3   4   5  1   2   3   4   5     ____ 
 
111.  hard-boiled egg (whole)    1   2   3   4   5  1   2   3   4   5     ____ 
112.  English muffin     1   2   3   4   5  1   2   3   4   5     ____ 
113.  popcorn (regular, buttered)    1   2   3   4   5  1   2   3   4   5     ____ 
114.  shoyu chicken     1   2   3   4   5  1   2   3   4   5     ____ 
115.  kalua pork      1   2   3   4   5  1   2   3   4   5     ____ 
116.  pasta with vegetables and olive oil   1   2   3   4   5  1   2   3   4   5     ____ 
117.  cauliflower      1   2   3   4   5  1   2   3   4   5     ____ 
118.  banana       1   2   3   4   5  1   2   3   4   5     ____ 
119.  ice cream bar (e.g., Dove Bar)   1   2   3   4   5  1   2   3   4   5     ____ 
120.  butter      1   2   3   4   5  1   2   3   4   5     ____ 
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        Food Survey p. 5  ID # _______________ 
 
 
  Frequency:               never              rarely       occasionally        often          very often 
   1                    2                    3                    4                    5 
  Fear/guilt:                none               slight          moderate          strong          very strong 
 
          Frequency     Fear/Guilt 
 
121.  orange      1   2   3   4   5  1   2   3   4   5     ____ 
122.  bean salad      1   2   3   4   5  1   2   3   4   5     ____ 
123.  carrots      1   2   3   4   5  1   2   3   4   5     ____ 
124.  wine      1   2   3   4   5  1   2   3   4   5     ____ 
125.  jello (regular)     1   2   3   4   5  1   2   3   4   5     ____ 
126.  plain yogurt      1   2   3   4   5  1   2   3   4   5     ____ 
127.  cream cheese     1   2   3   4   5  1   2   3   4   5     ____ 
128.  bagel (plain)     1   2   3   4   5  1   2   3   4   5     ____ 
129.  waffle or pancakes with syrup    1   2   3   4   5  1   2   3   4   5     ____ 
130.  nuts (peanuts, macadamias, cashews, pecans)  1   2   3   4   5  1   2   3   4   5     ____ 
 
131.  fried chicken     1   2   3   4   5  1   2   3   4   5     ____ 
132.  Portuguese sausage     1   2   3   4   5  1   2   3   4   5     ____ 
133.  stuffed peppers with rice and tomatoes   1   2   3   4   5  1   2   3   4   5     ____ 
134.  cheese and veggie pizza    1   2   3   4   5  1   2   3   4   5     ____ 
135.  chicken broth     1   2   3   4   5  1   2   3   4   5     ____ 
136.  grilled chicken caesar salad    1   2   3   4   5  1   2   3   4   5     ____ 
137.  Portuguese bean soup    1   2   3   4   5  1   2   3   4   5     ____ 
138.  creamed spinach     1   2   3   4   5  1   2   3   4   5     ____ 
139.  raisins or dried fruit     1   2   3   4   5  1   2   3   4   5     ____ 
140.  Diet Coke or Pepsi     1   2   3   4   5  1   2   3   4   5     ____ 
 
141.  mocha (regular milk, whipped cream)   1   2   3   4   5  1   2   3   4   5     ____ 
142.  shave ice      1   2   3   4   5  1   2   3   4   5     ____ 
143.  malasadas      1   2   3   4   5  1   2   3   4   5     ____ 
144.  premium ice cream (e.g., Ben & Jerry's)  1   2   3   4   5  1   2   3   4   5     ____ 
145.  soy sauce      1   2   3   4   5  1   2   3   4   5     ____ 
146.  sour cream (regular)     1   2   3   4   5  1   2   3   4   5     ____ 
147.  chicken or shrimp stir fry    1   2   3   4   5  1   2   3   4   5     ____ 
148.  crackers (e.g., Ritz, Triscuits)    1   2   3   4   5  1   2   3   4   5     ____ 
149.  cottage cheese (regular)    1   2   3   4   5  1   2   3   4   5     ____ 
150.  whole milk      1   2   3   4   5  1   2   3   4   5     ____ 
 
151.  white bread      1   2   3   4   5  1   2   3   4   5     ____ 
152.  granola bar      1   2   3   4   5  1   2   3   4   5     ____ 
153.  canned tuna (water-packed)    1   2   3   4   5  1   2   3   4   5     ____ 
154.  lean ground beef     1   2   3   4   5  1   2   3   4   5     ____ 
155.  barbecued ribs     1   2   3   4   5  1   2   3   4   5     ____ 
156.  baked potato stuffed with cheese   1   2   3   4   5  1   2   3   4   5     ____ 
157.  peanut butter sandwich    1   2   3   4   5  1   2   3   4   5     ____ 
158.  lima beans      1   2   3   4   5  1   2   3   4   5     ____ 
159.  kahlua and cream     1   2   3   4   5  1   2   3   4   5     ____ 
160.  mayonnaise      1   2   3   4   5  1   2   3   4   5     ____ 
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        Food Survey p. 6  ID # _______________ 
 
 
  Frequency:               never              rarely       occasionally       often             very often 
   1                    2                    3                    4                    5 
  Fear/guilt:                none               slight          moderate         strong            very strong 
 
 
          Frequency     Fear/Guilt 
 
 
161.  low-fat cheese (cheddar, Swiss, Monterey jack)  1   2   3   4   5  1   2   3   4   5     ____ 
162.  muffin (bran)     1   2   3   4   5  1   2   3   4   5     ____ 
163.  broiled fish      1   2   3   4   5  1   2   3   4   5     ____ 
164.  lean roast beef     1   2   3   4   5  1   2   3   4   5     ____ 
165.  ham and cheese sandwich    1   2   3   4   5  1   2   3   4   5     ____ 
166.  vegetable quiche     1   2   3   4   5  1   2   3   4   5     ____ 
167.  nachos with cheese     1   2   3   4   5  1   2   3   4   5     ____ 
168.  New England clam chowder    1   2   3   4   5  1   2   3   4   5     ____ 
169.  onion rings      1   2   3   4   5  1   2   3   4   5     ____ 
170.  low-fat ice cream     1   2   3   4   5  1   2   3   4   5     ____ 
 
171.  candy bar (e.g., Milky Way, Snickers)   1   2   3   4   5  1   2   3   4   5     ____ 
172.  hollandaise or bearnaise sauce   1   2   3   4   5  1   2   3   4   5     ____ 
173.  ham      1   2   3   4   5  1   2   3   4   5     ____ 
174.  broccoli with cheese sauce    1   2   3   4   5  1   2   3   4   5     ____ 
175.  vanilla wafers     1   2   3   4   5  1   2   3   4   5     ____ 
176.  cheesecake      1   2   3   4   5  1   2   3   4   5     ____ 
177.  regular Coke or Pepsi    1   2   3   4   5  1   2   3   4   5     ____ 
178.  corned beef      1   2   3   4   5  1   2   3   4   5     ____ 
179.  turkey frankfurter     1   2   3   4   5  1   2   3   4   5     ____ 
180.  cocktail shrimp     1   2   3   4   5  1   2   3   4   5     ____ 
 
 
Please list and rate below up to 3 foods not noted on this questionnaire 
     that you eat frequently: 
 
 _______________________________________________ 1   2   3   4   5  1   2   3   4   5 
 
 _______________________________________________ 1   2   3   4   5  1   2   3   4   5 
 
 _______________________________________________ 1   2   3   4   5  1   2   3   4   5 
 
Please list and rate below up to 3 foods not noted on this questionnaire 
     list that you fear eating or feel guilty about eating: 
 
 _______________________________________________ 1   2   3   4   5  1   2   3   4   5 
 
 _______________________________________________ 1   2   3   4   5  1   2   3   4   5 
 
 _______________________________________________ 1   2   3   4   5  1   2   3   4   5 
 
 
             
 134 
                ID # _____________ 
FOOD SURVEY: II 
 
 
Please rate each of the foods on the following pages according to how desirable or 
   appealing you find this food.   
 
In this case, we are asking about how much you like the food purely in terms of how much it appeals to 
you, independently from any other considerations about whether you consider the food healthy/ unhealthy, 
safe/dangerous, fattening/slimming, cheap/expensive, easy/difficult, or ethical/unethical. 
 
 
If there were no relationship between this food and health, weight, or any other kinds of 
   considerations, how appealing or desirable would this food be for you? 
 
  1                    2                    3                    4                    5 
      not at all            slightly        moderately    considerably    extremely 
 
              Appeal 
 
 1.  regular cheese (e.g., cheddar, Swiss, Monterey jack)   1   2   3   4   5  ____ 
 2.  oatmeal (plain)       1   2   3   4   5  ____ 
 3.  fried rice        1   2   3   4   5  ____ 
 4.  potato chips (low fat)       1   2   3   4   5  ____ 
 5.  baked chicken breast       1   2   3   4   5  ____ 
 6.  bacon        1   2   3   4   5  ____ 
 7.  grilled chicken sandwich      1   2   3   4   5  ____ 
 8.  spaghetti with meat sauce      1   2   3   4   5  ____ 
 9.  garden burger        1   2   3   4   5  ____ 
10.  tomato or cucumber salad      1   2   3   4   5  ____ 
 
11.  saimin        1   2   3   4   5  ____ 
12.  snow peas (Chinese pea pods)      1   2   3   4   5  ____ 
13.  candied yams       1   2   3   4   5  ____ 
14.  avocado        1   2   3   4   5  ____ 
15.  tomato juice or V-8 juice      1   2   3   4   5  ____ 
16.  butterscotch or vanilla pudding (regular)    1   2   3   4   5  ____ 
17.  ketchup        1   2   3   4   5  ____ 
18.  carrot cake with cream cheese frosting     1   2   3   4   5  ____ 
19.  corn        1   2   3   4   5  ____ 
20.  turkey sandwich       1   2   3   4   5  ____ 
 
21.  rice cake        1   2   3   4   5  ____ 
22.  2% milk        1   2   3   4   5  ____ 
23.  pretzels        1   2   3   4   5  ____ 
24.  caramel-coated popcorn (regular)     1   2   3   4   5  ____ 
25.  taco with shredded beef      1   2   3   4   5  ____ 
26.  tomato soup        1   2   3   4   5  ____ 
27.  cappucino or cocoa (low fat)      1   2   3   4   5  ____ 
28.  chocolate chip cookies      1   2   3   4   5  ____ 
29.  frozen yogurt       1   2   3   4   5  ____ 
30.  apple        1   2   3   4   5  ____ 
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If there were no relationship between this food and health, weight, or any other kinds of considerations, how 
   appealing or desirable would this food be for you? 
 
  1                    2                    3                    4                    5 
           not at all       slightly        moderately    considerably    extremely 
              Appeal 
 
31.  taco salad        1   2   3   4   5  ____ 
32.  sushi        1   2   3   4   5  ____ 
33.  power bar or cereal bar      1   2   3   4   5  ____ 
34.  skim milk        1   2   3   4   5  ____ 
35.  soft or semi-soft cheese (e.g., brie, camembert)    1   2   3   4   5  ____ 
36.  hamburger        1   2   3   4   5  ____ 
37.  green salad with regular salad dressing     1   2   3   4   5  ____ 
38.  tea or iced tea       1   2   3   4   5  ____ 
39.  fudgesicle (low fat)       1   2   3   4   5  ____ 
40.  cantaloupe or honeydew melon      1   2   3   4   5  ____ 
 
41.  milkshake        1   2   3   4   5  ____ 
42.  cheese lasagna       1   2   3   4   5  ____ 
43.  muffin (blueberry or cranberry)     1   2   3   4   5  ____ 
44.  white rice        1   2   3   4   5  ____ 
45.  omelet made with egg whites or low-fat egg substitute   1   2   3   4   5  ____ 
46.  dried vegetable chips       1   2   3   4   5  ____ 
47.  fried calamari       1   2   3   4   5  ____ 
48.  steak        1   2   3   4   5  ____ 
49.  tuna sandwich       1   2   3   4   5  ____ 
50.  cheese/veggie wrap or pita      1   2   3   4   5  ____ 
 
51.  miso soup        1   2   3   4   5  ____ 
52.  mixed vegetables with butter sauce     1   2   3   4   5  ____ 
53.  baked potato        1   2   3   4   5  ____ 
54.  grapes        1   2   3   4   5  ____ 
55.  cappucino or cocoa (regular milk)     1   2   3   4   5  ____ 
56.  fruit juice popsicle       1   2   3   4   5  ____ 
57.  mustard        1   2   3   4   5  ____ 
58.  berries with cream, whipped cream, or sour cream   1   2   3   4   5  ____ 
59.  macaroni salad       1   2   3   4   5  ____ 
60.  meatless chili and rice       1   2   3   4   5  ____ 
 
61.  fruit yogurt        1   2   3   4   5  ____ 
62.  cereal        1   2   3   4   5  ____ 
63.  doughnut        1   2   3   4   5  ____ 
64.  potato chips (regular)       1   2   3   4   5  ____ 
65.  plate lunch with teriyaki beef      1   2   3   4   5  ____ 
66.  asparagus        1   2   3   4   5  ____ 
67.  french fries        1   2   3   4   5  ____ 
68.  fruit juice (apple, orange, guava, passion fruit)    1   2   3   4   5  ____ 
69.  hot fudge sundae       1   2   3   4   5  ____ 
70.  snack cakes (e.g., Twinkies, HoHos, Ding Dongs)   1   2   3   4   5  ____ 
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              Food Survey II p. 3  ID # _______________ 
 
If there were no relationship between this food and health, weight, or any other kinds of considerations, how 
   appealing or desirable would this food be for you? 
 
  1                    2                    3                    4                    5 
      not at all              slightly        moderately    considerably    extremely 
 
              Appeal 
 
 71.  margarine (regular)       1   2   3   4   5  ____ 
 72.  green salad with vinegar or lemon juice     1   2   3   4   5  ____ 
 73.  grilled mahi burger       1   2   3   4   5  ____ 
 74.  bean burrito        1   2   3   4   5  ____ 
 75.  soy milk or rice dream      1   2   3   4   5  ____ 
 76.  cheese omelet (whole eggs, regular cheese)    1   2   3   4   5  ____ 
 77.  whole wheat bread       1   2   3   4   5  ____ 
 78.  scone        1   2   3   4   5  ____ 
 79.  popcorn (plain, air-popped)      1   2   3   4   5  ____ 
 80.  pastrami or corned beef sandwich     1   2   3   4   5  ____ 
 
 81.  fettucine alfredo       1   2   3   4   5  ____ 
 82.  green beans        1   2   3   4   5  ____ 
 83.  mango or papaya       1   2   3   4   5  ____ 
 84.  protein drink       1   2   3   4   5  ____ 
 85.  beer        1   2   3   4   5  ____ 
 86.  brownies        1   2   3   4   5  ____ 
 87.  tabasco or chili sauce       1   2   3   4   5  ____ 
 88.  strawberries        1   2   3   4   5  ____ 
 89.  peas        1   2   3   4   5  ____ 
 90.  manapua (steamed, with pork filling)     1   2   3   4   5  ____ 
 
 91.  cottage cheese (low fat)      1   2   3   4   5  ____ 
 92.  brown rice        1   2   3   4   5  ____ 
 93.  cinnamon roll       1   2   3   4   5  ____ 
 94.  crackers (e.g., saltines, soda crackers)     1   2   3   4   5  ____ 
 95.  turkey (white meat)       1   2   3   4   5  ____ 
 96.  fried fish        1   2   3   4   5  ____ 
 97.  spam        1   2   3   4   5  ____ 
 98.  macaroni and cheese       1   2   3   4   5  ____ 
 99.  chicken noodle soup       1   2   3   4   5  ____ 
100.  jello (diet)        1   2   3   4   5  ____ 
 
101.  fruit smoothie       1   2   3   4   5  ____ 
102.  hot dog and bun       1   2   3   4   5  ____ 
103.  sun chips or wheat chips      1   2   3   4   5  ____ 
104.  trail mix (nuts, sunflower seeds, dried fruit)    1   2   3   4   5  ____ 
105.  pork or beef chow mein with noodles     1   2   3   4   5  ____ 
106.  potato salad        1   2   3   4   5  ____ 
107.  coffee or iced coffee       1   2   3   4   5  ____ 
108.  oatmeal cookies       1   2   3   4   5  ____ 
109.  margarine (low fat)       1   2   3   4   5  ____ 
110.  tofu with vegetables       1   2   3   4   5  ____ 
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              Food Survey II p. 4  ID # _______________ 
 
If there were no relationship between this food and health, weight, or any other kinds of considerations, how 
   appealing or desirable would this food be for you? 
 
  1                    2                    3                    4                    5 
      not at all             slightly      moderately    considerably    extremely 
 
              Appeal 
 
111.  hard-boiled egg (whole)      1   2   3   4   5  ____ 
112.  English muffin       1   2   3   4   5  ____ 
113.  popcorn (regular, buttered)      1   2   3   4   5  ____ 
114.  shoyu chicken       1   2   3   4   5  ____ 
115.  kalua pork        1   2   3   4   5  ____ 
116.  pasta with vegetables and olive oil     1   2   3   4   5  ____ 
117.  cauliflower        1   2   3   4   5  ____ 
118.  banana         1   2   3   4   5  ____ 
119.  ice cream bar (e.g., Dove Bar)     1   2   3   4   5  ____ 
120.  butter        1   2   3   4   5  ____ 
 
121.  orange        1   2   3   4   5  ____ 
122.  bean salad        1   2   3   4   5  ____ 
123.  carrots        1   2   3   4   5  ____ 
124.  wine        1   2   3   4   5  ____ 
125.  jello (regular)       1   2   3   4   5  ____ 
126.  plain yogurt        1   2   3   4   5  ____ 
127.  cream cheese       1   2   3   4   5  ____ 
128.  bagel (plain)       1   2   3   4   5  ____ 
129.  waffle or pancakes with syrup      1   2   3   4   5  ____ 
130.  nuts (peanuts, macadamias, cashews, pecans)    1   2   3   4   5  ____ 
 
131.  fried chicken       1   2   3   4   5  ____ 
132.  Portuguese sausage       1   2   3   4   5  ____ 
133.  stuffed peppers with rice and tomatoes     1   2   3   4   5  ____ 
134.  cheese and veggie pizza      1   2   3   4   5  ____ 
135.  chicken broth       1   2   3   4   5  ____ 
136.  grilled chicken caesar salad      1   2   3   4   5  ____ 
137.  Portuguese bean soup      1   2   3   4   5  ____ 
138.  creamed spinach       1   2   3   4   5  ____ 
139.  raisins or dried fruit       1   2   3   4   5  ____ 
140.  Diet Coke or Pepsi       1   2   3   4   5  ____ 
 
141.  mocha (regular milk, whipped cream)     1   2   3   4   5  ____ 
142.  shave ice        1   2   3   4   5  ____ 
143.  malasadas        1   2   3   4   5  ____ 
144.  premium ice cream (e.g., Ben & Jerry's)    1   2   3   4   5  ____ 
145.  soy sauce        1   2   3   4   5  ____ 
146.  sour cream (regular)       1   2   3   4   5  ____ 
147.  chicken or shrimp stir fry      1   2   3   4   5  ____ 
148.  crackers (e.g., Ritz, Triscuits)      1   2   3   4   5  ____ 
149.  cottage cheese (regular)      1   2   3   4   5  ____ 
150.  whole milk        1   2   3   4   5  ____ 
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              Food Survey II p. 5  ID # _______________ 
 
If there were no relationship between this food and health, weight, or any other kinds of considerations, how 
   appealing or desirable would this food be for you? 
 
  1                    2                    3                    4                    5 
      not at all             slightly      moderately    considerably    extremely 
 
              Appeal 
151.  white bread        1   2   3   4   5  ____ 
152.  granola bar        1   2   3   4   5  ____ 
153.  canned tuna (water-packed)      1   2   3   4   5  ____ 
154.  lean ground beef       1   2   3   4   5  ____ 
155.  barbecued ribs       1   2   3   4   5  ____ 
156.  baked potato stuffed with cheese     1   2   3   4   5  ____ 
157.  peanut butter sandwich      1   2   3   4   5  ____ 
158.  lima beans        1   2   3   4   5  ____ 
159.  kahlua and cream       1   2   3   4   5  ____ 
160.  mayonnaise        1   2   3   4   5  ____ 
 
161.  low-fat cheese (cheddar, Swiss, Monterey jack)    1   2   3   4   5  ____ 
162.  muffin (bran)       1   2   3   4   5  ____ 
163.  broiled fish        1   2   3   4   5  ____ 
164.  lean roast beef       1   2   3   4   5  ____ 
165.  ham and cheese sandwich      1   2   3   4   5  ____ 
166.  vegetable quiche       1   2   3   4   5  ____ 
167.  nachos with cheese       1   2   3   4   5  ____ 
168.  New England clam chowder      1   2   3   4   5  ____ 
169.  onion rings        1   2   3   4   5  ____ 
170.  low-fat ice cream       1   2   3   4   5  ____ 
 
171.  candy bar (e.g., Milky Way, Snickers)     1   2   3   4   5  ____ 
172.  hollandaise or bearnaise sauce     1   2   3   4   5  ____ 
173.  ham        1   2   3   4   5  ____ 
174.  broccoli with cheese sauce      1   2   3   4   5  ____ 
175.  vanilla wafers       1   2   3   4   5  ____ 
176.  cheesecake        1   2   3   4   5  ____ 
177.  regular Coke or Pepsi      1   2   3   4   5  ____ 
178.  corned beef        1   2   3   4   5  ____ 
179.  turkey frankfurter       1   2   3   4   5  ____ 
180.  cocktail shrimp       1   2   3   4   5  ____ 
 
Please list and rate below up to 3 foods not noted on this questionnaire that you find appealing/desirable.  
     Rate each one to indicate how frequently you eat it (1 = never, 5 = very often), how much fear/guilt you feel 
     about eating it (1 = none, 5 = very strong), and how appealing you find it (using the scale above). 
 
        Frequency  Fear/Guilt    Appeal 
 
 ________________________________________ 1  2  3  4  5 1  2  3  4  5 1  2  3  4  5  
 
 ________________________________________ 1  2  3  4  5 1  2  3  4  5 1  2  3  4  5  
 
 ________________________________________ 1  2  3  4  5 1  2  3  4  5 1  2  3  4  5 
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Appendix B: In Vivo Exposure Scenarios Scale 
 
IVESS 
 
The following items describe a number of situations related to eating, weight, and shape. Take a 
minute to read through all the situations on this measure. As you read through each item, please 
try to imagine yourself in that situation as vividly as you can. 
 
After you have read through all the items on this measure, please go back over the items and 
write a number on a scale from 0 – 100 in the box next to each one describing how distressed 
(e.g., anxious, afraid, upset) you think you would be if you were in that situation. A score of 0 
indicates that you would not feel distressed in any way, while a score of 100 indicates that you 
would feel the greatest distress imaginable. 
 
Eating Settings 
Rating of 
Distress 
(0 – 100) 
 
   
1.  Eating in a sit-down restaurant (i.e., where you 
sit down and order food from a waiter) 
 
 
 
 
   
2. Eating in a fast-food restaurant 
 
 
 
 
   
3. Eating in a cafeteria 
 
 
 
 
   
4. Eating in a movie theater  
 
 
 
 
   
5. Eating at a buffet or potluck 
 
 
 
 
   
Social Situations 
Rating of 
Distress 
(0 – 100) 
 
   
6.  Receiving critical comments from someone 
about a meal that you are eating (e.g., “that meal 
has too many carbs in it”) 
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7.  Eating with someone who is making critical 
comments about their meal (e.g., “I shouldn’t be 
eating something with so many calories”) 
 
 
 
 
   
8.  Buying food with someone who criticizes 
what you are purchasing (e.g., “I’d suggest you 
buy something healthier than that”) 
 
 
 
 
   
9.  Declining to eat food that is offered to you 
 
 
 
 
   
Dietary Rules and Rituals 
Rating of 
Distress 
(0 – 100) 
 
   
10. Eating a meal late in the evening (e.g., after 
8:00 p.m.) 
 
 
 
 
   
11. Eating a meal with unknown calorie and 
nutritional properties 
 
 
 
 
   
12. Eating a meal in a limited period of time (e.g., 
less than 30 minutes) 
 
 
 
 
   
13. Eating a meal that was presented to you in an 
unexpected situation  
  
   
14. Eating a meal that is chosen by someone else 
 
 
 
 
   
15. Eating a meal with someone who is not eating 
 
 
 
 
   
16. Eating a meal with someone who is eating 
less than you are eating 
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17. Eating a meal when you are not hungry 
 
 
 
 
   
18. Eating a meal that most people would 
consider large 
 
 
 
 
   
19. Eating a second portion of a meal (i.e., having 
“seconds”) 
 
 
 
 
   
20. Selecting food items from a grocery store 
casually and quickly 
 
 
 
 
   
Body Image Situations 
Rating of 
Distress 
(0 – 100) 
 
   
21. Trying on tight clothing by yourself 
 
 
 
 
   
22.  Trying on tight clothing around others 
 
 
 
 
   
23. Working out at the gym with others 
 
 
 
 
   
24. Being in a bathing suit around others (e.g., at 
a pool, beach, or lake) 
 
 
 
 
   
25. Receiving complimentary comments from 
someone about your weight or shape (e.g., “your 
body looks great!”) 
  
   
26. Receiving critical comments from someone 
about your weight or shape (e.g., “you aren’t as 
in-shape as you used to be”) 
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27. Being with someone who is making 
complimentary comments about their own 
weight or shape (e.g., “I love being so thin!”) 
  
   
28. Being with someone who is making critical 
comments about their own weight or shape (e.g., 
“I hate how fat I’ve become”) 
  
   
29. Looking at yourself in a mirror for an 
extended period of time  
  
   
Other Situations (Write In) 
Rating of 
Distress 
(0 – 100) 
 
   
30.  
 
 
 
 
   
31. 
  
   
32. 
  
   
33. 
  
   
34. 
  
   
35.  
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Appendix C: In Vivo Exposure Feedback Form 
 
Date: __________________ 
 
The following questions ask about your experiences with in vivo exposure sessions as part of 
treatment at the Center for Cognitive Behavior Therapy.  
 
Please answer the following questions on a scale from 1 (strongly disagree) to 7 (strongly 
agree).  
 
1. In vivo exposure sessions added to the effectiveness of therapy (i.e., helped me make more 
progress).  
Strongly 
Disagree   
Neither 
Agree nor 
Disagree   
Strongly 
Agree 
1 2 3 4 5 6 7 
 
 
2. In vivo exposure sessions added to the efficiency of therapy (i.e., helped me make progress 
faster).  
Strongly 
Disagree   
Neither 
Agree nor 
Disagree   
Strongly 
Agree 
1 2 3 4 5 6 7 
 
 
3. Because of in vivo exposure sessions, I am more confident in my ability to handle a variety of 
eating- and/or weight-related situations in the future. 
Strongly 
Disagree   
Neither 
Agree nor 
Disagree   
Strongly 
Agree 
1 2 3 4 5 6 7 
 
 
4. The most helpful in vivo exposure sessions have been the ones that challenged me the most.   
Strongly 
Disagree   
Neither 
Agree nor 
Disagree   
Strongly 
Agree 
1 2 3 4 5 6 7 
 
 
CONTINUE TO BACK SIDE OF FORM 
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Please write your responses to the following open-ended questions.  
 
 
1. What aspects of in vivo exposure sessions have been helpful? 
 
 
 
 
 
 
 
 
 
 
2. What aspects of in vivo exposure sessions have been not useful?  
 
 
 
 
 
 
 
 
 
 
3. What aspects of in vivo exposure sessions have been challenging? 
 
 
 
 
 
 
 
 
 
 
4. Do you think future clients should participate in exposure sessions? Why or why not? 
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Appendix D: CCBT-ED Therapist Checklist 
 
Therapist(s) Name: _______________________     Client ID #: ____________    Date of Session: ____________ 
 
In-Session Weight: ___________ (Write “N/A” if the patient was not weighed this session) 
 
Write in the number of self-reported binge and purge episodes since the last treatment session:  
 
Objective Binge Episodes: ________       Subjective Binge Episodes: _________     Purging Episodes: ________ 
 
Indicate which of the following interventions were implemented during this treatment session. Next to each applied 
intervention, write the letter “C” for those conducted with just the client, “F” for those conducted with just the 
client’s family, and “B” for those conducted with both the client and the family (either in joint or separate sessions). 
 
Psychoeducation and Treatment Rationale 
_____  Binge-eating and purging psychoeducation  
_____  Body image psychoeducation  
_____  Case formulation of eating disorder  
_____  Explaining the basics and advantages of treatment  
_____  Functions of symptoms  
_____  Rationale for CBT  
_____  Regular eating and dieting psychoeducation  
_____  Weight psychoeducation  
_____  Other (specify: _________________________________________________________________________ ) 
 
Enhancing Motivation and Specific Strategic Techniques 
_____  Exploring dissonance between values and behaviors 
_____  Functionality of symptoms 
_____  Projecting into the future 
_____  Pros and cons 
_____  Short-term behavior contract 
_____  Use of analogies  
_____  Other (specify: _________________________________________________________________________ ) 
 
In-Session Weighing 
_____  Eliciting weight prediction before weigh-in and debriefing following weigh-in  
_____  Encouraging client to stop weighing self outside of treatment 
_____  Rationale for assessing body weight and in-session weigh-ins 
_____  Other (specify: _________________________________________________________________________ ) 
 
Self-Monitoring, Meal Planning, and Interrupting the Binge-Purge Cycle 
_____  Delay strategies, distraction techniques, and planning alternative behaviors  
_____  Food records  
_____  Meal planning 
_____  Other (specify: _________________________________________________________________________ ) 
 
Cognitive Interventions Addressing Eating, Weight, and Shape Concerns 
_____  Binge analysis, purge analysis  
_____  Enhancing other domains for self-evaluation  
_____  Identifying dysfunctional thinking patters, cognitive restructuring, and related cognitive interventions for ED  
            concerns 
_____  Problem solving techniques for ED concerns  
_____  Other (specify: _________________________________________________________________________ ) 
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 Behavioral Interventions Addressing Eating, Weight, and Shape Concerns 
_____  Assigning homework related to a recent in vivo exposure session  
_____  Back-translating accurate beliefs related to the ED into behaviors  
_____  Behavioral experiment for ED concerns  
_____  Conducting exposure in session to address body image or other ED concern 
_____  Debriefing about an in vivo exposure session  
_____  Role-playing in session for ED concerns  
_____  Setting up an in vivo exposure session 
_____  Other (specify: 
___________________________________________________________________________________ ) 
 
Cognitive and Behavioral Interventions Addressing Concerns Other Than Eating, Weight, and Shape 
Cognitive and behavioral interventions for:  
_____  academic and/or occupational issues  
_____  anxiety-related issues  
_____  interpersonal/relationship/family issues 
_____  mood-related issues  
_____  self-injury   
_____  other non-ED issue (describe): ______________________________________________________________ 
_____  other non-ED issue (describe): ______________________________________________________________  
_____  other non-ED issue (describe): ______________________________________________________________ 
 
_____  Distress tolerance skills 
_____  Emotion regulation skills 
_____  Mindfulness skills  
_____  Relaxation training 
_____  Sleep hygiene 
_____  Other (specify: _________________________________________________________________________ ) 
 
Relapse Prevention 
_____  Developing a plan to address prospective challenges and setbacks  
_____  Discussing concerns about ending treatment 
_____  Reviewing treatment progress and skills associated with positive outcomes 
_____  Other (specify: _________________________________________________________________________ ) 
 
Of the interventions endorsed above, rank order the top three that you focused on most during this session by 
adding the numbers “1,” “2,” and “3” next to the top three items. 
 
If there was anything notable about this session that could affect the course of treatment, please describe 
below. Also, if the patient is taking medication, write the medication name, dosage, and reported adherence 
below.  
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Appendix E: IVE Form 
 
COMPLETE THIS SIDE DURING GROUP SUPERVISION 
 
Client ID #: _________________          Date IVE Session was Formulated: _________________ 
 
Name of Primary Therapist(s): _______________________________________________ 
 
Specific item(s) that the IVE targets:  
1. ________________________________________________________________________ 
2. ________________________________________________________________________ 
3. ________________________________________________________________________ 
4. ________________________________________________________________________ 
5. ________________________________________________________________________ 
 
Specific item(s) that the IVE may generalize to:  
1. ________________________________________________________________________ 
2. ________________________________________________________________________ 
3. ________________________________________________________________________ 
4. ________________________________________________________________________ 
5. ________________________________________________________________________ 
6. ________________________________________________________________________ 
7. ________________________________________________________________________ 
8. ________________________________________________________________________ 
9. ________________________________________________________________________ 
 
Specific item(s) that the IVE will not likely generalize to:  
1. ________________________________________________________________________ 
2. ________________________________________________________________________ 
3. ________________________________________________________________________ 
4. ________________________________________________________________________ 
5. ________________________________________________________________________ 
6. ________________________________________________________________________ 
7. ________________________________________________________________________ 
8. ________________________________________________________________________ 
9. ________________________________________________________________________ 
 
Decision-making process for this IVE: 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
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COMPLETE THIS SIDE DURING OR IMMEDIATELY AFTER THE IVE SESSION 
 
 
Date of IVE Session: _________________ 
 
Name of IVE Therapist(s): __________________________________________________ 
 
Approximate Length of IVE Session (in minutes): _________________ 
 
Describe the IVE session (e.g., what was planned, what actually happened, what the client ate, 
what you ate, the goals of the session, the client’s prediction of how the session would go, the 
client’s perspective of how it went, etc.): 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
 
 
 
Document the client’s SUDS ratings from this IVE session on a scale from 0 – 100 below: 
 
_____ Sometime before the IVE session (approx. ____ minutes before the session started) 
 
_____ Immediately before the IVE session (approx. ____ minutes before the session started) 
 
_____ During the IVE session (approx. ____ minutes after the session started) 
_____ During the IVE session (approx. ____ minutes after the session started) 
____________________________________________________________________ 
____________________________________________________________________ 
____________________________________________________________________ 
____________________________________________________________________ 
____________________________________________________________________ 
 
 _____ Immediately after the IVE session (which occurred ____ minutes after the session ended) 
 
_____ Sometime after the IVE session (which occurred ____ minutes after the session ended) 
 149 
Appendix F: Study Consent Form 
 
Agreement to Participate  
 
Jamal H. Essayli, Primary Investigator 
(949) 292-3181, jessayli@hawaii.edu 
 
Kelly M. Vitousek, Faculty Advisor 
(808) 956-7326, vitousek@hawaii.edu 
 
You are invited to participate in a research study conducted by Jamal H. Essayli, M.A., as part of 
his program requirements as a graduate student in the Clinical Studies Program at the University 
of Hawai‘i at Mānoa (UHM). The overall purpose of this research is to explore the effectiveness 
of specific elements of treatment in helping people with eating disorders. If you agree to 
participate, you will be asked to fill out some additional questionnaires throughout the course of 
assessment and treatment. These questionnaires will provide information about how you 
experience specific elements of treatment. In particular, the study is interested in learning more 
about how helpful in vivo exposure is for reducing anxiety related to foods and different 
situations related to eating, weight, and shape. The therapist(s) from whom you receive 
individual treatment at the Center for Cognitive Behavior Therapy – Eating Disorders Clinic 
(CCBT-ED) will be responsible for administering these questionnaires. If you choose not to 
participate, you will still be offered standard treatment at the CCBT-ED, which includes 
completing questionnaires and participating in exposure sessions. The main difference for 
individuals who choose to participate is that they will be asked to fill out some additional 
questionnaires throughout treatment. If you have any questions about these questionnaires at any 
time, feel free to talk to your therapist about them. You must be at least 14 years old to 
participate in this study. It is estimated that approximately five individuals receiving treatment at 
the CCBT-ED will participate in this study. 
 
Study Procedures 
Your participation in this study will last for up to one year while you are receiving treatment at 
the CCBT-ED. If you agree to participate, your therapist will give you the additional 
questionnaires related to the study approximately once every six weeks, which are estimated to 
take a total of ten minutes to complete. Your therapist will also give you a brief questionnaire on 
a more frequent basis at the beginning of treatment sessions, which is estimated to take a total of 
two minutes to complete. These questionnaires will ask you about feared foods and situations 
related to eating, weight, and shape. 
 
Risks 
You may experience distress or discomfort when completing questionnaire items. If you feel 
upset or uncomfortable in any way as a result of completing these questionnaires, please inform 
your therapist. 
 
Benefits 
There are no guaranteed benefits for participating in this study. However, as a result of 
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completing the study’s questionnaires on a regular basis, we might be better able to identify 
foods and situations that are distressing to you and better address these issues in treatment. It is 
also hoped that the results of this study will provide increased knowledge about what aspects of 
treatment are effective, particularly in vivo exposure.  
 
Confidentiality 
Research data will be confidential to the extent allowed by law. Agencies with research 
oversight, such as the UH Committee on Human Studies, have the authority to review research 
data. All research records will be stored in a locked file at the CCBT-ED. Names or other 
identifying information would never be associated with presentations, reports, or articles using 
the data set. 
 
Costs and Compensation 
There will be no financial costs to you for participating in this study.  
 
Voluntary Participation 
Participation in this research project is completely voluntary. You are free to withdraw from 
participation at any time during the duration of the project with no penalty or loss of benefit to 
which you would otherwise be entitled. If you are provided with treatment services at the CCBT-
ED, these services will in no way be affected by your decision to participate in or withdraw from 
this study. If you are interested in withdrawing from this study at any time, you may do so by 
talking to your CCBT-ED therapist or contacting the primary investigator, Jamal Essayli, at 
jessayli@hawaii.edu or (949) 292-3181. You may also contact the clinical supervisor, Dr. Kelly 
Vitousek, with any questions or concerns at vitousek@hawaii.edu or (808) 956-7326. 
 
Questions about the Study 
If you have any questions regarding this research project, please contact the primary investigator, 
Jamal H. Essayli, at jessayli@hawaii.edu or (949) 292-3181, or the clinical supervisor, Dr. Kelly 
Vitousek, at vitousek@hawaii.edu or (808) 956-7326. 
 
If you have any questions regarding your rights as a research participant, please contact the 
University of Hawaii Human Studies Program at (808) 956-5007. 
 
Participant: 
I have read and understand the above information, and agree to participate in this research 
project.  
 
Name: __________________________       
 (printed)       
 
           __________________________                
 (signature)                             
 
Date: ___________________________   
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Appendix G: Study Consent Form – Parent Version 
 
Agreement to Participate 
 
Jamal H. Essayli, Primary Investigator 
(949) 292-3181, jessayli@hawaii.edu 
 
Kelly M. Vitousek, Faculty Advisor 
(808) 956-7326, vitousek@hawaii.edu 
 
Your child has been invited to participate in a research study conducted by Jamal H. Essayli, 
M.A., as part of his program requirements as a graduate student in the Clinical Studies Program 
at the University of Hawai‘i at Mānoa (UHM). The overall purpose of this research is to explore 
the effectiveness of specific elements of treatment in helping people with eating disorders. If you 
agree to your child’s participation, he or she will be asked to fill out some additional 
questionnaires throughout the course of assessment and treatment. These questionnaires will 
provide information about how your child experience specific elements of treatment. In 
particular, the study is interested in learning more about how helpful in vivo exposure is for 
reducing anxiety related to foods and different situations related to eating, weight, and shape. 
The therapist(s) from whom your child receives individual treatment at the Center for Cognitive 
Behavior Therapy – Eating Disorders Clinic (CCBT-ED) will be responsible for administering 
these questionnaires. If you do not want your child to participate, he or she will still be offered 
standard treatment at the CCBT-ED, which includes completing questionnaires and participating 
in exposure sessions. The main difference for individuals who choose to participate is that they 
will be asked to fill out additional questionnaires throughout treatment. If your child has any 
questions about these questionnaires at any time, he or she should feel free to talk to his or her 
therapist about them. Your child must be at least 14 years old to participate in this study. It is 
estimated that approximately five individuals receiving treatment at the CCBT-ED will 
participate in this study. 
 
Study Procedures 
Your child’s participation in this study will last for up to one year while he or she is receiving 
treatment at the CCBT-ED. If you agree to your child’s participation, your child’s therapist will 
give him or her the additional questionnaires related to the study approximately once every six 
weeks, which are estimated to take a total of ten minutes to complete. Your therapist will also 
give your child a brief questionnaire on a more frequent basis at the beginning of treatment 
sessions, which is estimated to take a total of two minutes to complete. These questionnaires will 
ask your child about feared foods and situations related to eating, weight, and shape. 
 
Risks 
Your child may experience distress or discomfort when completing questionnaire items. If your 
child feels upset or uncomfortable in any way as a result of completing these questionnaires, he 
or she should inform the therapist. 
 
Benefits 
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There are no guaranteed benefits for participating in this study. However, as a result of 
completing the study’s questionnaires on a regular basis, we might be better able to identify 
foods and situations that are distressing to your child and better address these issues in treatment. 
It is also hoped that the results of this study will provide increased knowledge about what aspects 
of treatment are effective, particularly in vivo exposure.  
 
Confidentiality 
Research data will be confidential to the extent allowed by law. Agencies with research 
oversight, such as the UH Committee on Human Studies, have the authority to review research 
data. All research records will be stored in a locked file at the CCBT-ED. Names or other 
identifying information would never be associated with presentations, reports, or articles using 
the data set. 
 
Costs and Compensation 
There will be no financial costs to you or your child for participating in this study.  
 
Voluntary Participation 
Participation in this research project is completely voluntary. You may withdraw your child from 
participation at any time during the duration of the project with no penalty or loss of benefit to 
which you or your child would otherwise be entitled. If your child is provided with treatment 
services at the CCBT-ED, these services will in no way be affected by the decision to participate 
in or withdraw from this study. If you are interested in withdrawing your child from this study at 
any time, you may do so by talking to your child’s CCBT-ED therapist or contacting the primary 
investigator, Jamal Essayli, at jessayli@hawaii.edu or (949) 292-3181. You may also contact the 
clinical supervisor, Dr. Kelly Vitousek, with any questions or concerns at vitousek@hawaii.edu 
or (808) 956-7326. 
 
Questions about the Study 
If you have any questions regarding this research project, please contact the primary investigator, 
Jamal H. Essayli, at jessayli@hawaii.edu or (949) 292-3181, or the clinical supervisor, Dr. Kelly 
Vitousek, at vitousek@hawaii.edu or (808) 956-7326. 
 
If you have any questions regarding you child’s rights as a research participant, please contact 
the University of Hawaii Human Studies Program at (808) 956-5007. 
 
Participant’s Legal Guardian: 
I have read and understand the above information, and agree to my child’s participation in this 
research project. 
 
Legal Guardian/Parent’s Name: __________________________       
                    (printed)                
                               __________________________               
                   (signature) 
                              
                       Date: ___________________________   
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Appendix H: Study Assent Form 
 
Agreement to Participate 
 
Jamal H. Essayli, Primary Investigator 
(949) 292-3181, jessayli@hawaii.edu 
 
Kelly M. Vitousek, Faculty Advisor 
(808) 956-7326, vitousek@hawaii.edu 
 
You are invited to participate in a research study. The overall purpose of this research is to 
explore the effectiveness of specific elements of treatment in helping people with eating 
disorders. If you agree to participate, you will be asked to fill out some additional questionnaires 
throughout the course of assessment and treatment. These questionnaires will provide 
information about how you experience specific elements of treatment. In particular, the study is 
interested in learning more about how helpful in vivo exposure is for reducing anxiety related to 
foods and different situations related to eating, weight, and shape. The therapist(s) from whom 
you receive individual treatment at the Center for Cognitive Behavior Therapy – Eating 
Disorders Clinic (CCBT-ED) will be responsible for administering these questionnaires. If you 
choose not to participate, you will still be offered standard treatment at the CCBT-ED, which 
includes completing questionnaires and participating in exposure sessions. The main difference 
for individuals who choose to participate is that they will be asked to fill out some additional 
questionnaires throughout treatment. If you have any questions about these questionnaires at any 
time, feel free to talk to your therapist about them. You must be at least 14 years old to 
participate in this study.  
 
Study Procedures 
Your participation in this study will last for up to one year while you are receiving treatment at 
the CCBT-ED. If you agree to participate, your therapist will give you the additional 
questionnaires related to the study approximately once every six weeks, which are estimated to 
take a total of ten minutes to complete. Your therapist will also give you a brief questionnaire on 
a more frequent basis at the beginning of treatment sessions, which is estimated to take a total of 
two minutes to complete. These questionnaires will ask you about feared foods and situations 
related to eating, weight, and shape. 
 
Risks 
You may experience distress or discomfort when completing questionnaire items. If you feel 
upset or uncomfortable in any way as a result of completing these questionnaires, please inform 
your therapist. 
 
Benefits 
There are no guaranteed benefits for participating in this study. However, as a result of 
completing the study’s questionnaires on a regular basis, we might be better able to identify 
foods and situations that are distressing to you and better address these issues in treatment. It is 
also hoped that the results of this study will provide increased knowledge about what aspects of 
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treatment are effective, particularly in vivo exposure.  
 
Confidentiality 
Research data will be confidential to the extent allowed by law. Agencies with research 
oversight, such as the UH Committee on Human Studies, have the authority to review research 
data. All research records will be stored in a locked file at the CCBT-ED. Names or other 
identifying information would never be associated with presentations, reports, or articles using 
the data set. 
 
Voluntary Participation 
Participation in this research project is completely voluntary. You are free to withdraw from 
participation at any time during the duration of the project with no penalty or loss of benefit to 
which you would otherwise be entitled. If you are provided with treatment services at the CCBT-
ED, these services will in no way be affected by your decision to participate in or withdraw from 
this study. If you are interested in withdrawing from this study at any time, you may do so by 
talking to your CCBT-ED therapist or contacting the primary investigator, Jamal Essayli, at 
jessayli@hawaii.edu or (949) 292-3181. You may also contact the clinical supervisor, Dr. Kelly 
Vitousek, with any questions or concerns at vitousek@hawaii.edu or (808) 956-7326. 
 
Questions about the Study 
If you have any questions regarding this research project, please contact the primary investigator, 
Jamal H. Essayli, at jessayli@hawaii.edu or (949) 292-3181, or the clinical supervisor, Dr. Kelly 
Vitousek, at vitousek@hawaii.edu or (808) 956-7326. 
 
If you have any questions regarding your rights as a research participant, please contact the 
University of Hawaii Human Studies Program at (808) 956-5007. 
 
 
Participant: 
I have read and understand the above information, and agree to participate in this research 
project.  
 
 
Name: __________________________       
 (printed)      
 
 
           __________________________              
 (signature)     
 
 
Date: ___________________________    
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Appendix I: Short Food Hierarchy 
 
Date:	  ______________________	   	   	   	   	   	   	   	  
Distress	  
Write	  a	  number	  on	  a	  scale	  from	  0	  (no	  distress)	  –	  100	  (most	  distress	  imaginable)	  describing	  how	  
distressed	  you	  would	  be	  to	  eat	  each	  of	  the	  foods	  below.	  Note	  that	  higher	  scores	  indicate	  more	  
distress.	  
	  
Lasagna 85 
Avocado 70 
Regular buttered popcorn 80 
Cheesecake 100 
Bagel with cream cheese 90 
  
 
 
Self-­‐Efficacy	  
Write	  a	  number	  on	  a	  scale	  from	  0	  (highly	  uncertain)	  –	  100	  (completely	  certain)	  describing	  how	  
certain	  you	  are	  that	  you	  can	  handle	  eating	  each	  of	  the	  foods	  below.	  Note	  that	  higher	  scores	  
indicate	  greater	  certainty	  in	  your	  ability	  to	  handle	  eating	  these	  foods.	  	  
	  
Lasagna 45 
Avocado 70 
Regular buttered popcorn 50 
Cheesecake 0 
Bagel with cream cheese 10 
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Appendix J: Short Scenario Hierarchy 
Date:	  ______________________	  
Distress	  
Write	  a	  number	  on	  a	  scale	  from	  0	  (no	  distress)	  –	  100	  (most	  distress	  imaginable)	  describing	  how	  
distressed	  you	  imagine	  yourself	  to	  be	  in	  each	  of	  the	  situations	  below.	  Note	  that	  higher	  scores	  
indicate	  more	  distress.	  
	  
Eating in a fast-food restaurant 65 
Eating a meal with someone who is eating less than you and bragging about 
how little they are eating 100 
Working out at a gym with someone who makes critical comments about your 
weight or shape 
95 
Eating a meal with unknown calorie and nutritional information 85 
Trying on clothes that are too small in a department store 80 
  
 
 
Self-­‐Efficacy	  
Write	  a	  number	  on	  a	  scale	  from	  0	  (highly	  uncertain)	  –	  100	  (completely	  certain)	  describing	  how	  
certain	  you	  are	  that	  you	  can	  handle	  each	  of	  the	  situations	  below.	  Note	  that	  higher	  scores	  
indicate	  greater	  certainty	  in	  your	  ability	  to	  handle	  these	  situations.	  	  
	  
Eating in a fast-food restaurant 60 
Eating a meal with someone who is eating less than you and bragging about 
how little they are eating 
0 
Working out at a gym with someone who makes critical comments about your 
weight or shape 5 
Eating a meal with unknown calorie and nutritional information 10 
Trying on clothes that are too small in a department store 20 
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